Elliott CG, Goldhaber SZ, Visani L, DeRosa M
Chest radiographs in acute pulmonary embolism. Results from the International Cooperative Pulmonary Embolism Registry. Chest. 2000 Jul; 118(1):33-8.
Chest radiographs in acute pulmonary embolism. Results from the International Cooperative Pulmonary Embolism Registry.
Bassand JP, Accetta G, Al Mahmeed W, Corbalan R, Eikelboom J, Fitzmaurice DA, Fox KAA, Gao H, Goldhaber SZ, Goto S, Haas S, Kayani G, Pieper K, Turpie AGG, van Eickels M, Verheugt FWA, Kakkar AK
Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation. PLoS One. 2018; 13(1):e0191592.
Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation.
Diagnosis of deep venous thrombosis. Clin Cornerstone. 2000; 2(4):29-37.
Upper-extremity deep vein thrombosis. Circulation. 2002 Oct 01; 106(14):1874-80.
Dunn KL, Wolf JP, Dorfman DM, Fitzpatrick P, Baker JL, Goldhaber SZ
Journal of the American College of Cardiology
Normal D-dimer levels in emergency department patients suspected of acute pulmonary embolism. J Am Coll Cardiol. 2002 Oct 16; 40(8):1475-8.
Normal D-dimer levels in emergency department patients suspected of acute pulmonary embolism.
Molecular Genetics and Gene Therapy of Cardiovascular Diseases, edited by Stephen C. Mockrin
Molecular Genetics and Gene Therapy of Cardiovascular Diseases, edited by Stephen C. Mockrin. 1996.
Holman BL, Goldhaber SZ, Kirsch CM, Polak JF, Friedman BJ, English RJ, Wynne J
Measurement of infarct size using single photon emission computed tomography and technetium-99m pyrophosphate: a description of the method and comparison with patient prognosis. Am J Cardiol. 1982 Sep; 50(3):503-11.
Measurement of infarct size using single photon emission computed tomography and technetium-99m pyrophosphate: a description of the method and comparison with patient prognosis.
Goldhaber SZ, Newell JB, Alpert NM, Andrews E, Pohost GM, Ingwall JS
Effects of ischemic-like insult on myocardial thallium-201 accumulation. Circulation. 1983 Apr; 67(4):778-86.
Effects of ischemic-like insult on myocardial thallium-201 accumulation.
Pearson SD, Polak JL, Cartwright S, McCabe-Hassan S, Lee TH, Goldhaber SZ
A critical pathway to evaluate suspected deep vein thrombosis. Arch Intern Med. 1995 Sep 11; 155(16):1773-8.
A critical pathway to evaluate suspected deep vein thrombosis.
Thrombolytic therapy in venous thromboembolism. Clinical trials and current indications. Clin Chest Med. 1995 Jun; 16(2):307-20.
Thrombolytic therapy in venous thromboembolism. Clinical trials and current indications.
Tamoxifen: preventing breast cancer and placing the risk of deep vein thrombosis in perspective. Circulation. 2005 Feb 08; 111(5):539-41.
Tamoxifen: preventing breast cancer and placing the risk of deep vein thrombosis in perspective.
Clinical advances in hematology & oncology : H&O
Long term anticoagulation of idiopathic venous thromboembolism: do we have the answers? Clin Adv Hematol Oncol. 2003 May; 1(5):276-7.
Long term anticoagulation of idiopathic venous thromboembolism: do we have the answers?
Acute myocardial infarction complicated by pulmonary embolism after thrombolytic therapy: problems in clinical management. Chest. 2005 Nov; 128(5):3572-5.
Acute myocardial infarction complicated by pulmonary embolism after thrombolytic therapy: problems in clinical management.
Kucher N, Rossi E, De Rosa M, Goldhaber SZ
Massive pulmonary embolism. Circulation. 2006 Jan 31; 113(4):577-82.
Gastrointestinal complications of dual antiplatelet therapy. Circulation. 2006 Mar 28; 113(12):e655-8.
Gastrointestinal complications of dual antiplatelet therapy.
Connolly S, Yusuf S, Budaj A, Camm J, Chrolavicius S, Commerford PJ, Flather M, Fox KA, Hart R, Hohnloser S, Joyner C, Pfeffer M, Anand I, Arthur H, Avezum A, Bethala-Sithya M, Blumenthal M, Ceremuzynski L, De Caterina R, Diaz R, Flaker G, Frangin G, Franzosi MG, Gaudin C, Golitsyn S, Goldhaber S, Granger C, Halon D, Hermosillo A, Hunt D, Jansky P, Karatzas N, Keltai M, Lanas F, Lau CP, Le Heuzey JY, Lewis BS, Morais J, Morillo C, Oto A, Paolasso E, Peters RJ, Pfisterer M, Piegas L, Pipillis T, Proste C, Sitkei E, Swedberg K, Synhorst D, Talajic M, Trégou V, Valentin V, van Mieghem W, Weintraub W, Varigos J
Rationale and design of ACTIVE: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events. Am Heart J. 2006 Jun; 151(6):1187-93.
Rationale and design of ACTIVE: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events.
Do take that break. Harv Bus Rev. 2009 May; 87(5):30, 128.
Goldhaber SZ, ed. Atals of Heart Diseases, Volume III, Cardiopulmonary Diseases and Cardiac Tumors,Braunwald E, Series Ed.
Prevention of venous thrombosis. Goldhaber SZ, ed. Atals of Heart Diseases, Volume III, Cardiopulmonary Diseases and Cardiac Tumors,Braunwald E, Series Ed. 1995; 13.1-13.18.
Goldhaber SZ, Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J.
Harrison’s Principles of Internal Medicine
Deep Vein Thrombosis and Pulmonary Embolism. Harrison’s Principles of Internal Medicine. 2008; 1651-1657.
Deep Vein Thrombosis and Pulmonary Embolism
Pharmacoinvasive Therapy in Acute Myocardial Infarction. Edited by Harold L. Dauerman and Burton E. Sobel
Pharmacoinvasive Therapy in Acute Myocardial Infarction. Edited by Harold L. Dauerman and Burton E. Sobel. 2005.
Prevention of pulmonary embolism in patients undergoing urological surgery. American Urological Association. 2004; 23:130-135.
Prevention of pulmonary embolism in patients undergoing urological surgery
Lessons from the International Cooperative Pulmonary Embolism Registry
Lessons from the International Cooperative Pulmonary Embolism Registry. 2000.
Agnelli G, ed., Trombolisi Yearbook 2000
La terapia thrombolitica nell'embolia polmonare. Agnelli G, ed., Trombolisi Yearbook 2000. 2000; 213-244.
La terapia thrombolitica nell'embolia polmonare
Goldhaber SZ, Hennekens CH, Markisz JA, McNeil BJ, Glynn MA, Bettmann MA, Schur PH
The American review of respiratory disease
Low sensitivity of plasma DNA in screening for pulmonary embolism. Am Rev Respir Dis. 1982 Aug; 126(2):360-1.
Low sensitivity of plasma DNA in screening for pulmonary embolism.
Bolus and accelerated thrombolysis. Experimental observations and clinical management of myocardial infarction and pulmonary embolism. Chest. 1995 Apr; 107(4):889-92.
Bolus and accelerated thrombolysis. Experimental observations and clinical management of myocardial infarction and pulmonary embolism.
Two trials of reduced bolus alteplase in the treatment of pulmonary embolism. An overview. Chest. 1994 Sep; 106(3):725-6.
Two trials of reduced bolus alteplase in the treatment of pulmonary embolism. An overview.
Pulmonary embolic disease: diagnosis, pathophysiologic aspects, and treatment with thrombolytic therapy. Curr Probl Cardiol. 1993 Oct; 18(10):587-633.
Pulmonary embolic disease: diagnosis, pathophysiologic aspects, and treatment with thrombolytic therapy.
Agnelli G, Iorio A, Parise P, Goldhaber SZ, Levine MN
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
Fibrinogenolysis and thrombin generation after reduced dose bolus or conventional rt-PA for pulmonary embolism. The Coagulation Project Investigators of the Bolus Alteplase Pulmonary Embolism Group. Blood Coagul Fibrinolysis. 1997 Jun; 8(4):216-22.
Fibrinogenolysis and thrombin generation after reduced dose bolus or conventional rt-PA for pulmonary embolism. The Coagulation Project Investigators of the Bolus Alteplase Pulmonary Embolism Group.
Clinical Neurocardiology, Louis R. Caplan, J. Willis Hurst, and Mark I. Chimowitz
Clinical Neurocardiology, Louis R. Caplan, J. Willis Hurst, and Mark I. Chimowitz. 1999.
Oudkerk M, van Beek EJR, ten Cate JW, eds., Pulmonary Embolism
Thrombolysis for treatment of venous thromboembolism. Oudkerk M, van Beek EJR, ten Cate JW, eds., Pulmonary Embolism. 1999; 364-381.
Thrombolysis for treatment of venous thromboembolism
Anticoagulants underutilized: Study says half of strokes are preventable with better use of anticoagulants
Anticoagulants underutilized: Study says half of strokes are preventable with better use of anticoagulants. 1995.
Kasper DL, Braunwald E, Fauci AS, Hauser Sl, Longo Dl, Jameson JL, ed. Harrison's Principles of Internal Medicine
Pulmonary thromboembolism. Kasper DL, Braunwald E, Fauci AS, Hauser Sl, Longo Dl, Jameson JL, ed. Harrison's Principles of Internal Medicine. 2005; 1561-1565.
Rapidly progressing dyspnea associated with a mass in the right side of the heart. Chest. 1995 Mar; 107(3):866-8.
Rapidly progressing dyspnea associated with a mass in the right side of the heart.
D-dimer and duration of anticoagulation. N Engl J Med. 2007 Jan 25; 356(4):422-3; author reply 423.
D-dimer and duration of anticoagulation.
Ersoy H, Goldhaber SZ, Cai T, Luu T, Rosebrook J, Mulkern R, Rybicki F
Time-resolved MR angiography: a primary screening examination of patients with suspected pulmonary embolism and contraindications to administration of iodinated contrast material. AJR Am J Roentgenol. 2007 May; 188(5):1246-54.
Time-resolved MR angiography: a primary screening examination of patients with suspected pulmonary embolism and contraindications to administration of iodinated contrast material.
Cohen AT, Turpie AG, Leizorovicz A, Olsson CG, Vaitkus PT, Goldhaber SZ
Thromboprophylaxis with dalteparin in medical patients: which patients benefit? Vasc Med. 2007 May; 12(2):123-7.
Thromboprophylaxis with dalteparin in medical patients: which patients benefit?
Hunsaker AR, Zou KH, Poh AC, Trotman-Dickenson B, Jacobson FL, Gill RR, Goldhaber SZ
Routine pelvic and lower extremity CT venography in patients undergoing pulmonary CT angiography. AJR Am J Roentgenol. 2008 Feb; 190(2):322-6.
Routine pelvic and lower extremity CT venography in patients undergoing pulmonary CT angiography.
The Journal of bone and joint surgery. American volume
Complications of heparin therapy after total joint arthroplasty. J Bone Joint Surg Am. 1990 Aug; 72(7):1114.
Complications of heparin therapy after total joint arthroplasty.
Short-term response to thrombolytic therapy in deep venous thrombosis: predictive value of venographic appearance. Radiology. 1992 Aug; 184(2):345-8.
Short-term response to thrombolytic therapy in deep venous thrombosis: predictive value of venographic appearance.
Baroletti S, Labreche M, Niles M, Fanikos J, Goldhaber SZ
Prescription of fondaparinux in hospitalised patients. Thromb Haemost. 2009 Jun; 101(6):1091-4.
Prescription of fondaparinux in hospitalised patients.
Sutedjo JL, Ng RK, Piazza G, Goldhaber SZ
Medicare's new regulations for deep vein thrombosis as a "never event": wise or worrisome? Am J Med. 2009 Nov; 122(11):975-6.
Medicare's new regulations for deep vein thrombosis as a "never event": wise or worrisome?
Gibson CM, Nafee T, Yee MK, Chi G, Korjian S, Daaboul Y, AlKhalfan F, Kerneis M, Goldhaber SZ, Hull R, Hernandez AF, Cohen AT, Harrington RA
Symptomatic event reduction with extended-duration betrixaban in acute medically ill hospitalized patients. Am Heart J. 2018 04; 198:84-90.
Symptomatic event reduction with extended-duration betrixaban in acute medically ill hospitalized patients.
Chi G, Gibson CM, Hernandez AF, Hull RD, Kazmi SHA, Younes A, Walia SS, Pitliya A, Singh A, Kahe F, Kalayci A, Nafee T, Kerneis M, AlKhalfan F, Cohen AT, Harrington RA, Goldhaber SZ
Association of Anemia with Venous Thromboembolism in Acutely Ill Hospitalized Patients: An APEX Trial Substudy. Am J Med. 2018 08; 131(8):972.e1-972.e7.
Association of Anemia with Venous Thromboembolism in Acutely Ill Hospitalized Patients: An APEX Trial Substudy.
Acute pulmonary embolism: part I: epidemiology, pathophysiology, and diagnosis. Circulation. 2003 Dec 02; 108(22):2726-9.
Acute pulmonary embolism: part I: epidemiology, pathophysiology, and diagnosis.
Amorosi SL, Tsilimingras K, Thompson D, Fanikos J, Weinstein MC, Goldhaber SZ
Cost analysis of "bridging therapy" with low-molecular-weight heparin versus unfractionated heparin during temporary interruption of chronic anticoagulation. Am J Cardiol. 2004 Feb 15; 93(4):509-11.
Cost analysis of "bridging therapy" with low-molecular-weight heparin versus unfractionated heparin during temporary interruption of chronic anticoagulation.
Epidemiology of pulmonary embolism. Semin Vasc Med. 2001 Nov; 1(2):139-46.
How chest CT for the diagnosis of pulmonary embolism (PE) has changed my professional life: reflections from a PE doctor. Semin Roentgenol. 2005 Jan; 40(1):8-10.
How chest CT for the diagnosis of pulmonary embolism (PE) has changed my professional life: reflections from a PE doctor.
Ferder NS, Eby CS, Deych E, Harris JK, Ridker PM, Milligan PE, Goldhaber SZ, King CR, Giri T, McLeod HL, Glynn RJ, Gage BF
Journal of thrombosis and haemostasis : JTH
Ability of VKORC1 and CYP2C9 to predict therapeutic warfarin dose during the initial weeks of therapy. J Thromb Haemost. 2010 Jan; 8(1):95-100.
Ability of VKORC1 and CYP2C9 to predict therapeutic warfarin dose during the initial weeks of therapy.
Diagnosis and Management of Pulmonary Embolism. Seminars in Vascular Medicine. 2001; 1:133-252.
Diagnosis and Management of Pulmonary Embolism
New strategies for the evaluation and management of venous thromboembolic disease
New strategies for the evaluation and management of venous thromboembolic disease. 2006.
Goldhaber SZ, Meyerovitz MF, Markis JE, Kim D, Kessler CM, Sharma GV, Vaughan DE, Selwyn AP, Dawley DL, Loscalzo J
Thrombolytic therapy of acute pulmonary embolism: current status and future potential. J Am Coll Cardiol. 1987 Nov; 10(5 Suppl B):96B-104B.
Thrombolytic therapy of acute pulmonary embolism: current status and future potential.
Pulmonary Embolism after shoulder arthroplasty: Don't shrug it off
Pulmonary Embolism after shoulder arthroplasty: Don't shrug it off. 2002.
Carlson KJ, Eisenstat SA, Frigoletto FD, Schiff I, eds. Primary Care of Women
Thromboembolic disease in pregnancy. Carlson KJ, Eisenstat SA, Frigoletto FD, Schiff I, eds. Primary Care of Women. 1995; 375-379.
Pulmonary embolism in hospital practice: Lessons from the International Cooperative Pulmonary Embolism Registry (ICOPER). Cardiologia. 1997; 42(Suppl 3):631-634.
Pulmonary embolism in hospital practice: Lessons from the International Cooperative Pulmonary Embolism Registry (ICOPER)
Agnelli G, ed., Thrombolisi Yearbook 1996
La terapia trombolitica nell'embolia polmonare. Agnelli G, ed., Thrombolisi Yearbook 1996. 1996; 183-209.
La terapia trombolitica nell'embolia polmonare
Peacock AJ, Rubin LJ, eds. Pulmonary Circulation: Diseases and their treatment
Acute Pulmonary Embolism: Treatment. Peacock AJ, Rubin LJ, eds. Pulmonary Circulation: Diseases and their treatment. 2004; 429-439.
Agnelli G, ed. Thrombolisi Yearbook 1994
La terapia throbolitica nell'embolia polmonare. Agnelli G, ed. Thrombolisi Yearbook 1994. 1994; 156-177.
La terapia throbolitica nell'embolia polmonare
Digital subtraction pulmonary angiography: an internist's and radiologist's view. Cardiovascular Intervent Radiol. 1983; 6:239-240.
Digital subtraction pulmonary angiography: an internist's and radiologist's view
Cardiopulmonary Diseases and Cardiac Tumors Volume II in Braunwald E, Series Ed. Atlas of Heart Diseases
Cardiopulmonary Diseases and Cardiac Tumors Volume II in Braunwald E, Series Ed. Atlas of Heart Diseases. 1995.
Michelsen CB, Michaelson M, D'Attellis NP, Wilson MG, Goldhaber SZ
Poss R, et al., eds. Orthopaedic Knowledge Update 3
Perioperative considerations. Poss R, et al., eds. Orthopaedic Knowledge Update 3. 1990; 105-114.
D'Amico AV, Denham JW, Crook J, Chen MH, Goldhaber SZ, Lamb DS, Tai KH, Malone S, Ludgate C, Steigler A, Kantoff PW
The influence of adrogen suppression therapy for prostate cancer on the timing of fatal myocardial infarction. J Clin Ocology. 2007; 25:2420-2425.
The influence of adrogen suppression therapy for prostate cancer on the timing of fatal myocardial infarction
Cancer and venous thromboembolism. Arch Intern Med. 1987 Feb; 147(2):216.
Goldhaber SZ, Pohost GM, Kloner RA, Andrews E, Newell JB, Ingwall JS
Inosine: a protective agent in an organ culture model of myocardial ischemia. Circ Res. 1982 Aug; 51(2):181-8.
Inosine: a protective agent in an organ culture model of myocardial ischemia.
Angioplasty or coronary bypass graft? Lancet. 1993 Mar 06; 341(8845):599-600.
Simons GR, Piwnica-Worms DR, Goldhaber SZ
Ovarian vein thrombosis. Am Heart J. 1993 Sep; 126(3 Pt 1):641-7.
Medicine without frills: a rural hospital in Colombia. Science. 1975 Sep 26; 189(4208):1067-71.
Medicine without frills: a rural hospital in Colombia.
Pharmacomechanical Therapy for Deep-Vein Thrombosis. N Engl J Med. 2018 05 03; 378(18):1752-1753.
Pharmacomechanical Therapy for Deep-Vein Thrombosis.
Glynn RJ, Ridker PM, Goldhaber SZ, Zee RY, Buring JE
Effects of random allocation to vitamin E supplementation on the occurrence of venous thromboembolism: report from the Women's Health Study. Circulation. 2007 Sep 25; 116(13):1497-503.
Effects of random allocation to vitamin E supplementation on the occurrence of venous thromboembolism: report from the Women's Health Study.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Deep-vein thrombosis in the elderly. Clin Appl Thromb Hemost. 2008 Oct; 14(4):393-8.
Tebbe U, Bramlage P, Graf A, Lechleitner P, Bode C, Riess FC, Clemens N, Al-Rawi Y, Konstantinides S, Goldhaber SZ
Desmoteplase in acute massive pulmonary thromboembolism. Thromb Haemost. 2009 Mar; 101(3):557-62.
Desmoteplase in acute massive pulmonary thromboembolism.
Schulman S, Kearon C, Kakkar AK, Mismetti P, Schellong S, Eriksson H, Baanstra D, Schnee J, Goldhaber SZ
Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med. 2009 Dec 10; 361(24):2342-52.
Dabigatran versus warfarin in the treatment of acute venous thromboembolism.
Venous thromboembolism and atherothrombosis: an integrated approach. Circulation. 2010 May 18; 121(19):2146-50.
Venous thromboembolism and atherothrombosis: an integrated approach.
Paradoxical embolism. Circulation. 2010 Nov 09; 122(19):1968-72.
Platz E, Hassanein AH, Shah A, Goldhaber SZ, Solomon SD
Regional right ventricular strain pattern in patients with acute pulmonary embolism. Echocardiography. 2012 Apr; 29(4):464-70.
Regional right ventricular strain pattern in patients with acute pulmonary embolism.
The European respiratory journal. Supplement
Modern treatment of pulmonary embolism. Eur Respir J Suppl. 2002 Feb; 35:22s-27s.
Urokinase versus tissue plasminogen activator in pulmonary embolism. Lancet. 1988 Oct 15; 2(8616):915.
Urokinase versus tissue plasminogen activator in pulmonary embolism.
Kakkar AK, Mueller I, Bassand JP, Fitzmaurice DA, Goldhaber SZ, Goto S, Haas S, Hacke W, Lip GY, Mantovani LG, Verheugt FW, Jamal W, Misselwitz F, Rushton-Smith S, Turpie AG
International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD). Am Heart J. 2012 Jan; 163(1):13-19.e1.
International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD).
Academic emergency medicine : official journal of the Society for Academic Emergency Medicine
The contribution of the subjective component of the Canadian Pulmonary Embolism Score to the overall score in emergency department patients. Acad Emerg Med. 2005 Oct; 12(10):915-20.
The contribution of the subjective component of the Canadian Pulmonary Embolism Score to the overall score in emergency department patients.
Venous thromboembolism in children. Circulation. 2006 Jan 17; 113(2):e12-6.
Chest pain. May H, ed. Emergency Medicine. 1984; 111-127.
Intravascular Ultrasound Imaging in Coronary Artery Disease, edited by Robert J. Siegel
Intravascular Ultrasound Imaging in Coronary Artery Disease, edited by Robert J. Siegel. 1998.
Kabrhel C, Varraso R, Goldhaber SZ, Rimm EB, Camargo CA
Prospective Study of BMI and the Risk of Pulmonary Embolism in Women. Obesity. 2009; in press..
Prospective Study of BMI and the Risk of Pulmonary Embolism in Women
Complications of Coronary Angioplasty, edited by Alexander J. R. Black, H. Vernon Anderson, and Stephen G. Ellis
Complications of Coronary Angioplasty, edited by Alexander J. R. Black, H. Vernon Anderson, and Stephen G. Ellis. 1991.
Goldhaber SZ, Kessler CM, Heit J, Markis JE, Sharma GV, Dawley DL, Meyerovitz MF, Vaughan DE, Parker JA, Come PC
Tissue plasminogen activator and acute pulmonary embolism. J Cell Biochem. 1988 Dec; 38(4):303-12.
Tissue plasminogen activator and acute pulmonary embolism.
Atherosclerosis Cardiovascular Disease, Hemostasis, and Endothelial Function, edited by Robert Boyer Francis, Jr.
Atherosclerosis Cardiovascular Disease, Hemostasis, and Endothelial Function, edited by Robert Boyer Francis, Jr. 1992.
Natriuretic peptides for assessing the prognosis of acute pulmonary embolism. CHEST. 2008; 133:1531-1532.
Natriuretic peptides for assessing the prognosis of acute pulmonary embolism
Lu MT, Cai T, Ersoy H, Whitmore AG, Quiroz R, Goldhaber SZ, Rybicki FJ
Interval increase in right-left ventricular diameter ratios at CT as a predictor of 30-day mortality after acute pulmonary embolism: initial experience. Radiology. 2008 Jan; 246(1):281-7.
Interval increase in right-left ventricular diameter ratios at CT as a predictor of 30-day mortality after acute pulmonary embolism: initial experience.
Cardiology patient pages. Treatment of blood clots. Circulation. 2002 Nov 12; 106(20):e138-40.
Cardiology patient pages. Treatment of blood clots.
Fanikos J, Stevens LA, Labreche M, Piazza G, Catapane E, Novack L, Goldhaber SZ
Adherence to pharmacological thromboprophylaxis orders in hospitalized patients. Am J Med. 2010 Jun; 123(6):536-41.
Adherence to pharmacological thromboprophylaxis orders in hospitalized patients.
Epidemiology and diagnosis of acute pulmonary embolism: theheart.org
Epidemiology and diagnosis of acute pulmonary embolism: theheart.org. 1999.
Agnelli G. Ed., Thrombolysis Yearbook 1994
Thrombolytic therapy in pulmonary embolism. Agnelli G. Ed., Thrombolysis Yearbook 1994. 1994; 151-169.
Thrombolytic therapy in pulmonary embolism
Pulmonary Embolism and Heart Failure. 2001.
Diagnosis and management of venous thromboembolism
Diagnosis and management of venous thromboembolism. 1997.
Heparin-Induced Thrombocytopenia, edited by Theodore E. Warkentin and Andreas Greinacher
Heparin-Induced Thrombocytopenia, edited by Theodore E. Warkentin and Andreas Greinacher. 2000.
Administration of epinephrine by EMT's. N Engl J Med. 2000; 342:822.
Multidetector-row computed tomography in suspected pulmonary embolism. N Engl J Med. 2005; 353:631.
Multidetector-row computed tomography in suspected pulmonary embolism
Crawford MH, ed. Current Diagnosis and Treatment in Cardiology
Pulmonary embolic disease. Crawford MH, ed. Current Diagnosis and Treatment in Cardiology. 2003; 365-381.
Drug Treatment of Hyperlipidemia, edited by Basil M. Rifkind
Drug Treatment of Hyperlipidemia, edited by Basil M. Rifkind. 1991.
Medical education: Harvard reverts to tradition. Science. 1973 Sep 14; 181(4104):1027-32.
Medical education: Harvard reverts to tradition.
Congestive Cardiac Failure: Pathophysiology and Treatment, edited by David B. Barnett, Hubert Pouleur, and Gary S. Francis
Congestive Cardiac Failure: Pathophysiology and Treatment, edited by David B. Barnett, Hubert Pouleur, and Gary S. Francis. 1993.
Cannon CP, O'Gara PT, ed., Critical Pathways in Cardiology
Pulmonary Embolism. Cannon CP, O'Gara PT, ed., Critical Pathways in Cardiology. 2001; 197-203.
Atlas of Heart Disease, Volume III, Cardiopulmonary Diseases and Cardiac Tumors, Braunwald E, Goldhaber SZ, eds
Diagnosis of acute pulmonary embolism. Atlas of Heart Disease, Volume III, Cardiopulmonary Diseases and Cardiac Tumors, Braunwald E, Goldhaber SZ, eds. 1995; 2.1-2.31.
Interventional Cardiology: New Techniques and Strategies for Diagnosis and Treatment, edited by Christopher J. White and Stephen R. Ramee
Interventional Cardiology: New Techniques and Strategies for Diagnosis and Treatment, edited by Christopher J. White and Stephen R. Ramee. 1995.
Cardiotonic Drugs: A Clinical Review, Second Edition, Revised and Expanded, edited by Carl V. Leier
Cardiotonic Drugs: A Clinical Review, Second Edition, Revised and Expanded, edited by Carl V. Leier. 1991.
Verstraete M, Fuster V, Topol EJ, eds., Cardiovascular Thrombosis: Thrombocardiology and Thromboneurology
Treatment of deep venous thrombosis and pulmonary embolism. Verstraete M, Fuster V, Topol EJ, eds., Cardiovascular Thrombosis: Thrombocardiology and Thromboneurology. 1998; 673-682.
Treatment of deep venous thrombosis and pulmonary embolism
Streiff MB, Bockenstedt PL, Cataland SR, Chesney C, Eby C, Fanikos J, Fogarty PF, Gao S, Garcia-Aguilar J, Goldhaber SZ, Hassoun H, Hendrie P, Holmstrom B, Jones KA, Kuderer N, Lee JT, Millenson MM, Neff AT, Ortel TL, Smith JL, Yee GC, Zakarija A
Journal of the National Comprehensive Cancer Network : JNCCN
Venous thromboembolic disease. J Natl Compr Canc Netw. 2011 Jul 01; 9(7):714-77.
Piazza G, Goldhaber SZ, Kroll A, Goldberg RJ, Emery C, Spencer FA
Venous thromboembolism in patients with chronic obstructive pulmonary disease. Am J Med. 2012 Oct; 125(10):1010-8.
Venous thromboembolism in patients with chronic obstructive pulmonary disease.
Preventing DVT in peripherally inserted central catheters. Chest. 2013 Mar; 143(3):589-590.
Preventing DVT in peripherally inserted central catheters.
Thrombolysis and Adjunctive Therapy for Acute Myocardial Infarction, edited by Eric R. Bates
Thrombolysis and Adjunctive Therapy for Acute Myocardial Infarction, edited by Eric R. Bates. 1992.
Cardiopulmonary Physiology in Critical Care, edited by Steven M. Scharf
Cardiopulmonary Physiology in Critical Care, edited by Steven M. Scharf. 1992.
Kucher N, Connolly S, Beckman JA, Cheng LH, Tsilimingras KV, Fanikos J, Goldhaber SZ
International normalized ratio increase before warfarin-associated hemorrhage: brief and subtle. Arch Intern Med. 2004 Oct 25; 164(19):2176-9.
International normalized ratio increase before warfarin-associated hemorrhage: brief and subtle.
Hirsch DR, Reis SE, Polak JF, Donovan BC, Goldhaber SZ
Prolonged bleeding time as a marker of venous clot lysis during streptokinase therapy. Am Heart J. 1991 Oct; 122(4 Pt 1):965-71.
Prolonged bleeding time as a marker of venous clot lysis during streptokinase therapy.
Prevention of venous thromboembolism among hospitalized medical patients. Circulation. 2005 Jan 04; 111(1):e1-3.
Prevention of venous thromboembolism among hospitalized medical patients.
Vaitkus PT, Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Goldhaber SZ
Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients. Thromb Haemost. 2005 Jan; 93(1):76-9.
Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients.
Scridon T, Scridon C, Skali H, Alvarez A, Goldhaber SZ, Solomon SD
Prognostic significance of troponin elevation and right ventricular enlargement in acute pulmonary embolism. Am J Cardiol. 2005 Jul 15; 96(2):303-5.
Prognostic significance of troponin elevation and right ventricular enlargement in acute pulmonary embolism.
American journal of obstetrics and gynecology
Thrombosis during pregnancy and the postpartum period. Am J Obstet Gynecol. 2005 Jul; 193(1):216-9.
Thrombosis during pregnancy and the postpartum period.
Acute pulmonary embolism: part II: treatment and prophylaxis. Circulation. 2006 Jul 18; 114(3):e42-7.
Acute pulmonary embolism: part II: treatment and prophylaxis.
Randomized clinical trials of transdermal nitroglycerin systems for the treatment of angina: a meta-analysis. Am Heart J. 1988 Jul; 116(1 Pt 1):174-80.
Randomized clinical trials of transdermal nitroglycerin systems for the treatment of angina: a meta-analysis.
Thrombolysis in Cardiopulmonary Disease. CHEST. 1990; 97:115S-181S.
Medicine withour frills: a rural hospital in Columbia. Science. 1975; 189:1067-1071.
Medicine withour frills: a rural hospital in Columbia
Sobel BE, Collen D, Grossbard E, eds. Tissue Plasminogen Activator In Thrombolytic Therapy
Tissue plasminogen activators in the treatment of acute pulmonary embolism. Sobel BE, Collen D, Grossbard E, eds. Tissue Plasminogen Activator In Thrombolytic Therapy. 1987; 147-169.
Tissue plasminogen activators in the treatment of acute pulmonary embolism
Agnelli G, ed., Thrombolisi Yearbook 1998
La terapia thrombolitica nell'embolia polmonare. Agnelli G, ed., Thrombolisi Yearbook 1998. 1998; 203-234.
Coronary Thrombolysis in Perspective: Principles Underlying Conjunctive and Adjunctive Therapy, edited by Burton E. Sobel and Desire Collen
Coronary Thrombolysis in Perspective: Principles Underlying Conjunctive and Adjunctive Therapy, edited by Burton E. Sobel and Desire Collen. 1993.
Moser KM, Hull R, Saltzman HA, Dantzker DR, Goldhaber SZ, Greenfield LJ
Recent advances in diagnosis of pulmonary embolism and deep venous thrombosis. Am Rev Respir Dis. 1988 Oct; 138(4):1046-7.
Recent advances in diagnosis of pulmonary embolism and deep venous thrombosis.
Fareed J, Bick RL, Rao G, Goldhaber SZ, Sasahara A, Messmore HL, Happensteadt DA, Nicolaides A
The immunogenic potential of generic version of low-molecular-weight heparins may not be the same as the branded products. Clin Appl Thromb Hemost. 2008 Jan; 14(1):5-7.
The immunogenic potential of generic version of low-molecular-weight heparins may not be the same as the branded products.
Venous Thromboembolism Guidebook: fifth edition. Crit Pathw Cardiol. 2006 Dec; 5(4):211-27.
Venous Thromboembolism Guidebook: fifth edition.
Lu MT, Cai T, Ersoy H, Whitmore AG, Levit NA, Goldhaber SZ, Rybicki FJ
The international journal of cardiovascular imaging
Comparison of ECG-gated versus non-gated CT ventricular measurements in thirty patients with acute pulmonary embolism. Int J Cardiovasc Imaging. 2009 Jan; 25(1):101-7.
Comparison of ECG-gated versus non-gated CT ventricular measurements in thirty patients with acute pulmonary embolism.
Tissue plasminogen activator in acute pulmonary embolism. Chest. 1989 May; 95(5 Suppl):282S-289S.
Tissue plasminogen activator in acute pulmonary embolism.
Piazza G, Fanikos J, Zayaruzny M, Goldhaber SZ
Venous thromboembolic events in hospitalised medical patients. Thromb Haemost. 2009 Sep; 102(3):505-10.
Venous thromboembolic events in hospitalised medical patients.
Nguyen PL, Chen MH, Goldhaber SZ, Martin NE, Beard CJ, Dosoretz DE, Katin MJ, Ross R, Salenius SA, D'Amico AV
Coronary revascularization and mortality in men with congestive heart failure or prior myocardial infarction who receive androgen deprivation. Cancer. 2011 Jan 15; 117(2):406-13.
Coronary revascularization and mortality in men with congestive heart failure or prior myocardial infarction who receive androgen deprivation.
Tapson VF, Sterling K, Jones N, Elder M, Tripathy U, Brower J, Maholic RL, Ross CB, Natarajan K, Fong P, Greenspon L, Tamaddon H, Piracha AR, Engelhardt T, Katopodis J, Marques V, Sharp ASP, Piazza G, Goldhaber SZ
A Randomized Trial of the Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Intermediate-Risk Pulmonary Embolism: The OPTALYSE PE Trial. JACC Cardiovasc Interv. 2018 07 23; 11(14):1401-1410.
A Randomized Trial of the Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Intermediate-Risk Pulmonary Embolism: The OPTALYSE PE Trial.
Heart failure in patients with deep vein thrombosis. Am J Cardiol. 2008 Apr 01; 101(7):1056-9.
Heart failure in patients with deep vein thrombosis.
Piazza G, Nguyen TN, Morrison R, Cios D, Hohlfelder B, Fanikos J, Paterno MD, Goldhaber SZ
Patient education program for venous thromboembolism prevention in hospitalized patients. Am J Med. 2012 Mar; 125(3):258-64.
Patient education program for venous thromboembolism prevention in hospitalized patients.
Fangel MV, Nielsen PB, Larsen TB, Christensen B, Overvad TF, Lip GYH, Goldhaber SZ, Jensen MB
Type 1 versus type 2 diabetes and thromboembolic risk in patients with atrial fibrillation: A Danish nationwide cohort study. Int J Cardiol. 2018 Oct 01; 268:137-142.
Type 1 versus type 2 diabetes and thromboembolic risk in patients with atrial fibrillation: A Danish nationwide cohort study.
Best practice & research. Clinical haematology
Venous thromboembolism: epidemiology and magnitude of the problem. Best Pract Res Clin Haematol. 2012 Sep; 25(3):235-42.
Venous thromboembolism: epidemiology and magnitude of the problem.
Agnelli G, ed., Thrombolisi Yearbook 1997
La terapia thrombolitica nell'embolia polmonare. Agnelli G, ed., Thrombolisi Yearbook 1997. 1997; 185-216.
Pulmonary embolism. Braunwald E, ed., Heart Disease. 1997; 1582-1603.
National Investigators Collaborating on Enoxaparin (NICE-3). Cardiology Scientific Update. 2000.
National Investigators Collaborating on Enoxaparin (NICE-3)
Pulmonary embolism. Cariology Rounds. 1998; 2:1-7.
Epidemiology of pulmonary embolism. Morpurgo M, ed., Pulmonary Embolism. 1994; 9-16.
Tailored management of pulmonary embolism
Tailored management of pulmonary embolism. 2001.
Goldhaber SZ, Ridker PM, ed., Thrombosis and Thromboembolism
Venous thromboembolism: Clinical impact and multifactorial etiology. Goldhaber SZ, Ridker PM, ed., Thrombosis and Thromboembolism. 2002; 211-224.
Venous thromboembolism: Clinical impact and multifactorial etiology
Silent Myocardial Ischemia and Infarction: Third Edition, Peter F. Cohn
Silent Myocardial Ischemia and Infarction: Third Edition, Peter F. Cohn. 1993.
Simons GR, Skibo LK, Polak JF, Creager MA, Klapec-Fay JM, Goldhaber SZ
Utility of leg ultrasonography in suspected symptomatic isolated calf deep venous thrombosis. Am J Med. 1995 Jul; 99(1):43-7.
Utility of leg ultrasonography in suspected symptomatic isolated calf deep venous thrombosis.
Stein PD, Goldhaber SZ, Henry JW, Miller AC
Arterial blood gas analysis in the assessment of suspected acute pulmonary embolism. Chest. 1996 Jan; 109(1):78-81.
Arterial blood gas analysis in the assessment of suspected acute pulmonary embolism.
Silent Myocardial Ischemia and Infarction, Fourth Edition, edited by Peter F. Cohn
Silent Myocardial Ischemia and Infarction, Fourth Edition, edited by Peter F. Cohn. 2000.
Cautionary Notes About Outpatient Treatment of Acute Pulmonary Embolism. Chest. 2018 08; 154(2):233-234.
Cautionary Notes About Outpatient Treatment of Acute Pulmonary Embolism.
Chopard R, Piazza G, Gale SA, Campia U, Albertsen IE, Kim J, Goldhaber SZ
Dementia and Atrial Fibrillation: Pathophysiological Mechanisms and Therapeutic Implications. Am J Med. 2018 12; 131(12):1408-1417.
Dementia and Atrial Fibrillation: Pathophysiological Mechanisms and Therapeutic Implications.
Morganroth J, Parisi A, Pohost GM, eds. Noninvasive Cardiac Imaging
Radionuclide imaging of intracardiac masses. Morganroth J, Parisi A, Pohost GM, eds. Noninvasive Cardiac Imaging. 1983; 349-358.
Radionuclide imaging of intracardiac masses
Pulmonary Embolism and Deep Venous Thrombosis
Pulmonary Embolism and Deep Venous Thrombosis. 1985.
Shortfalls in DVT Prevention: A New York study shows inadequacies; length of stay raises more concerns
Shortfalls in DVT Prevention: A New York study shows inadequacies; length of stay raises more concerns. 1996.
Venous thromboembolism guidebook. Crit Pathw Cardiol. 2002 Mar; 1(1):26-43.
Nursing Home Residents with Venous Thrombosis: A Vulnerable, Fragile and Disenfranchised Population. Thromb Haemost. 2018 09; 118(9):1507-1508.
Nursing Home Residents with Venous Thrombosis: A Vulnerable, Fragile and Disenfranchised Population.
Prevalence of deep venous thrombosis among patients in medical intensive care. JAMA. 1995 Jul 26; 274(4):335-7.
Prevalence of deep venous thrombosis among patients in medical intensive care.
Reduced dose bolus alteplase vs conventional alteplase infusion for pulmonary embolism thrombolysis. An international multicenter randomized trial. The Bolus Alteplase Pulmonary Embolism Group. Chest. 1994 Sep; 106(3):718-24.
Reduced dose bolus alteplase vs conventional alteplase infusion for pulmonary embolism thrombolysis. An international multicenter randomized trial. The Bolus Alteplase Pulmonary Embolism Group.
Goldhaber SZ, Simons GR, Elliott CG, Haire WD, Toltzis R, Blacklow SC, Doolittle MH, Weinberg DS
Quantitative plasma D-dimer levels among patients undergoing pulmonary angiography for suspected pulmonary embolism. JAMA. 1993 Dec 15; 270(23):2819-22.
Quantitative plasma D-dimer levels among patients undergoing pulmonary angiography for suspected pulmonary embolism.
Goldhaber SZ, Polak JF, Feldstein ML, Meyerovitz MF, Creager MA
Efficacy and safety of repeated boluses of urokinase in the treatment of deep venous thrombosis. Am J Cardiol. 1994 Jan 01; 73(1):75-9.
Efficacy and safety of repeated boluses of urokinase in the treatment of deep venous thrombosis.
Wagman LD, Baird MF, Bennett CL, Bockenstedt PL, Cataland SR, Fanikos J, Fogarty PF, Goldhaber SZ, Grover TS, Haire W, Hassoun H, Hutchinson S, Jahanzeb M, Lee J, Linenberger ML, Millenson MM, Ortel TL, Salem R, Smith JL, Streiff MB, Vedantham S
Venous thromboembolic disease. NCCN. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2008 Sep; 6(8):716-53.
Venous thromboembolic disease. NCCN. Clinical practice guidelines in oncology.
Eradication of hospital-acquired venous thromboembolism. Thromb Haemost. 2010 Dec; 104(6):1089-92.
Eradication of hospital-acquired venous thromboembolism.
Piazza G, Nguyen TN, Cios D, Labreche M, Hohlfelder B, Fanikos J, Fiumara K, Goldhaber SZ
Anticoagulation-associated adverse drug events. Am J Med. 2011 Dec; 124(12):1136-42.
Anticoagulation-associated adverse drug events.
Varraso R, Kabrhel C, Goldhaber SZ, Rimm EB, Camargo CA
Prospective study of diet and venous thromboembolism in US women and men. Am J Epidemiol. 2012 Jan 15; 175(2):114-26.
Prospective study of diet and venous thromboembolism in US women and men.
Raja AS, Ip IK, Prevedello LM, Sodickson AD, Farkas C, Zane RD, Hanson R, Goldhaber SZ, Gill RR, Khorasani R
Effect of computerized clinical decision support on the use and yield of CT pulmonary angiography in the emergency department. Radiology. 2012 Feb; 262(2):468-74.
Effect of computerized clinical decision support on the use and yield of CT pulmonary angiography in the emergency department.
Come PC, Kim D, Parker JA, Goldhaber SZ, Braunwald E, Markis JE
Early reversal of right ventricular dysfunction in patients with acute pulmonary embolism after treatment with intravenous tissue plasminogen activator. J Am Coll Cardiol. 1987 Nov; 10(5):971-8.
Early reversal of right ventricular dysfunction in patients with acute pulmonary embolism after treatment with intravenous tissue plasminogen activator.
Exercise and the Heart in Health and Disease, edited by Roy J. Shephard and Henry S. Miller, Jr.
Exercise and the Heart in Health and Disease, edited by Roy J. Shephard and Henry S. Miller, Jr. 1992.
Risks and benefits of hormone replacement therapy
Risks and benefits of hormone replacement therapy. 1998.
ACCP Consensus Committee on Pulmonary Embolism
Opinions regarding the diagnosis and management of venous thromboembolic disease. CHEST. 1998; 113:499-504.
Opinions regarding the diagnosis and management of venous thromboembolic disease
Goldhaber SZ, Libby P, Bonow RO, Mann DL, Zipes DP.
Pulmonary Embolism. Braunwald’s Heart Disease. 2008; 1863-1879.
Koo S, Kucher N, Fanikos J, Goldhaber SZ
A correct evaluation of renal function could decrease bleeding risk in anticoagulated elderly patients-Reply. Arch Intern Med. 2005; 165:349-350.
A correct evaluation of renal function could decrease bleeding risk in anticoagulated elderly patients-Reply
Heparin-induced thrombocytopenia (HIT) happens: The optimal approach to prevention and management. ACCEL Online. 2004; 110:e454-e458.
Heparin-induced thrombocytopenia (HIT) happens: The optimal approach to prevention and management
Venous Thromboembolism Guidebook- Third Edition
Venous Thromboembolism Guidebook- Third Edition. 2006.
Rubin IL, Crocker AC, eds. Developmental Disabilites: Delivery of Medical Care for Children and Adults
Cardiac disorders. Rubin IL, Crocker AC, eds. Developmental Disabilites: Delivery of Medical Care for Children and Adults. 1989; 230-239.
Low-Molecular-Weight Heparins in Prophylaxis and Therapy of Thromboembolic Diseases, edited by Henri Bounameaux
Low-Molecular-Weight Heparins in Prophylaxis and Therapy of Thromboembolic Diseases, edited by Henri Bounameaux. 1994.
St. John Sutton MG, Rutherford JD, eds. Clinical Cardiovascular Imaging
Pulmonary embolism, pulmonary hypertension, and cor pulmonale. St. John Sutton MG, Rutherford JD, eds. Clinical Cardiovascular Imaging. 2004; 339-353.
Pulmonary embolism, pulmonary hypertension, and cor pulmonale
New therapeutic agents in Thrombosis and Thrombolysis. Second Edition edited by Arthur A. Sasahara and Joseph Loscalzo
New therapeutic agents in Thrombosis and Thrombolysis. Second Edition edited by Arthur A. Sasahara and Joseph Loscalzo. 2003.
Recent advances in the diagnosis and treatment of pulmonary thromboembolism. ACC Current Journal Review. 2003; 12:28-32.
Recent advances in the diagnosis and treatment of pulmonary thromboembolism
Stampfer MJ, Goldhaber SZ, Yusuf S, Peto R, Hennekens CH
Effect of intravenous streptokinase on acute myocardial infarction: pooled results from randomized trials. N Engl J Med. 1982 Nov 04; 307(19):1180-2.
Effect of intravenous streptokinase on acute myocardial infarction: pooled results from randomized trials.
Goldhaber SZ, Savage DD, Garrison RJ, Castelli WP, Kannel WB, McNamara PM, Gherardi G, Feinleib M
Risk factors for pulmonary embolism. The Framingham Study. Am J Med. 1983 Jun; 74(6):1023-8.
Risk factors for pulmonary embolism. The Framingham Study.
The Journal of thoracic and cardiovascular surgery
Constrictive pericarditis: a case requiring pericardiectomy following Dressler's postmyocardial infarction syndrome. J Thorac Cardiovasc Surg. 1981 May; 81(5):793-6.
Constrictive pericarditis: a case requiring pericardiectomy following Dressler's postmyocardial infarction syndrome.
The International Cooperative Pulmonary Embolism Registry. Chest. 1995 Aug; 108(2):302-4.
The International Cooperative Pulmonary Embolism Registry.
Pulse-spray thrombolysis: the "careful analysis". Radiology. 1994 Nov; 193(2):320-4.
Pulse-spray thrombolysis: the "careful analysis".
Wolfe MW, Lee RT, Feldstein ML, Parker JA, Come PC, Goldhaber SZ
Prognostic significance of right ventricular hypokinesis and perfusion lung scan defects in pulmonary embolism. Am Heart J. 1994 May; 127(5):1371-5.
Prognostic significance of right ventricular hypokinesis and perfusion lung scan defects in pulmonary embolism.
Stein PD, Sostman HD, Dalen JE, Bailey DL, Bajc M, Goldhaber SZ, Goodman LR, Gottschalk A, Hull RD, Matta F, Pistolesi M, Tapson VF, Weg JG, Wells PS, Woodard PK
Controversies in diagnosis of pulmonary embolism. Clin Appl Thromb Hemost. 2011 Apr; 17(2):140-9.
Controversies in diagnosis of pulmonary embolism.
Piazza G, Goldhaber SZ, Lessard DM, Goldberg RJ, Emery C, Spencer FA
Venous thromboembolism in heart failure: preventable deaths during and after hospitalization. Am J Med. 2011 Mar; 124(3):252-9.
Venous thromboembolism in heart failure: preventable deaths during and after hospitalization.
Pulmonary embolism: risk assessment and management. Eur Heart J. 2012 Dec; 33(24):3014-22.
Pulmonary embolism: risk assessment and management.
Prospective study of BMI and the risk of pulmonary embolism in women. Obesity (Silver Spring). 2009 Nov; 17(11):2040-6.
Harvard heart letter : from Harvard Medical School
Ask the doctor. I am due to have a colonoscopy. My cardiologist told me that I will need to stop taking Coumadin, which I take for atrial fibrillation, a few days before the procedure and get some injections. Is this really necessary? Harv Heart Lett. 2009 Jun; 19(10):8.
Ask the doctor. I am due to have a colonoscopy. My cardiologist told me that I will need to stop taking Coumadin, which I take for atrial fibrillation, a few days before the procedure and get some injections. Is this really necessary?
Kakkar AK, Cohen AT, Tapson VF, Bergmann JF, Goldhaber SZ, Deslandes B, Huang W, Anderson FA
Venous thromboembolism risk and prophylaxis in the acute care hospital setting (ENDORSE survey): findings in surgical patients. Ann Surg. 2010 Feb; 251(2):330-8.
Venous thromboembolism risk and prophylaxis in the acute care hospital setting (ENDORSE survey): findings in surgical patients.
Ask the doctor. My 61-year-old mother plans to take a long plane trip. Her legs usually become swollen when she flies a long distance. Should she wear elastic stockings or take any other precautions so she doesn't develop a blood clot in her legs? Harv Heart Lett. 2011 Oct; 22(2):7.
Ask the doctor. My 61-year-old mother plans to take a long plane trip. Her legs usually become swollen when she flies a long distance. Should she wear elastic stockings or take any other precautions so she doesn't develop a blood clot in her legs?
Pulmonary embolism and deep vein thrombosis. Lancet. 2012 May 12; 379(9828):1835-46.
Pulmonary embolism and deep vein thrombosis.
Plasma D-dimer levels and diagnosis of pulmonary embolism. JAMA. 1994; 271:1404.
Plasma D-dimer levels and diagnosis of pulmonary embolism
Satellite Teleconference. Medical Grand Rounds
Satellite Teleconference. Medical Grand Rounds. 1998.
Pulmonary Embolism: Epidemiology, Pathophysiology, Diagnosis, and Management. CHEST. 1995; 107:1S-57S.
Pulmonary Embolism: Epidemiology, Pathophysiology, Diagnosis, and Management
Pathogenesis and risk factors for deep vein thrombosis
Pathogenesis and risk factors for deep vein thrombosis. 1994.
Colman RW, Marder VJ, Clowes AW, George JN, Goldhaber SZ, eds. Hemostasis and Thrombosis: Basic Prinicples and Clinical Practice
Risk stratification in patients with pulmonary embolism. Colman RW, Marder VJ, Clowes AW, George JN, Goldhaber SZ, eds. Hemostasis and Thrombosis: Basic Prinicples and Clinical Practice. 2006; 1299-1306.
Risk stratification in patients with pulmonary embolism
Optimal strategy for diagnosis and treatment of pulmonary embolism due to right atrial thrombus. Mayo Clin Proc. 1988 Dec; 63(12):1261-4.
Optimal strategy for diagnosis and treatment of pulmonary embolism due to right atrial thrombus.
Cardiovascular Disease in the Elderly. Third Edition edited by Wilbert S. Aronow and Jerome L. Fleg
Cardiovascular Disease in the Elderly. Third Edition edited by Wilbert S. Aronow and Jerome L. Fleg. 2004.
Goldhaber SZ, ed. Prevention of Venous Thromboembolism
Practical aspects of venous thromboembolism prevention: An overview. Goldhaber SZ, ed. Prevention of Venous Thromboembolism. 1993; 129-144.
Practical aspects of venous thromboembolism prevention: An overview
Creager MA, ed. Atlas of Vascular Disease. Braunwald E, series ed.
Deep vein thrombosis, pulmonary embolism, and primary pulmonary hypertension. Creager MA, ed. Atlas of Vascular Disease. Braunwald E, series ed. 2002; 205-227.
Deep vein thrombosis, pulmonary embolism, and primary pulmonary hypertension
Harrison's Prinicples of Internal Medicine
Pulmonary Thromboembolism. Harrison's Prinicples of Internal Medicine. 1998; 1469-1472.
Goldhaber SZ, Nagel JS, Théard M, Levine JD, Sutton MG
Treatment of right atrial thrombus with urokinase. Am Heart J. 1988 Apr; 115(4):894-7.
Treatment of right atrial thrombus with urokinase.
Thrombolytic Therapy in Cardiopulmonary Disease. CHEST. 1991; 99:95S-179S.
Thrombolytic Therapy in Cardiopulmonary Disease
Pulmonary Embolism: Pathways for Diagnosis, Treatment, and Prevention.
Pulmonary Embolism: Pathways for Diagnosis, Treatment, and Prevention. 2007.
Goldhaber SZ, Hirsch DR, MacDougall RC, Polak JF, Creager MA, Cohn LH
Prevention of venous thrombosis after coronary artery bypass surgery (a randomized trial comparing two mechanical prophylaxis strategies). Am J Cardiol. 1995 Nov 15; 76(14):993-6.
Prevention of venous thrombosis after coronary artery bypass surgery (a randomized trial comparing two mechanical prophylaxis strategies).
An obsessive-compulsive neurotic patient in crisis. West J Med. 1977 Aug; 127(2):120-8.
An obsessive-compulsive neurotic patient in crisis.
Chi G, Gibson CM, Liu Y, Hernandez AF, Hull RD, Cohen AT, Harrington RA, Goldhaber SZ
Inverse relationship of serum albumin to the risk of venous thromboembolism among acutely ill hospitalized patients: Analysis from the APEX trial. Am J Hematol. 2019 01; 94(1):21-28.
Inverse relationship of serum albumin to the risk of venous thromboembolism among acutely ill hospitalized patients: Analysis from the APEX trial.
Smilowitz NR, Gupta N, Guo Y, Maldonado TS, Eikelboom JW, Goldhaber SZ, Bangalore S, Berger JS
TH open : companion journal to thrombosis and haemostasis
Trends in Perioperative Venous Thromboembolism Associated with Major Noncardiac Surgery. TH Open. 2017 Jul; 1(2):e82-e91.
Trends in Perioperative Venous Thromboembolism Associated with Major Noncardiac Surgery.
Albertsen IE, Nielsen PB, Søgaard M, Goldhaber SZ, Overvad TF, Rasmussen LH, Larsen TB
Risk of Recurrent Venous Thromboembolism: A Danish Nationwide Cohort Study. Am J Med. 2018 09; 131(9):1067-1074.e4.
Risk of Recurrent Venous Thromboembolism: A Danish Nationwide Cohort Study.
Schoenenberger RA, Pearson SD, Goldhaber SZ, Lee TH
Variation in the management of deep vein thrombosis: implications for the potential impact of a critical pathway. Am J Med. 1996 Mar; 100(3):278-82.
Variation in the management of deep vein thrombosis: implications for the potential impact of a critical pathway.
Joffe HV, Xu R, Johnson FB, Longtine J, Kucher N, Goldhaber SZ
Warfarin dosing and cytochrome P450 2C9 polymorphisms. Thromb Haemost. 2004 Jun; 91(6):1123-8.
Warfarin dosing and cytochrome P450 2C9 polymorphisms.
Thrombolytic therapy in pulmonary embolism. Semin Vasc Med. 2001 Nov; 1(2):213-20.
Joffe HV, Kucher N, Tapson VF, Goldhaber SZ
Upper-extremity deep vein thrombosis: a prospective registry of 592 patients. Circulation. 2004 Sep 21; 110(12):1605-11.
Upper-extremity deep vein thrombosis: a prospective registry of 592 patients.
Kipfmueller F, Quiroz R, Goldhaber SZ, Schoepf UJ, Costello P, Kucher N
Chest CT assessment following thrombolysis or surgical embolectomy for acute pulmonary embolism. Vasc Med. 2005 May; 10(2):85-9.
Chest CT assessment following thrombolysis or surgical embolectomy for acute pulmonary embolism.
Cushman M, Glynn RJ, Goldhaber SZ, Moll S, Bauer KA, Deitcher S, Shrivastava S, Ridker PM
Hormonal factors and risk of recurrent venous thrombosis: the prevention of recurrent venous thromboembolism trial. J Thromb Haemost. 2006 Oct; 4(10):2199-203.
Hormonal factors and risk of recurrent venous thrombosis: the prevention of recurrent venous thromboembolism trial.
Manson JE, Grobbee DE, Stampfer MJ, Taylor JO, Goldhaber SZ, Gaziano JM, Ridker PM, Buring JE, Hennekens CH
Aspirin in the primary prevention of angina pectoris in a randomized trial of United States physicians. Am J Med. 1990 Dec; 89(6):772-6.
Aspirin in the primary prevention of angina pectoris in a randomized trial of United States physicians.
Di Carli MF, Dorbala S, Curillova Z, Kwong RJ, Goldhaber SZ, Rybicki FJ, Hachamovitch R
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
Relationship between CT coronary angiography and stress perfusion imaging in patients with suspected ischemic heart disease assessed by integrated PET-CT imaging. J Nucl Cardiol. 2007 Nov-Dec; 14(6):799-809.
Relationship between CT coronary angiography and stress perfusion imaging in patients with suspected ischemic heart disease assessed by integrated PET-CT imaging.
Baim DS, ed. Grossman's Cardiac Catheterization, Angiography, and Intervention
Pulmonary angiography. Baim DS, ed. Grossman's Cardiac Catheterization, Angiography, and Intervention. 2006; 234-253.
Hull R, Pineo GF, eds., Disorders of Thrombosis
Thrombolytic therapy for venous thromboembolism. Hull R, Pineo GF, eds., Disorders of Thrombosis. 1996; 321-328.
Thrombolytic therapy for venous thromboembolism
Outpatient monitoring of anticoagulation
Outpatient monitoring of anticoagulation. 1994.
Percutaneous mechanical thrombectomy for massive pulmonary embolism: Improve safety and efficacy by sharing information. CCI. 2007; in press.
Percutaneous mechanical thrombectomy for massive pulmonary embolism: Improve safety and efficacy by sharing information
Deep Venous Thrombosis. Cannon CP, O'Gara PT, ed., Critical Pathways in Cardiology. 2001; 191-195.
Electronic alerts to prevent venous thromboembolism- Reply. N Engl J Med. 2005; 352:2349-2350.
Electronic alerts to prevent venous thromboembolism- Reply
Impact of lung scanning on the management of suspected pulmonary embolism. Am Heart J. 1987 Sep; 114(3):669-71.
Impact of lung scanning on the management of suspected pulmonary embolism.
Appalachia: 2 approaches in student summer health projects. Science. 1970 Aug 21; 169(3947):746-50.
Appalachia: 2 approaches in student summer health projects.
Cardiovascular and interventional radiology
Digital subtraction pulmonary angiography--an internist's and radiologist's view. Cardiovasc Intervent Radiol. 1983; 6(4-6):239-40.
Digital subtraction pulmonary angiography--an internist's and radiologist's view.
Periprocedural management of the chronically anticoagulated patient: critical pathways for bridging therapy. Crit Pathw Cardiol. 2003 Jun; 2(2):96-103.
Periprocedural management of the chronically anticoagulated patient: critical pathways for bridging therapy.
Kanter DS, Mikkola KM, Patel SR, Parker JA, Goldhaber SZ
Thrombolytic therapy for pulmonary embolism. Frequency of intracranial hemorrhage and associated risk factors. Chest. 1997 May; 111(5):1241-5.
Thrombolytic therapy for pulmonary embolism. Frequency of intracranial hemorrhage and associated risk factors.
Ridker PM, Miletich JP, Stampfer MJ, Goldhaber SZ, Lindpaintner K, Hennekens CH
Factor V Leiden and risks of recurrent idiopathic venous thromboembolism. Circulation. 1995 Nov 15; 92(10):2800-2.
Factor V Leiden and risks of recurrent idiopathic venous thromboembolism.
Contemporary pulmonary embolism thrombolysis. Chest. 1995 Jan; 107(1 Suppl):45S-51S.
Contemporary pulmonary embolism thrombolysis.
Pulmonary embolism diagnosis: remember the history and physical exam. Thromb Haemost. 2009 Jan; 101(1):7-8.
Pulmonary embolism diagnosis: remember the history and physical exam.
Cardiology patient pages. A patient's guide to taking coumadin/warfarin. Circulation. 2009 Mar 03; 119(8):e220-2.
Cardiology patient pages. A patient's guide to taking coumadin/warfarin.
Ask the doctor. I am 95 years old and recently began treatment for early macular degeneration in one eye. My retinologist said that PreserVision might help protect the other eye. But she cautioned that it contains a large dose of vitamin E, which could cause a bleeding problem with the Coumadin I take because of a mechanical aortic valve. What would you suggest? Harv Heart Lett. 2010 Apr; 20(8):7.
Ask the doctor. I am 95 years old and recently began treatment for early macular degeneration in one eye. My retinologist said that PreserVision might help protect the other eye. But she cautioned that it contains a large dose of vitamin E, which could cause a bleeding problem with the Coumadin I take because of a mechanical aortic valve. What would you suggest?
Diagnosis. Magnetic resonance angiography and venography were sensitive but had poor technical adequacy for diagnosing pulmonary embolism. Ann Intern Med. 2010 Jul 20; 153(2):JC1-12.
Diagnosis. Magnetic resonance angiography and venography were sensitive but had poor technical adequacy for diagnosing pulmonary embolism.
Chronic thromboembolic pulmonary hypertension. N Engl J Med. 2011 Jan 27; 364(4):351-60.
Chronic thromboembolic pulmonary hypertension.
Baroletti S, Hurwitz S, Conti NA, Fanikos J, Piazza G, Goldhaber SZ
Thrombosis in suspected heparin-induced thrombocytopenia occurs more often with high antibody levels. Am J Med. 2012 Jan; 125(1):44-9.
Thrombosis in suspected heparin-induced thrombocytopenia occurs more often with high antibody levels.
Goldhaber SZ, Leizorovicz A, Kakkar AK, Haas SK, Merli G, Knabb RM, Weitz JI
Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients. N Engl J Med. 2011 Dec 08; 365(23):2167-77.
Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients.
What's the "go to" anticoagulant for stroke prevention in atrial fibrillation? Thromb Haemost. 2012 Mar; 107(3):397-8.
What's the "go to" anticoagulant for stroke prevention in atrial fibrillation?
Venous thromboembolism in patients with diabetes mellitus. Am J Med. 2012 Jul; 125(7):709-16.
Venous thromboembolism in patients with diabetes mellitus.
Perspectives on the Harvard Medical School
Perspectives on the Harvard Medical School. 1974; 93 pp..
Pulmonary embolism. Rakel JE, ed. Conn's Current Therapy. 1993; 203-208.
Prevention of venous thromboembolism. Kardiovaskulare Medizin. 2006; 9:102-108.
Goldhaber SZ, Piazza G, Fanikos J, McKean S, Kosowsky J
Barriers to Prevention in DVT/PE: An Integrated Approach
Barriers to Prevention in DVT/PE: An Integrated Approach. 2007.
Individualized Therapy of Hypertension, edited by Norman M. Kaplan and C. Venkata S. Ram
Individualized Therapy of Hypertension, edited by Norman M. Kaplan and C. Venkata S. Ram. 1994.
Antithrombotic therapy in valvular heart disease
Antithrombotic therapy in valvular heart disease. 2007.
Braunwald E, Goldman L, eds. Primary Cardiology
Pulmonary embolism, deep vein thrombosis, and cor pulmonale. Braunwald E, Goldman L, eds. Primary Cardiology. 2003; 673-689.
Pulmonary embolism, deep vein thrombosis, and cor pulmonale
Nakano T, Goldhaber SZ, eds., Pulmonary Embolism
Overview of Pulmonary Embolism. Nakano T, Goldhaber SZ, eds., Pulmonary Embolism. 1999; 3-18.
Time trends in hospital mortality and diagnosis of pulmonary embolism. Am Heart J. 1982 Aug; 104(2 Pt 1):305-6.
Time trends in hospital mortality and diagnosis of pulmonary embolism.
Alveolar-arterial oxygen gradient in the assessment of acute pulmonary embolism. Chest. 1995 Jan; 107(1):139-43.
Alveolar-arterial oxygen gradient in the assessment of acute pulmonary embolism.
Goldhaber SZ, Haire WD, Feldstein ML, Miller M, Toltzis R, Smith JL, Taveira da Silva AM, Come PC, Lee RT, Parker JA
Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet. 1993 Feb 27; 341(8844):507-11.
Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion.
Pearson SD, Lee TH, McCabe-Hassan S, Dorsey JL, Goldhaber SZ
A critical pathway to treat proximal lower-extremity deep vein thrombosis. Am J Med. 1996 Mar; 100(3):283-9.
A critical pathway to treat proximal lower-extremity deep vein thrombosis.
Nass N, McConnell MV, Goldhaber SZ, Chyu S, Solomon SD
Recovery of regional right ventricular function after thrombolysis for pulmonary embolism. Am J Cardiol. 1999 Mar 01; 83(5):804-6, A10.
Recovery of regional right ventricular function after thrombolysis for pulmonary embolism.
Prediction of 30-day mortality after acute pulmonary embolism using interval increase in RV/LV diameter ratio between a negative prior and a positive diagnostic CT -- initial experience. Radiology. 2008; 246:281-287.
Prediction of 30-day mortality after acute pulmonary embolism using interval increase in RV/LV diameter ratio between a negative prior and a positive diagnostic CT -- initial experience
Obesity and Cardiovascular Disease. Edited by Malcolm K. Robinson and Abraham Thomas
Obesity and Cardiovascular Disease. Edited by Malcolm K. Robinson and Abraham Thomas. 2007.
Carlson KJ, Eisenstat SA, Frigoletto FD Jr., Schiff I, ed., Primary Care of Women
Venous thromboemolic disease. Carlson KJ, Eisenstat SA, Frigoletto FD Jr., Schiff I, ed., Primary Care of Women. 2002; 46-48.
Sulodexide in venous disease. J Thromb Haemost. 2019 01; 17(1):31-38.
Serneri GGN, Gensini GF, Abbate R, Frisco D, eds. Thrombosis: An Update
Thrombolysis in pulmonary embolism: State of the art. Serneri GGN, Gensini GF, Abbate R, Frisco D, eds. Thrombosis: An Update. 1992; 581-592.
Thrombolysis in pulmonary embolism: State of the art
Cardiac Remodeling: Mechanisms and Treatment. Edited by Barry Greenberg
Cardiac Remodeling: Mechanisms and Treatment. Edited by Barry Greenberg. 2006.
Agnelli G, ed., Thrombolisi Yearbook 1999
La terapia thrombolitica nell'embolia polmonare. Agnelli G, ed., Thrombolisi Yearbook 1999. 1999; 207-236.
Thromboembolic pulmonary disease. Current Opinion in Cardiology. 1990; 5:672-678.
Satellite Teleconference. Differentiation of Low Molecular Weight Heparins
Satellite Teleconference. Differentiation of Low Molecular Weight Heparins. 1999.
Rutherford JD, ed. Cardiology Core Curriculum
Pulmonary embolism and pulmonary hypertension. Rutherford JD, ed. Cardiology Core Curriculum. 2003; 445-475.
Pulmonary embolism and pulmonary hypertension
Thrombolytic therapy in pulmonary embolism. 1994.
Tributes to Lewis Dexter. Texas Heart Institute Journal. 2001; 28:238.
Venous thromboembolism prophylaxis in medical patients. Thromb Haemost. 1999 Aug; 82(2):899-901.
Venous thromboembolism prophylaxis in medical patients.
Kalayci A, Gibson CM, Chi G, Yee MK, Korjian S, Datta S, Nafee T, Gurin M, Haroian N, Qamar I, Hull RD, Hernandez AF, Cohen AT, Harrington RA, Goldhaber SZ
Asymptomatic Deep Vein Thrombosis is Associated with an Increased Risk of Death: Insights from the APEX Trial. Thromb Haemost. 2018 Dec; 118(12):2046-2052.
Asymptomatic Deep Vein Thrombosis is Associated with an Increased Risk of Death: Insights from the APEX Trial.
Coronary Restenosis: From Genetics to Therapeutics, edited by Giora Z. Feuerstein
Coronary Restenosis: From Genetics to Therapeutics, edited by Giora Z. Feuerstein. 1997.
Goldhaber SZ, Reardon FE, Goulart DT, Rubin IL
Cardiac surgery for adults with mental retardation. Dilemmas in management. Am J Med. 1985 Oct; 79(4):403-6.
Cardiac surgery for adults with mental retardation. Dilemmas in management.
The importance of rapidly treating patients with acute myocardial infarction. Chest. 1995 Mar; 107(3):598-600.
The importance of rapidly treating patients with acute myocardial infarction.
Kandarpa K, Chopra PS, Aruny JE, Polak JF, Donaldson MC, Whittemore AD, Mannick JA, Goldhaber SZ, Meyerovitz MF
Intraarterial thrombolysis of lower extremity occlusions: prospective, randomized comparison of forced periodic infusion and conventional slow continuous infusion. Radiology. 1993 Sep; 188(3):861-7.
Intraarterial thrombolysis of lower extremity occlusions: prospective, randomized comparison of forced periodic infusion and conventional slow continuous infusion.
Evolving concepts in thrombolytic therapy for pulmonary embolism. Chest. 1992 Apr; 101(4 Suppl):183S-185S.
Evolving concepts in thrombolytic therapy for pulmonary embolism.
Implantable Cardioverter-Defibrillators: a Comprehensive Textbook, edited by N.A. Mark Estes III, Antonis S. Manolis, and Paul J. Wang
Implantable Cardioverter-Defibrillators: a Comprehensive Textbook, edited by N.A. Mark Estes III, Antonis S. Manolis, and Paul J. Wang. 1994.
Molecular Biology of Cardiovascular Disease, edited by Andrew R. Marks and Mark B. Taubman
Molecular Biology of Cardiovascular Disease, edited by Andrew R. Marks and Mark B. Taubman. 1997.
Malpractice claims related to PE and DVT.
Malpractice claims related to PE and DVT. 1994.
Low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism: the authors reply. N Engl J Med. 2003; 349:398-400.
Low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism: the authors reply
Goldhaber SZ, Ricker PM, ed., Thrombosis and Thromboembolism
Management of massive pulmonary embolism. Goldhaber SZ, Ricker PM, ed., Thrombosis and Thromboembolism. 2002; 235-245.
Management of massive pulmonary embolism
Plasminogen activator in treatment of acute pulmonary embolism
Plasminogen activator in treatment of acute pulmonary embolism. 1986.
Efficacy of intravenous streptokinase during acute myocardial infarction: Pooled results from randomized trials
Efficacy of intravenous streptokinase during acute myocardial infarction: Pooled results from randomized trials. 1983.
Nicolaides AN, Fareed J, Kakkar AK, Breddin HK, Goldhaber SZ, Hull R, Kakkar VV, Michiels JJ, Myers K, Samama M, Sasahara A, Kalodiki E
Prevention and treatment of venous thromboembolism. International Consensus Statement (guidelines according to scientific evidence). Int Angiol. 2006; 25:101-161.
Prevention and treatment of venous thromboembolism. International Consensus Statement (guidelines according to scientific evidence)
Medical management of venous thromboembolic disease. JVIR. 2000; 11:160-162 (Supplement).
Medical management of venous thromboembolic disease
Intensive Review of Internal Medicine. 1995.
Streiff MB, Holmstrom B, Angelini D, Ashrani A, Bockenstedt PL, Chesney C, Fanikos J, Fenninger RB, Fogerty AE, Gao S, Goldhaber SZ, Gundabolu K, Hendrie P, Lee AI, Lee JT, Mann J, McMahon B, Millenson MM, Morton C, Ortel TL, Ozair S, Paschal R, Shattil S, Siddiqi T, Smock KJ, Soff G, Wang TF, Williams E, Zakarija A, Hammond L, Dwyer MA, Engh AM
NCCN Guidelines Insights: Cancer-Associated Venous Thromboembolic Disease, Version 2.2018. J Natl Compr Canc Netw. 2018 11; 16(11):1289-1303.
NCCN Guidelines Insights: Cancer-Associated Venous Thromboembolic Disease, Version 2.2018.
Chopard R, Piazza G, Hurwitz S, Fanikos J, Goldhaber SZ
Fatal warfarin-associated intracranial hemorrhage in atrial fibrillation inpatients. J Thromb Thrombolysis. 2019 Feb; 47(2):331-335.
Fatal warfarin-associated intracranial hemorrhage in atrial fibrillation inpatients.
Ridker PM, Everett BM, Pradhan A, MacFadyen JG, Solomon DH, Zaharris E, Mam V, Hasan A, Rosenberg Y, Iturriaga E, Gupta M, Tsigoulis M, Verma S, Clearfield M, Libby P, Goldhaber SZ, Seagle R, Ofori C, Saklayen M, Butman S, Singh N, Le May M, Bertrand O, Johnston J, Paynter NP, Glynn RJ
Low-Dose Methotrexate for the Prevention of Atherosclerotic Events. N Engl J Med. 2019 02 21; 380(8):752-762.
Low-Dose Methotrexate for the Prevention of Atherosclerotic Events.
Braunwald E, ed. Essential Atlas of Heart Disease
Pulmonary embolism, pulmonary hypertension, and cardiac tumors. Braunwald E, ed. Essential Atlas of Heart Disease. 2005; 327-344.
Pulmonary embolism, pulmonary hypertension, and cardiac tumors
Cardiac biomarkers for risk stratification of patients with acute pulmonary embolism. Circulation. 2003 Nov 04; 108(18):2191-4.
Cardiac biomarkers for risk stratification of patients with acute pulmonary embolism.
Goldhaber SZ, Buring JE, Lipnick RJ, Hennekens CH
Pooled analyses of randomized trials of streptokinase and heparin in phlebographically documented acute deep venous thrombosis. Am J Med. 1984 Mar; 76(3):393-7.
Pooled analyses of randomized trials of streptokinase and heparin in phlebographically documented acute deep venous thrombosis.
Right ventricular dysfunction after acute pulmonary embolism: pathophysiologic factors, detection, and therapeutic implications. Am Heart J. 1995 Dec; 130(6):1276-82.
Right ventricular dysfunction after acute pulmonary embolism: pathophysiologic factors, detection, and therapeutic implications.
Goldhaber SZ, Lilly LS, Selwyn AP, Nash DT, Collins JJ
Spontaneous remission and prolonged survival in postinfarction cardiomyopathy. Am Heart J. 1986 Aug; 112(2):409-12.
Spontaneous remission and prolonged survival in postinfarction cardiomyopathy.
Thrombolytic therapy for venous thromboembolism. Baillieres Clin Haematol. 1990 Jul; 3(3):693-704.
Piazza G, Rosenbaum EJ, Pendergast W, Jacobson JO, Pendleton RC, McLaren GD, Elliott CG, Stevens SM, Patton WF, Dabbagh O, Paterno MD, Catapane E, Li Z, Goldhaber SZ
Physician alerts to prevent symptomatic venous thromboembolism in hospitalized patients. Circulation. 2009 Apr 28; 119(16):2196-201.
Physician alerts to prevent symptomatic venous thromboembolism in hospitalized patients.
Optimal duration of anticoagulation after venous thromboembolism: fixed and evidence-based, or flexible and personalized? Ann Intern Med. 2009 May 05; 150(9):644-6.
Optimal duration of anticoagulation after venous thromboembolism: fixed and evidence-based, or flexible and personalized?
Calfon M, Seddighzadeh A, Piazza G, Goldhaber SZ
Deep vein thrombosis in orthopedic surgery. Clin Appl Thromb Hemost. 2009 Oct; 15(5):512-6.
Deep vein thrombosis in orthopedic surgery.
Physician alerts to prevent venous thromboembolism. J Thromb Thrombolysis. 2010 Jul; 30(1):1-6.
Physician alerts to prevent venous thromboembolism.
Development of the revised drinking water standard for chromium. Sci Total Environ. 1989 Oct 01; 86(1-2):43-51.
Development of the revised drinking water standard for chromium.
Fibrinolysis for acute pulmonary embolism. Vasc Med. 2010 Oct; 15(5):419-28.
Fibrinolysis for acute pulmonary embolism.
Anderson FA, Goldhaber SZ, Tapson VF, Bergmann JF, Kakkar AK, Deslandes B, Huang W, Cohen AT
Improving Practices in US Hospitals to Prevent Venous Thromboembolism: lessons from ENDORSE. Am J Med. 2010 Dec; 123(12):1099-1106.e8.
Improving Practices in US Hospitals to Prevent Venous Thromboembolism: lessons from ENDORSE.
Atay JK, Fiumara K, Piazza G, Fanikos J, Goldhaber SZ
Hospital budget implications of substituting dabigatran for warfarin in an anticoagulation service. Clin Appl Thromb Hemost. 2012 Mar-Apr; 18(2):181-4.
Hospital budget implications of substituting dabigatran for warfarin in an anticoagulation service.
Bergmann JF, Lloret-Linares C, Rami A, Cohen AT, Garay RP, Kakkar AK, Goldhaber SZ, Deslandes B, Tapson VF, Anderson FA
[Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): results obtained in France]. Presse Med. 2011 Dec; 40(12 Pt 1):e528-37.
[Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): results obtained in France].
Kakkar AK, Cimminiello C, Goldhaber SZ, Parakh R, Wang C, Bergmann JF
Low-molecular-weight heparin and mortality in acutely ill medical patients. N Engl J Med. 2011 Dec 29; 365(26):2463-72.
Low-molecular-weight heparin and mortality in acutely ill medical patients.
Counterpoint: should coagulopathy be repaired prior to central venous line insertion? No. Chest. 2012 May; 141(5):1142-1144.
Counterpoint: should coagulopathy be repaired prior to central venous line insertion? No.
Bikdeli B, Wang Y, Jimenez D, Ross JS, Monreal M, Goldhaber SZ, Krumholz HM
Association of Inferior Vena Cava Filter Use With Mortality Rates in Older Adults With Acute Pulmonary Embolism. JAMA Intern Med. 2019 02 01; 179(2):263-265.
Association of Inferior Vena Cava Filter Use With Mortality Rates in Older Adults With Acute Pulmonary Embolism.
Let's Stop Dichotomizing Venous Thromboembolism as Provoked or Unprovoked. Circulation. 2018 12 04; 138(23):2591-2593.
Let's Stop Dichotomizing Venous Thromboembolism as Provoked or Unprovoked.
Suction catheter embolectomy and other primary treatment strategies in the management of pulmonary embolism. Adv Vasc Surg. 1996; 4:243-251.
Suction catheter embolectomy and other primary treatment strategies in the management of pulmonary embolism
The Pericardium: A Comprehensive Textbook, David H. Spodick
The Pericardium: A Comprehensive Textbook, David H. Spodick. 1997.
Carlson KJ, Eisenstat SA, Frigoletto FD Jr., Schiff I, ed. Primary Care of Women
Venous thromboembolic disease in pregnancy. Carlson KJ, Eisenstat SA, Frigoletto FD Jr., Schiff I, ed. Primary Care of Women. 2002; 550-553.
Venous thromboembolic disease in pregnancy
Crawford MH, ed., Current Diagnosis and Treatment in Cardiology
Pulmonary embolic disease. Crawford MH, ed., Current Diagnosis and Treatment in Cardiology. 1995; 293-302.
Pulmonary embolic disease and primary pulmonary hypertension
Pulmonary embolic disease and primary pulmonary hypertension. 2002.
Heart Failure: A Comprehensive Guide to Diagnosis and Treatment. Edited by G. William
Heart Failure: A Comprehensive Guide to Diagnosis and Treatment. Edited by G. William. 2005.
Prevention of venous thromboembolism. International consensus statement (Guidelines according to scientific evidence). Int Angiol. 1997; 16:3-38.
Prevention of venous thromboembolism. International consensus statement (Guidelines according to scientific evidence)
Cooke JP, Frohlich ED, eds. Current Management of Hypertensive and Vascular Diseases
Deep venous thrombosis. Cooke JP, Frohlich ED, eds. Current Management of Hypertensive and Vascular Diseases. 1992; 285-293.
Goldhaber SZ, ed. Pulmonary Embolism and Deep Venous Thrombosis
Prevention of venous thromboembolism. Goldhaber SZ, ed. Pulmonary Embolism and Deep Venous Thrombosis. 1985; 135-157.
Pediatric Heart Failure. Edited by Robert Shaddy and Gil WErnovsky
Pediatric Heart Failure. Edited by Robert Shaddy and Gil WErnovsky. 2005.
Atrial Fibrillation. Edited by Peter Kowey and Gerald Naccarelli
Atrial Fibrillation. Edited by Peter Kowey and Gerald Naccarelli. 2005.
Bassand JP, Virdone S, Goldhaber SZ, Camm AJ, Fitzmaurice DA, Fox KAA, Goto S, Haas S, Hacke W, Kayani G, Mantovani LG, Misselwitz F, Pieper KS, Turpie AGG, van Eickels M, Verheugt FWA, Kakkar AK
Early Risks of Death, Stroke/Systemic Embolism, and Major Bleeding in Patients With Newly Diagnosed Atrial Fibrillation. Circulation. 2019 02 05; 139(6):787-798.
Early Risks of Death, Stroke/Systemic Embolism, and Major Bleeding in Patients With Newly Diagnosed Atrial Fibrillation.
Comerota AJ, Kearon C, Gu CS, Julian JA, Goldhaber SZ, Kahn SR, Jaff MR, Razavi MK, Kindzelski AL, Bashir R, Patel P, Sharafuddin M, Sichlau MJ, Saad WE, Assi Z, Hofmann LV, Kennedy M, Vedantham S
Endovascular Thrombus Removal for Acute Iliofemoral Deep Vein Thrombosis. Circulation. 2019 02 26; 139(9):1162-1173.
Endovascular Thrombus Removal for Acute Iliofemoral Deep Vein Thrombosis.
Ageno W, Haas S, Weitz JI, Goldhaber SZ, Turpie AGG, Goto S, Angchaisuksiri P, Nielsen JD, Kayani G, Pieper KS, Schellong S, Bounameaux H, Mantovani LG, Prandoni P, Kakkar AK
Characteristics and Management of Patients with Venous Thromboembolism: The GARFIELD-VTE Registry. Thromb Haemost. 2019 Feb; 119(2):319-327.
Characteristics and Management of Patients with Venous Thromboembolism: The GARFIELD-VTE Registry.
CBW: interagency conflicts stall Administration action. Science. 1970 Jul 31; 169(3944):454-6.
CBW: interagency conflicts stall Administration action.
O'Connor GT, Hennekens CH, Willett WC, Goldhaber SZ, Paffenbarger RS, Breslow JL, Lee IM, Buring JE
Physical exercise and reduced risk of nonfatal myocardial infarction. Am J Epidemiol. 1995 Dec 01; 142(11):1147-56.
Physical exercise and reduced risk of nonfatal myocardial infarction.
Kondo NI, Maddi R, Ewenstein BM, Goldhaber SZ
Anticoagulation and hemostasis in cardiac surgical patients. J Card Surg. 1994 Jul; 9(4):443-61.
Anticoagulation and hemostasis in cardiac surgical patients.
Heart disease and stroke : a journal for primary care physicians
Recognition and management of pulmonary embolism. Heart Dis Stroke. 1993 Mar-Apr; 2(2):142-6.
Recognition and management of pulmonary embolism.
Deep Venous Thrombosis: Early Discharge Strategies and Outpatient Management. J Thromb Thrombolysis. 1997; 4(3/4):365-374.
Deep Venous Thrombosis: Early Discharge Strategies and Outpatient Management.
Berl T, Hunsicker LG, Lewis JB, Pfeffer MA, Porush JG, Rouleau JL, Drury PL, Esmatjes E, Hricik D, Parikh CR, Raz I, Vanhille P, Wiegmann TB, Wolfe BM, Locatelli F, Goldhaber SZ, Lewis EJ
Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy. Ann Intern Med. 2003 Apr 01; 138(7):542-9.
Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy.
Kucher N, Castellanos LR, Quiroz R, Koo S, Fanikos J, Goldhaber SZ
Time trends in warfarin-associated hemorrhage. Am J Cardiol. 2004 Aug 01; 94(3):403-6.
Time trends in warfarin-associated hemorrhage.
Thrombolysis in venous thromboembolism. An international perspective. Chest. 1990 Apr; 97(4 Suppl):176S-181S.
Thrombolysis in venous thromboembolism. An international perspective.
Trials that matter: can patients with venous thromboembolism be treated with fixed-dose subcutaneous unfractionated heparin? Ann Intern Med. 2006 Dec 19; 145(12):929-31.
Trials that matter: can patients with venous thromboembolism be treated with fixed-dose subcutaneous unfractionated heparin?
Double trouble for 2,609 hospitalized medical patients who developed deep vein thrombosis: prophylaxis omitted more often and pulmonary embolism more frequent. Chest. 2007 Aug; 132(2):554-61.
Double trouble for 2,609 hospitalized medical patients who developed deep vein thrombosis: prophylaxis omitted more often and pulmonary embolism more frequent.
Shetty R, Seddighzadeh A, Piazza G, Goldhaber SZ
Chronic obstructive pulmonary disease and deep vein thrombosis: a prevalent combination. J Thromb Thrombolysis. 2008 Aug; 26(1):35-40.
Chronic obstructive pulmonary disease and deep vein thrombosis: a prevalent combination.
Grasso-Correnti N, Goldszer RC, Goldhaber SZ
The critical pathways of an anticoagulation service. Crit Pathw Cardiol. 2003 Mar; 2(1):41-5.
The critical pathways of an anticoagulation service.
Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ
Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008 Jun; 133(6 Suppl):454S-545S.
Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Seddighzadeh A, Wolf AT, Parasuraman S, Shetty R, Vallurupalli N, Reddy S, Goldhaber SZ
Gastrointestinal complications after 3 months of dual antiplatelet therapy for drug-eluting stents as assessed by wireless capsule endoscopy. Clin Appl Thromb Hemost. 2009 Mar-Apr; 15(2):171-6.
Gastrointestinal complications after 3 months of dual antiplatelet therapy for drug-eluting stents as assessed by wireless capsule endoscopy.
Flaker GC, Pogue J, Yusuf S, Pfeffer MA, Goldhaber SZ, Granger CB, Anand IS, Hart R, Connolly SJ
Circulation. Cardiovascular quality and outcomes
Cognitive function and anticoagulation control in patients with atrial fibrillation. Circ Cardiovasc Qual Outcomes. 2010 May; 3(3):277-83.
Cognitive function and anticoagulation control in patients with atrial fibrillation.
Ask the doctor. Last year I had a deep-vein thrombosis with a small pulmonary embolism, apparently precipitated by flying across the country without getting up and walking around. I did just fine with anticoagulation and am now off all medications. Is it safe to fly again? If so, what precautions would you recommend? Harv Heart Lett. 2010 Jun; 20(10):7.
Ask the doctor. Last year I had a deep-vein thrombosis with a small pulmonary embolism, apparently precipitated by flying across the country without getting up and walking around. I did just fine with anticoagulation and am now off all medications. Is it safe to fly again? If so, what precautions would you recommend?
Lu MT, Demehri S, Cai T, Parast L, Hunsaker AR, Goldhaber SZ, Rybicki FJ
Axial and reformatted four-chamber right ventricle-to-left ventricle diameter ratios on pulmonary CT angiography as predictors of death after acute pulmonary embolism. AJR Am J Roentgenol. 2012 Jun; 198(6):1353-60.
Axial and reformatted four-chamber right ventricle-to-left ventricle diameter ratios on pulmonary CT angiography as predictors of death after acute pulmonary embolism.
Goldhaber SZ, Brown WD, Robertson N, Rubin IL, Sutton MG
Aortic regurgitation and mitral valve prolapse with Down's syndrome: a case-control study. J Ment Defic Res. 1988 Aug; 32 ( Pt 4):333-6.
Aortic regurgitation and mitral valve prolapse with Down's syndrome: a case-control study.
Prevention of Venous Thromboembolism. 1993.
Hypercoagulable states and other risk factors for venous thromboembolism. Dalen JF, ed. Venous Thromboembolism. 2003; 11-38.
Hypercoagulable states and other risk factors for venous thromboembolism
Tissue Plasminogen Activator (tPA) in Cardiopulmonary Disease. CHEST. 1989; 95:243S-292S.
Tissue Plasminogen Activator (tPA) in Cardiopulmonary Disease
Heart Failure: Basic Science and Clinical Aspects, edited by Judith K. Gwathmey, G. Maurice Briggs, and Paul D. Allen
Heart Failure: Basic Science and Clinical Aspects, edited by Judith K. Gwathmey, G. Maurice Briggs, and Paul D. Allen. 1993.
Cardiovascular Drug Development: Protocol Design and Methodology, edited by Jeffrey S. Borer and John C. Somberg
Cardiovascular Drug Development: Protocol Design and Methodology, edited by Jeffrey S. Borer and John C. Somberg. 1999.
Acute pulmonary embolism treated with thrombolytic agents: current status of tPA and future implications for emergency medicine. Ann Emerg Med. 1988 Nov; 17(11):1216-20.
Acute pulmonary embolism treated with thrombolytic agents: current status of tPA and future implications for emergency medicine.
Bounameaux H, ed., Low-Molecular-Weight Heparins In Prophylaxis And Therapy Of Thromboembolic Diseases.
Deep venous thrombosis. An overview of diagnosis, treatment, and prevention. Bounameaux H, ed., Low-Molecular-Weight Heparins In Prophylaxis And Therapy Of Thromboembolic Diseases. 1994; 55-74.
Deep venous thrombosis. An overview of diagnosis, treatment, and prevention
Thrombolysis in Cardiopulmonary Disease. CHEST. 1992; 101:89S-185S.
Kearon C, Gu CS, Julian JA, Goldhaber SZ, Comerota AJ, Gornik HL, Murphy TP, Lewis L, Kahn SR, Kindzelski AL, Slater D, Geary R, Winokur R, Natarajan K, Dietzek A, Leung DA, Kim S, Vedantham S
Pharmacomechanical Catheter-Directed Thrombolysis in Acute Femoral-Popliteal Deep Vein Thrombosis: Analysis from a Stratified Randomized Trial. Thromb Haemost. 2019 Apr; 119(4):633-644.
Pharmacomechanical Catheter-Directed Thrombolysis in Acute Femoral-Popliteal Deep Vein Thrombosis: Analysis from a Stratified Randomized Trial.
Fine-tuning the decision to initiate anticoagulation in atrial fibrillation by accounting for age and cardiovascular comorbidities. Eur Heart J. 2019 05 14; 40(19):1515-1517.
Fine-tuning the decision to initiate anticoagulation in atrial fibrillation by accounting for age and cardiovascular comorbidities.
Goldhaber SZ, Dricker E, Buring JE, Eberlein K, Godleski JJ, Mayer RJ, Hennekens CH
Clinical suspicion of autopsy-proven thrombotic and tumor pulmonary embolism in cancer patients. Am Heart J. 1987 Dec; 114(6):1432-5.
Clinical suspicion of autopsy-proven thrombotic and tumor pulmonary embolism in cancer patients.
Hirsch DR, Lee TH, Morrison RB, Carlson W, Goldhaber SZ
Shortened hospitalization by means of adjusted-dose subcutaneous heparin for deep venous thrombosis. Am Heart J. 1996 Feb; 131(2):276-80.
Shortened hospitalization by means of adjusted-dose subcutaneous heparin for deep venous thrombosis.
Goto S, Angchaisuksiri P, Bassand JP, Camm AJ, Dominguez H, Illingworth L, Gibbs H, Goldhaber SZ, Goto S, Jing ZC, Haas S, Kayani G, Koretsune Y, Lim TW, Oh S, Sawhney JPS, Turpie AGG, van Eickels M, Verheugt FWA, Kakkar AK
Journal of the American Heart Association
Management and 1-Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD - AF Registry. J Am Heart Assoc. 2019 02 05; 8(3):e010510.
Management and 1-Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD - AF Registry.
Chi G, Gibson CM, Kalayci A, Cohen AT, Hernandez AF, Hull RD, Kahe F, Jafarizade M, Sharfaei S, Liu Y, Harrington RA, Goldhaber SZ
Extended-duration betrixaban versus shorter-duration enoxaparin for venous thromboembolism prophylaxis in critically ill medical patients: an APEX trial substudy. Intensive Care Med. 2019 04; 45(4):477-487.
Extended-duration betrixaban versus shorter-duration enoxaparin for venous thromboembolism prophylaxis in critically ill medical patients: an APEX trial substudy.
Cornell RF, Goldhaber SZ, Engelhardt BG, Moslehi J, Jagasia M, Patton D, Harrell S, Hall R, Wyatt H, Piazza G
Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma Receiving Immunomodulatory Therapy. Front Oncol. 2019; 9:45.
Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma Receiving Immunomodulatory Therapy.
Nafee T, Gibson CM, Yee MK, Kerneis M, Daaboul Y, Korjian S, Chi G, Kalayci A, Afzal MK, Kazmi H, Datta S, AlKhalfan F, Hernandez AF, Hull RD, Harrington RA, Cohen AT, Goldhaber SZ
Reduction of Cardiovascular Mortality and Ischemic Events in Acute Medically Ill Patients. Circulation. 2019 02 26; 139(9):1234-1236.
Reduction of Cardiovascular Mortality and Ischemic Events in Acute Medically Ill Patients.
Taslakian B, Li C, Goldhaber SZ, Mikkelsen KZ, Horowitz JM, Kabrhel C, Barnes GD, Sista AK
How the Results of a Randomized Trial of Catheter-Directed Thrombolysis Versus Anticoagulation alone for Submassive Pulmonary Embolism Would Affect Patient and Physician Decision Making: Report of an Online Survey. J Clin Med. 2019 Feb 07; 8(2).
How the Results of a Randomized Trial of Catheter-Directed Thrombolysis Versus Anticoagulation alone for Submassive Pulmonary Embolism Would Affect Patient and Physician Decision Making: Report of an Online Survey.
Bajaj NS, Vaduganathan M, Qamar A, Gupta K, Gupta A, Golwala H, Butler J, Goldhaber SZ, Mehra MR
Extended prophylaxis for venous thromboembolism after hospitalization for medical illness: A trial sequential and cumulative meta-analysis. PLoS Med. 2019 04; 16(4):e1002797.
Extended prophylaxis for venous thromboembolism after hospitalization for medical illness: A trial sequential and cumulative meta-analysis.
Corbalan R, Bassand JP, Illingworth L, Ambrosio G, Camm AJ, Fitzmaurice DA, Fox KAA, Goldhaber SZ, Goto S, Haas S, Kayani G, Mantovani LG, Misselwitz F, Pieper KS, Turpie AGG, Verheugt FWA, Kakkar AK
Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation: A Report From the GARFIELD-AF Registry. JAMA Cardiol. 2019 06 01; 4(6):526-548.
Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation: A Report From the GARFIELD-AF Registry.
Højen AA, Søgaard M, Melgaard L, Lane DA, Sørensen EE, Goldhaber SZ, Larsen TB
Psychotropic drug use following venous thromboembolism versus diabetes mellitus in adolescence or young adulthood: a Danish nationwide cohort study. BMJ Open. 2019 05 14; 9(5):e026159.
Psychotropic drug use following venous thromboembolism versus diabetes mellitus in adolescence or young adulthood: a Danish nationwide cohort study.
Campia U, Gerhard-Herman M, Piazza G, Goldhaber SZ
Peripheral Artery Disease: Past, Present, and Future. Am J Med. 2019 10; 132(10):1133-1141.
Peripheral Artery Disease: Past, Present, and Future.
Piazza G, Hurwitz S, Galvin CE, Harrigan L, Baklla S, Hohlfelder B, Carroll B, Landman AB, Emani S, Goldhaber SZ
Alert-based computerized decision support for high-risk hospitalized patients with atrial fibrillation not prescribed anticoagulation: a randomized, controlled trial (AF-ALERT). Eur Heart J. 2020 03 07; 41(10):1086-1096.
Alert-based computerized decision support for high-risk hospitalized patients with atrial fibrillation not prescribed anticoagulation: a randomized, controlled trial (AF-ALERT).
Haas S, Ageno W, Weitz JI, Goldhaber SZ, Turpie AGG, Goto S, Angchaisuksiri P, Dalsgaard Nielsen J, Kayani G, Zaghdoun A, Farjat AE, Schellong S, Bounameaux H, Mantovani LG, Prandoni P, Kakkar AK
Anticoagulation therapy patterns for acute treatment of venous thromboembolism in GARFIELD-VTE patients. J Thromb Haemost. 2019 10; 17(10):1694-1706.
Anticoagulation therapy patterns for acute treatment of venous thromboembolism in GARFIELD-VTE patients.
Ageno W, Haas S, Weitz JI, Goldhaber SZ, Turpie AGG, Goto S, Angchaisuksiri P, Dalsgaard Nielsen J, Kayani G, Farjat AE, Zaghdoun A, Schellong S, Bounameaux H, Mantovani LG, Prandoni P, Darius H, Kakkar AK
Upper Extremity DVT versus Lower Extremity DVT: Perspectives from the GARFIELD-VTE Registry. Thromb Haemost. 2019 Aug; 119(8):1365-1372.
Upper Extremity DVT versus Lower Extremity DVT: Perspectives from the GARFIELD-VTE Registry.
Piazza G, Hurwitz S, Harrigan LM, Jenkins KL, Hohlfelder B, Fanikos J, Goldhaber SZ
Anticoagulation and Mortality Rates among Hospitalized Patients with Atrial Fibrillation. TH Open. 2018 Jan; 2(1):e33-e38.
Anticoagulation and Mortality Rates among Hospitalized Patients with Atrial Fibrillation.
Yee MK, Gibson CM, Nafee T, Kerneis M, Daaboul Y, Korjian S, Chi G, AlKhalfan F, Hernandez AF, Hull RD, Cohen AT, Goldhaber SZ
Characterization of Major and Clinically Relevant Non-Major Bleeds in the APEX Trial. TH Open. 2019 Apr; 3(2):e103-e108.
Characterization of Major and Clinically Relevant Non-Major Bleeds in the APEX Trial.
Chopard R, Goldhaber SZ, Karipineni N, Goldberg HS, Piazza G
Antiplatelet Prescription in Atrial Fibrillation: Association with a Low Rate of Anticoagulation. TH Open. 2018 Apr; 2(2):e229-e232.
Antiplatelet Prescription in Atrial Fibrillation: Association with a Low Rate of Anticoagulation.
Williams JS, Autori PJ, Kidd SK, Piazza G, Connors MC, Czeisler CA, Scheuermaier KD, Duffy J, Klerman EB, Scheer FA, Kozak M, Driscoll SM, Goldhaber SZ
Heparin-Induced Thrombocytopenia in Healthy Individuals with Continuous Heparin Infusion. TH Open. 2018 Jan; 2(1):e49-e53.
Heparin-Induced Thrombocytopenia in Healthy Individuals with Continuous Heparin Infusion.
Gibson CM, Spyropoulos AC, Cohen AT, Hull RD, Goldhaber SZ, Yusen RD, Hernandez AF, Korjian S, Daaboul Y, Gold A, Harrington RA, Chi G
The IMPROVEDD VTE Risk Score: Incorporation of D-Dimer into the IMPROVE Score to Improve Venous Thromboembolism Risk Stratification. TH Open. 2017 Jun; 1(1):e56-e65.
The IMPROVEDD VTE Risk Score: Incorporation of D-Dimer into the IMPROVE Score to Improve Venous Thromboembolism Risk Stratification.
Gibson CM, Jennings LK, Chi G, Yee MK, Halaby R, Nafee T, AlKhalfan F, Kerneis M, Korjian S, Daaboul Y, Goldhaber SZ, Hull RD, Hernandez AF, Cohen AT, Harrington RA
Association of D-dimer Levels with Clinical Event Rates and the Efficacy of Betrixaban versus Enoxaparin in the APEX Trial. TH Open. 2018 Jan; 2(1):e16-e24.
Association of D-dimer Levels with Clinical Event Rates and the Efficacy of Betrixaban versus Enoxaparin in the APEX Trial.
Verheugt FWA, Ambrosio G, Atar D, Bassand JP, Camm AJ, Costabel JP, Fitzmaurice DA, Illingworth L, Goldhaber SZ, Goto S, Haas S, Jansky P, Kayani G, Stepinska J, Turpie AGG, van Eickels M, Kakkar AK
Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF. Am J Med. 2019 12; 132(12):1431-1440.e7.
Outcomes in Newly Diagnosed Atrial Fibrillation and History of Acute Coronary Syndromes: Insights from GARFIELD-AF.
Schellong SM, Goldhaber SZ, Weitz JI, Ageno W, Bounameaux H, Turpie AGG, Angchaisuksiri P, Haas S, Goto S, Zaghdoun A, Farjat A, Nielsen JD, Kayani G, Mantovani LG, Prandoni P, Kakkar AK
Isolated Distal Deep Vein Thrombosis: Perspectives from the GARFIELD-VTE Registry. Thromb Haemost. 2019 10; 119(10):1675-1685.
Isolated Distal Deep Vein Thrombosis: Perspectives from the GARFIELD-VTE Registry.
Weinberg I, Vedantham S, Salter A, Hadley G, Al-Hammadi N, Kearon C, Julian JA, Razavi MK, Gornik HL, Goldhaber SZ, Comerota AJ, Kindzelski AL, Schainfeld RM, Angle JF, Misra S, Schor JA, Hurst D, Jaff MR
Relationships between the use of pharmacomechanical catheter-directed thrombolysis, sonographic findings, and clinical outcomes in patients with acute proximal DVT: Results from the ATTRACT Multicenter Randomized Trial. Vasc Med. 2019 10; 24(5):442-451.
Relationships between the use of pharmacomechanical catheter-directed thrombolysis, sonographic findings, and clinical outcomes in patients with acute proximal DVT: Results from the ATTRACT Multicenter Randomized Trial.
Pulmonary Embolism in Patients With Syncope: Horse or Zebra? J Am Coll Cardiol. 2019 08 13; 74(6):755-758.
Pulmonary Embolism in Patients With Syncope: Horse or Zebra?
Ageno W, Lopes RD, Yee MK, Hernandez A, Hull RD, Goldhaber SZ, Gibson CM, Cohen AT
Net-clinical benefit of extended prophylaxis of venous thromboembolism with betrixaban in medically ill patients aged 80 or more. J Thromb Haemost. 2019 12; 17(12):2089-2098.
Net-clinical benefit of extended prophylaxis of venous thromboembolism with betrixaban in medically ill patients aged 80 or more.
Fernandes CJ, Steigner ML, Piazza G, Goldhaber SZ
Collaborative Cardiology and Pulmonary Management of Pulmonary Hypertension. Chest. 2019 08; 156(2):200-202.
Collaborative Cardiology and Pulmonary Management of Pulmonary Hypertension.
Bikdeli B, Visvanathan R, Jimenez D, Monreal M, Goldhaber SZ, Bikdeli B
Use of Prophylaxis for Prevention of Venous Thromboembolism in Patients with Isolated Foot or Ankle Surgery: A Systematic Review and Meta-Analysis. Thromb Haemost. 2019 10; 119(10):1686-1694.
Use of Prophylaxis for Prevention of Venous Thromboembolism in Patients with Isolated Foot or Ankle Surgery: A Systematic Review and Meta-Analysis.
Bikdeli B, Wang Y, Jimenez D, Parikh SA, Monreal M, Goldhaber SZ, Krumholz HM
Pulmonary Embolism Hospitalization, Readmission, and Mortality Rates in US Older Adults, 1999-2015. JAMA. 2019 08 13; 322(6):574-576.
Pulmonary Embolism Hospitalization, Readmission, and Mortality Rates in US Older Adults, 1999-2015.
Ageno W, Lopes RD, Yee MK, Hernandez A, Hull R, Goldhaber SZ, Gibson CM, Cohen AT
Extended prophylaxis of venous thromboembolism with betrixaban in acutely ill medical patients with and without cancer: insights from the APEX trial. J Thromb Thrombolysis. 2020 Feb; 49(2):214-219.
Extended prophylaxis of venous thromboembolism with betrixaban in acutely ill medical patients with and without cancer: insights from the APEX trial.
McLaughlin K, Rimsans J, Sylvester KW, Fanikos J, Dorfman DM, Senna P, Connors JM, Goldhaber SZ
Evaluation of Antifactor-Xa Heparin Assay and Activated Partial Thromboplastin Time Values in Patients on Therapeutic Continuous Infusion Unfractionated Heparin Therapy. Clin Appl Thromb Hemost. 2019 Jan-Dec; 25:1076029619876030.
Evaluation of Antifactor-Xa Heparin Assay and Activated Partial Thromboplastin Time Values in Patients on Therapeutic Continuous Infusion Unfractionated Heparin Therapy.
Albertsen IE, Goldhaber SZ, Piazza G, Overvad TF, Nielsen PB, Larsen TB, Søgaard M
Predictors of Not Initiating Anticoagulation After Incident Venous Thromboembolism: A Danish Nationwide Cohort Study. Am J Med. 2020 04; 133(4):463-472.e5.
Predictors of Not Initiating Anticoagulation After Incident Venous Thromboembolism: A Danish Nationwide Cohort Study.
Martin AC, Huang W, Goldhaber SZ, Hull RD, Hernandez AF, Gibson CM, Anderson FA, Cohen AT
Estimation of Acutely Ill Medical Patients at Venous Thromboembolism Risk Eligible for Extended Thromboprophylaxis Using APEX Criteria in US Hospitals. Clin Appl Thromb Hemost. 2019 Jan-Dec; 25:1076029619880008.
Estimation of Acutely Ill Medical Patients at Venous Thromboembolism Risk Eligible for Extended Thromboprophylaxis Using APEX Criteria in US Hospitals.
Magnuson EA, Chinnakondepalli K, Vilain K, Kearon C, Julian JA, Kahn SR, Goldhaber SZ, Jaff MR, Kindzelski AL, Herman K, Brady PS, Sharma K, Black CM, Vedantham S, Cohen DJ
Cost-Effectiveness of Pharmacomechanical Catheter-Directed Thrombolysis Versus Standard Anticoagulation in Patients With Proximal Deep Vein Thrombosis: Results From the ATTRACT Trial. Circ Cardiovasc Qual Outcomes. 2019 10; 12(10):e005659.
Cost-Effectiveness of Pharmacomechanical Catheter-Directed Thrombolysis Versus Standard Anticoagulation in Patients With Proximal Deep Vein Thrombosis: Results From the ATTRACT Trial.
Atar D, Berge E, Le Heuzey JY, Virdone S, Camm AJ, Steffel J, Gibbs H, Goldhaber SZ, Goto S, Kayani G, Misselwitz F, Stepinska J, Turpie AGG, Bassand JP, Kakkar AK
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
The association between patterns of atrial fibrillation, anticoagulation, and cardiovascular events. Europace. 2020 02 01; 22(2):195-204.
The association between patterns of atrial fibrillation, anticoagulation, and cardiovascular events.
Kahn SR, Julian JA, Kearon C, Gu CS, Cohen DJ, Magnuson EA, Comerota AJ, Goldhaber SZ, Jaff MR, Razavi MK, Kindzelski AL, Schneider JR, Kim P, Chaer R, Sista AK, McLafferty RB, Kaufman JA, Wible BC, Blinder M, Vedantham S
Journal of vascular surgery. Venous and lymphatic disorders
Quality of life after pharmacomechanical catheter-directed thrombolysis for proximal deep venous thrombosis. J Vasc Surg Venous Lymphat Disord. 2020 01; 8(1):8-23.e18.
Quality of life after pharmacomechanical catheter-directed thrombolysis for proximal deep venous thrombosis.
Goto S, Goto S, Pieper KS, Bassand JP, Camm AJ, Fitzmaurice DA, Goldhaber SZ, Haas S, Parkhomenko A, Oto A, Misselwitz F, Turpie AGG, Verheugt FWA, Fox KAA, Gersh BJ, Kakkar AK
European heart journal. Cardiovascular pharmacotherapy
New artificial intelligence prediction model using serial prothrombin time international normalized ratio measurements in atrial fibrillation patients on vitamin K antagonists: GARFIELD-AF. Eur Heart J Cardiovasc Pharmacother. 2020 09 01; 6(5):301-309.
New artificial intelligence prediction model using serial prothrombin time international normalized ratio measurements in atrial fibrillation patients on vitamin K antagonists: GARFIELD-AF.
Rahaghi FN, San José Estépar R, Goldhaber SZ, Minhas JK, Nardelli P, Vegas Sanchez-Ferrero G, De La Bruere I, Hassan SM, Mason S, Ash SY, Come CE, Washko GR, Piazza G
Quantification and Significance of Pulmonary Vascular Volume in Predicting Response to Ultrasound-Facilitated, Catheter-Directed Fibrinolysis in Acute Pulmonary Embolism (SEATTLE-3D). Circ Cardiovasc Imaging. 2019 12; 12(12):e009903.
Quantification and Significance of Pulmonary Vascular Volume in Predicting Response to Ultrasound-Facilitated, Catheter-Directed Fibrinolysis in Acute Pulmonary Embolism (SEATTLE-3D).
Hacke W, Bassand JP, Virdone S, Camm AJ, Fitzmaurice DA, Fox KA, Goldhaber SZ, Goto S, Haas S, Kayani G, Mantovani LG, Misselwitz F, Pieper KS, Turpie AG, van Eickels M, Verheugt FW, Kakkar AK
International journal of stroke : official journal of the International Stroke Society
Prior stroke and transient ischemic attack as risk factors for subsequent stroke in atrial fibrillation patients: A report from the GARFIELD-AF registry. Int J Stroke. 2020 04; 15(3):308-317.
Prior stroke and transient ischemic attack as risk factors for subsequent stroke in atrial fibrillation patients: A report from the GARFIELD-AF registry.
Pellegrini VD, Eikelboom J, McCollister Evarts C, Franklin PD, Goldhaber SZ, Iorio R, Lambourne CA, Magaziner JS, Magder LS
Selection Bias, Orthopaedic Style: Knowing What We Don't Know About Aspirin. J Bone Joint Surg Am. 2020 Apr 01; 102(7):631-633.
Selection Bias, Orthopaedic Style: Knowing What We Don't Know About Aspirin.
Bikdeli B, Wang Y, Jimenez D, Ross JS, Gupta A, Desai MM, Parikh SA, Monreal M, Goldhaber SZ, Krumholz HM
Recent trends in use of inferior vena caval filters in US older adults with acute pulmonary embolism. Thromb Res. 2020 02; 186:78-79.
Recent trends in use of inferior vena caval filters in US older adults with acute pulmonary embolism.
Venous Thromboembolism in Heart Failure Patients: Pathophysiology, Predictability, Prevention. J Am Coll Cardiol. 2020 01 21; 75(2):159-162.
Venous Thromboembolism in Heart Failure Patients: Pathophysiology, Predictability, Prevention.
Nafee T, Gibson CM, Travis R, Yee MK, Kerneis M, Chi G, AlKhalfan F, Hernandez AF, Hull RD, Cohen AT, Harrington RA, Goldhaber SZ
Research and practice in thrombosis and haemostasis
Machine learning to predict venous thrombosis in acutely ill medical patients. Res Pract Thromb Haemost. 2020 Feb; 4(2):230-237.
Machine learning to predict venous thrombosis in acutely ill medical patients.
Fox KAA, Velentgas P, Camm AJ, Bassand JP, Fitzmaurice DA, Gersh BJ, Goldhaber SZ, Goto S, Haas S, Misselwitz F, Pieper KS, Turpie AGG, Verheugt FWA, Dabrowski E, Luo K, Gibbs L, Kakkar AK
Outcomes Associated With Oral Anticoagulants Plus Antiplatelets in Patients With Newly Diagnosed Atrial Fibrillation. JAMA Netw Open. 2020 02 05; 3(2):e200107.
Outcomes Associated With Oral Anticoagulants Plus Antiplatelets in Patients With Newly Diagnosed Atrial Fibrillation.
Rabinovich A, Gu CS, Vedantham S, Kearon C, Goldhaber SZ, Gornik HL, Kahn SR
External validation of the SOX-PTS score in a prospective multicenter trial of patients with proximal deep vein thrombosis. J Thromb Haemost. 2020 06; 18(6):1381-1389.
External validation of the SOX-PTS score in a prospective multicenter trial of patients with proximal deep vein thrombosis.
Lewin AR, Collins PE, Sylvester KW, Rimsans J, Fanikos J, Goldhaber SZ, Connors JM
Development of an Institutional Peri-procedural Management Guideline for Oral Anticoagulants. Crit Pathw Cardiol. 2020 Apr 01.
Development of an Institutional Peri-procedural Management Guideline for Oral Anticoagulants.
Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, Nigoghossian C, Ageno W, Madjid M, Guo Y, Tang LV, Hu Y, Giri J, Cushman M, Quéré I, Dimakakos EP, Gibson CM, Lippi G, Favaloro EJ, Fareed J, Caprini JA, Tafur AJ, Burton JR, Francese DP, Wang EY, Falanga A, McLintock C, Hunt BJ, Spyropoulos AC, Barnes GD, Eikelboom JW, Weinberg I, Schulman S, Carrier M, Piazza G, Beckman JA, Steg PG, Stone GW, Rosenkranz S, Goldhaber SZ, Parikh SA, Monreal M, Krumholz HM, Konstantinides SV, Weitz JI, Lip GYH
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020 06 16; 75(23):2950-2973.
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review.
Cornell RF, Goldhaber SZ, Engelhardt BG, Moslehi J, Jagasia M, Harrell S, Rubinstein SM, Hall R, Wyatt H, Piazza G
Primary prevention of venous thromboembolism with apixaban for multiple myeloma patients receiving immunomodulatory agents. Br J Haematol. 2020 08; 190(4):555-561.
Primary prevention of venous thromboembolism with apixaban for multiple myeloma patients receiving immunomodulatory agents.
Goldhaber SZ, Ageno W, Casella IB, Chee KH, Schellong S, Singer DE, Desch M, Reilly PA, Donado E, Tang W, Voccia I, Schulman S
Profile of Patients Diagnosed With Acute Venous Thromboembolism in Routine Clinical Practice: The RE-COVERY DVT/PE™ Study. Am J Med. 2020 08; 133(8):936-945.
Profile of Patients Diagnosed With Acute Venous Thromboembolism in Routine Clinical Practice: The RE-COVERY DVT/PE™ Study.
Barkoudah E, Piazza G, Hecht TEH, Grant P, Deitelzweig S, Fang MC, Fanikos J, Kao CK, Barnes GD, Chen T, Ramishvili T, Schnipper JL, Goldstein JN, Ruff CT, Kaatz S, Schwartz A, Connors JM, Goldhaber SZ
Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative. Am J Med. 2020 05; 133 Suppl 1:1-27.
Extended Venous Thromboembolism Prophylaxis in Medically Ill Patients: An NATF Anticoagulation Action Initiative.
Albertsen IE, Søgaard M, Goldhaber SZ, Piazza G, Skjøth F, Overvad TF, Larsen TB, Nielsen PB
Development of Sex-Stratified Prediction Models for Recurrent Venous Thromboembolism: A Danish Nationwide Cohort Study. Thromb Haemost. 2020 May; 120(5):805-814.
Development of Sex-Stratified Prediction Models for Recurrent Venous Thromboembolism: A Danish Nationwide Cohort Study.
Bounameaux H, Haas S, Farjat AE, Ageno W, Weitz JI, Goldhaber SZ, Turpie AGG, Goto S, Angchaisuksiri P, Nielsen JD, Kayani G, Schellong S, Mantovani LG, Prandoni P, Kakkar AK
Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE. Thromb Res. 2020 07; 191:103-112.
Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE.
Bikdeli B, Madhavan MV, Gupta A, Jimenez D, Burton JR, Der Nigoghossian C, Chuich T, Nouri SN, Dreyfus I, Driggin E, Sethi S, Sehgal K, Chatterjee S, Ageno W, Madjid M, Guo Y, Tang LV, Hu Y, Bertoletti L, Giri J, Cushman M, Quéré I, Dimakakos EP, Gibson CM, Lippi G, Favaloro EJ, Fareed J, Tafur AJ, Francese DP, Batra J, Falanga A, Clerkin KJ, Uriel N, Kirtane A, McLintock C, Hunt BJ, Spyropoulos AC, Barnes GD, Eikelboom JW, Weinberg I, Schulman S, Carrier M, Piazza G, Beckman JA, Leon MB, Stone GW, Rosenkranz S, Goldhaber SZ, Parikh SA, Monreal M, Krumholz HM, Konstantinides SV, Weitz JI, Lip GYH
Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research. Thromb Haemost. 2020 Jul; 120(7):1004-1024.
Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research.
Spyropoulos AC, Ageno W, Cohen AT, Gibson CM, Goldhaber SZ, Raskob G
Prevention of Venous Thromboembolism in Hospitalized Medically Ill Patients: A U.S. Perspective. Thromb Haemost. 2020 Jun; 120(6):924-936.
Prevention of Venous Thromboembolism in Hospitalized Medically Ill Patients: A U.S. Perspective.
Sardar P, Piazza G, Goldhaber SZ, Liu PY, Prabhu W, Soukas P, Aronow HD
Circulation. Cardiovascular interventions
Predictors of Treatment Response Following Ultrasound-Facilitated Catheter-Directed Thrombolysis for Submassive and Massive Pulmonary Embolism: A SEATTLE II Substudy. Circ Cardiovasc Interv. 2020 06; 13(6):e008747.
Predictors of Treatment Response Following Ultrasound-Facilitated Catheter-Directed Thrombolysis for Submassive and Massive Pulmonary Embolism: A SEATTLE II Substudy.
Thromboembolism Prophylaxis for Patients Discharged From the Hospital: Easier Said Than Done. J Am Coll Cardiol. 2020 06 30; 75(25):3148-3150.
Thromboembolism Prophylaxis for Patients Discharged From the Hospital: Easier Said Than Done.
Weitz JI, Haas S, Ageno W, Goldhaber SZ, Turpie AGG, Goto S, Angchaisuksiri P, Nielsen JD, Kayani G, Farjat AE, Schellong S, Bounameaux H, Mantovani LG, Prandoni P, Kakkar AK
Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE. J Thromb Thrombolysis. 2020 Aug; 50(2):267-277.
Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE.
Zekery-Saad SA, Lewin A, Pham M, Sylvester KW, Fanikos J, Goldhaber SZ, Connors JM
Evaluation and optimization of prescribed concomitant antiplatelet and anticoagulation therapy centrally managed by an anticoagulation management service. J Thromb Thrombolysis. 2021 Feb; 51(2):405-412.
Evaluation and optimization of prescribed concomitant antiplatelet and anticoagulation therapy centrally managed by an anticoagulation management service.
Piazza G, Sterling KM, Tapson VF, Ouriel K, Sharp ASP, Liu PY, Goldhaber SZ
One-Year Echocardiographic, Functional, and Quality of Life Outcomes After Ultrasound-Facilitated Catheter-Based Fibrinolysis for Pulmonary Embolism. Circ Cardiovasc Interv. 2020 08; 13(8):e009012.
One-Year Echocardiographic, Functional, and Quality of Life Outcomes After Ultrasound-Facilitated Catheter-Based Fibrinolysis for Pulmonary Embolism.
ECMO and Surgical Embolectomy: Two Potent Tools to Manage High-Risk Pulmonary Embolism. J Am Coll Cardiol. 2020 08 25; 76(8):912-915.
ECMO and Surgical Embolectomy: Two Potent Tools to Manage High-Risk Pulmonary Embolism.
Bhatia K, Uberoi G, Bajaj NS, Jain V, Arora S, Tafur A, Bangalore S, Olin JW, Piazza G, Goldhaber SZ, Vaduganathan M, Qamar A
Meta-Analysis Comparing Direct Oral Anticoagulants to Low Molecular Weight Heparin for Treatment of Venous Thromboembolism in Patients With Cancer. Am J Cardiol. 2020 10 15; 133:175-178.
Meta-Analysis Comparing Direct Oral Anticoagulants to Low Molecular Weight Heparin for Treatment of Venous Thromboembolism in Patients With Cancer.
Ageno W, Casella IB, Chee KH, Schellong S, Schulman S, Singer DE, Desch M, Tang W, Voccia I, Zint K, Goldhaber SZ
Profile of patients diagnosed with acute venous thromboembolism in routine practice according to age and renal function: RE-COVERY DVT/PE study. J Thromb Thrombolysis. 2021 Apr; 51(3):561-570.
Profile of patients diagnosed with acute venous thromboembolism in routine practice according to age and renal function: RE-COVERY DVT/PE study.
Camm AJ, Cools F, Virdone S, Bassand JP, Fitzmaurice DA, Arthur Fox KA, Goldhaber SZ, Goto S, Haas S, Mantovani LG, Kayani G, Grierson Turpie AG, Antoon Verheugt FW, Kakkar AK
Mortality in Patients With Atrial Fibrillation Receiving Nonrecommended Doses of Direct Oral Anticoagulants. J Am Coll Cardiol. 2020 09 22; 76(12):1425-1436.
Mortality in Patients With Atrial Fibrillation Receiving Nonrecommended Doses of Direct Oral Anticoagulants.
Razavi MK, Salter A, Goldhaber SZ, Lancia S, Kahn SR, Weinberg I, Kearon C, Azene EM, Patel NH, Vedantham S
Journal of vascular and interventional radiology : JVIR
Correlation between Post-Procedure Residual Thrombus and Clinical Outcome in Deep Vein Thrombosis Patients Receiving Pharmacomechanical Thrombolysis in a Multicenter Randomized Trial. J Vasc Interv Radiol. 2020 Oct; 31(10):1517-1528.e2.
Correlation between Post-Procedure Residual Thrombus and Clinical Outcome in Deep Vein Thrombosis Patients Receiving Pharmacomechanical Thrombolysis in a Multicenter Randomized Trial.
Bikdeli B, Talasaz AH, Rashidi F, Sharif-Kashani B, Farrokhpour M, Bakhshandeh H, Sezavar H, Dabbagh A, Beigmohammadi MT, Payandemehr P, Yadollahzadeh M, Riahi T, Khalili H, Jamalkhani S, Rezaeifar P, Abedini A, Lookzadeh S, Shahmirzaei S, Tahamtan O, Matin S, Amin A, Parhizgar SE, Jimenez D, Gupta A, Madhavan MV, Parikh SA, Monreal M, Hadavand N, Hajighasemi A, Maleki M, Sadeghian S, Mohebbi B, Piazza G, Kirtane AJ, Lip GYH, Krumholz HM, Goldhaber SZ, Sadeghipour P
Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies. Thromb Res. 2020 12; 196:382-394.
Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies.
Piazza G, Hurwitz S, Carroll B, Goldhaber SZ
Patients with perceived high-bleeding risk and computerized decision support for stroke prevention in atrial fibrillation: an AF-ALERT substudy : Piazza: outcomes of high-bleeding risk AF patients. J Thromb Thrombolysis. 2021 Jul; 52(1):281-290.
Patients with perceived high-bleeding risk and computerized decision support for stroke prevention in atrial fibrillation: an AF-ALERT substudy : Piazza: outcomes of high-bleeding risk AF patients.
Barco S, Valerio L, Ageno W, Cohen AT, Goldhaber SZ, Hunt BJ, Iorio A, Jimenez D, Klok FA, Kucher N, Mahmoudpour SH, Middeldorp S, Münzel T, Tagalakis V, Wendelboe AM, Konstantinides SV
Age-sex specific pulmonary embolism-related mortality in the USA and Canada, 2000-18: an analysis of the WHO Mortality Database and of the CDC Multiple Cause of Death database. Lancet Respir Med. 2021 01; 9(1):33-42.
Age-sex specific pulmonary embolism-related mortality in the USA and Canada, 2000-18: an analysis of the WHO Mortality Database and of the CDC Multiple Cause of Death database.
Sylvester KW, Wagner C, Lewin A, Fanikos J, Goldhaber SZ, Connors JM
Reasons for new patient warfarin referrals to an anticoagulant management service in 2019: a single institution experience. J Thromb Thrombolysis. 2021 Jul; 52(1):158-160.
Reasons for new patient warfarin referrals to an anticoagulant management service in 2019: a single institution experience.
Bikdeli B, Chatterjee S, Kirtane AJ, Parikh SA, Andreozzi GM, Desai NR, Francese DP, Gibson CM, Piazza G, Goldhaber SZ, Eikelboom JW, Krumholz HM, Stone GW
Sulodexide versus Control and the Risk of Thrombotic and Hemorrhagic Events: Meta-Analysis of Randomized Trials. Semin Thromb Hemost. 2020 Nov; 46(8):908-918.
Sulodexide versus Control and the Risk of Thrombotic and Hemorrhagic Events: Meta-Analysis of Randomized Trials.
Piazza G, Campia U, Hurwitz S, Snyder JE, Rizzo SM, Pfeferman MB, Morrison RB, Leiva O, Fanikos J, Nauffal V, Almarzooq Z, Goldhaber SZ
Registry of Arterial and Venous Thromboembolic Complications in Patients With COVID-19. J Am Coll Cardiol. 2020 11 03; 76(18):2060-2072.
Registry of Arterial and Venous Thromboembolic Complications in Patients With COVID-19.
Goto S, Haas S, Ageno W, Goldhaber SZ, Turpie AGG, Weitz JI, Angchaisuksiri P, Nielsen JD, Kayani G, Farjat A, Schellong S, Bounameaux H, Mantovani LG, Prandoni P, Kakkar AK
Assessment of Outcomes Among Patients With Venous Thromboembolism With and Without Chronic Kidney Disease. JAMA Netw Open. 2020 10 01; 3(10):e2022886.
Assessment of Outcomes Among Patients With Venous Thromboembolism With and Without Chronic Kidney Disease.
Development of an Institutional Periprocedural Management Guideline for Oral Anticoagulants. Crit Pathw Cardiol. 2020 12; 19(4):178-186.
Development of an Institutional Periprocedural Management Guideline for Oral Anticoagulants.
O'Connell C, Escalante CP, Goldhaber SZ, McBane R, Connors JM, Raskob GE
Treatment of Cancer-Associated Venous Thromboembolism with Low-Molecular-Weight Heparin or Direct Oral Anticoagulants: Patient Selection, Controversies, and Caveats. Oncologist. 2021 01; 26(1):e8-e16.
Treatment of Cancer-Associated Venous Thromboembolism with Low-Molecular-Weight Heparin or Direct Oral Anticoagulants: Patient Selection, Controversies, and Caveats.
Collins P, Lewin A, Vincze Irving N, Sylvester K, Fanikos J, Goldhaber SZ, Connors JM
Atrial Fibrillation Patients on Warfarin and Their Transition to Direct Oral Anticoagulants. Crit Pathw Cardiol. 2021 06 01; 20(2):103-107.
Atrial Fibrillation Patients on Warfarin and Their Transition to Direct Oral Anticoagulants.
Nauffal V, Achanta A, Goldhaber SZ, Piazza G
Association of ABO blood group type with cardiovascular events in COVID-19. J Thromb Thrombolysis. 2021 Apr; 51(3):584-586.
Association of ABO blood group type with cardiovascular events in COVID-19.
Jerjes-Sánchez C, Rodriguez D, Farjat AE, Kayani G, MacCallum P, Lopes RD, Turpie AGG, Weitz JI, Haas S, Ageno W, Goto S, Goldhaber SZ, Angchaisuksiri P, Nielsen JD, Schellong S, Bounameaux H, Mantovani LG, Prandoni P, Kakkar AK
Pregnancy-Associated Venous Thromboembolism: Insights from GARFIELD-VTE. TH Open. 2021 Jan; 5(1):e24-e34.
Pregnancy-Associated Venous Thromboembolism: Insights from GARFIELD-VTE.
Camm AJ, Fox KAA, Virdone S, Bassand JP, Fitzmaurice DA, Berchuck SI, Gersh BJ, Goldhaber SZ, Goto S, Haas S, Misselwitz F, Pieper KS, Turpie AGG, Verheugt FWA, Cappato R, Kakkar AK
Comparative effectiveness of oral anticoagulants in everyday practice. Heart. 2021 May 26; 107(12):962-970.
Comparative effectiveness of oral anticoagulants in everyday practice.
Bassand JP, Virdone S, Badoz M, Verheugt FWA, Camm AJ, Cools F, Fox KAA, Goldhaber SZ, Goto S, Haas S, Hacke W, Kayani G, Misselwitz F, Pieper KS, Turpie AGG, van Eickels M, Kakkar AK
Bleeding and related mortality with NOACs and VKAs in newly diagnosed atrial fibrillation: results from the GARFIELD-AF registry. Blood Adv. 2021 02 23; 5(4):1081-1091.
Bleeding and related mortality with NOACs and VKAs in newly diagnosed atrial fibrillation: results from the GARFIELD-AF registry.
Ording AG, Skjøth F, Søgaard M, Højen AA, Overvad TF, Noble S, Goldhaber SZ, Larsen TB
Increasing Incidence and Declining Mortality After Cancer-Associated Venous Thromboembolism: A Nationwide Cohort Study. Am J Med. 2021 07; 134(7):868-876.e5.
Increasing Incidence and Declining Mortality After Cancer-Associated Venous Thromboembolism: A Nationwide Cohort Study.
Angchaisuksiri P, Goto S, Farjat AE, Fryk H, Bang SM, Chiang CE, Jing ZC, Kondo K, Sathar J, Tse E, Phusanti S, Kayani G, Weitz JI, Ageno W, Goldhaber SZ, Kakkar AK
Venous thromboembolism in Asia and worldwide: Emerging insights from GARFIELD-VTE. Thromb Res. 2021 05; 201:63-72.
Venous thromboembolism in Asia and worldwide: Emerging insights from GARFIELD-VTE.
Ageno W, Farjat A, Haas S, Weitz JI, Goldhaber SZ, Turpie AGG, Goto S, Angchaisuksiri P, Dalsgaard Nielsen J, Kayani G, Schellong S, Bounameaux H, Mantovani LG, Prandoni P, Kakkar AK
Provoked versus unprovoked venous thromboembolism: Findings from GARFIELD-VTE. Res Pract Thromb Haemost. 2021 Feb; 5(2):326-341.
Provoked versus unprovoked venous thromboembolism: Findings from GARFIELD-VTE.
Sadeghipour P, Talasaz AH, Rashidi F, Sharif-Kashani B, Beigmohammadi MT, Farrokhpour M, Sezavar SH, Payandemehr P, Dabbagh A, Moghadam KG, Jamalkhani S, Khalili H, Yadollahzadeh M, Riahi T, Rezaeifar P, Tahamtan O, Matin S, Abedini A, Lookzadeh S, Rahmani H, Zoghi E, Mohammadi K, Sadeghipour P, Abri H, Tabrizi S, Mousavian SM, Shahmirzaei S, Bakhshandeh H, Amin A, Rafiee F, Baghizadeh E, Mohebbi B, Parhizgar SE, Aliannejad R, Eslami V, Kashefizadeh A, Kakavand H, Hosseini SH, Shafaghi S, Ghazi SF, Najafi A, Jimenez D, Gupta A, Madhavan MV, Sethi SS, Parikh SA, Monreal M, Hadavand N, Hajighasemi A, Maleki M, Sadeghian S, Piazza G, Kirtane AJ, Van Tassell BW, Dobesh PP, Stone GW, Lip GYH, Krumholz HM, Goldhaber SZ, Bikdeli B
Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial. JAMA. 2021 04 27; 325(16):1620-1630.
Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial.
Talasaz AH, Sadeghipour P, Kakavand H, Aghakouchakzadeh M, Kordzadeh-Kermani E, Van Tassell BW, Gheymati A, Ariannejad H, Hosseini SH, Jamalkhani S, Sholzberg M, Monreal M, Jimenez D, Piazza G, Parikh SA, Kirtane AJ, Eikelboom JW, Connors JM, Hunt BJ, Konstantinides SV, Cushman M, Weitz JI, Stone GW, Krumholz HM, Lip GYH, Goldhaber SZ, Bikdeli B
Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review. J Am Coll Cardiol. 2021 04 20; 77(15):1903-1921.
Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review.
O'Toole RV, Stein DM, Frey KP, O'Hara NN, Scharfstein DO, Slobogean GP, Taylor TJ, Haac BE, Carlini AR, Manson TT, Sudini K, Mullins CD, Wegener ST, Firoozabadi R, Haut ER, Bosse MJ, Seymour RB, Holden MB, Gitajn IL, Goldhaber SZ, Eastman AL, Jurkovich GJ, Vallier HA, Gary JL, Kleweno CP, Cuschieri J, Marvel D, Castillo RC
PREVENTion of CLots in Orthopaedic Trauma (PREVENT CLOT): a randomised pragmatic trial protocol comparing aspirin versus low-molecular-weight heparin for blood clot prevention in orthopaedic trauma patients. BMJ Open. 2021 03 24; 11(3):e041845.
PREVENTion of CLots in Orthopaedic Trauma (PREVENT CLOT): a randomised pragmatic trial protocol comparing aspirin versus low-molecular-weight heparin for blood clot prevention in orthopaedic trauma patients.
Fahmy M, Sylvester KW, Migliore M, Eguale T, Fanikos J, Connors JM, Goldhaber SZ
Extended duration venous thromboembolism prophylaxis with betrixaban for patients re-admitted with venous thromboembolism. J Thromb Thrombolysis. 2021 Jul; 52(1):22-29.
Extended duration venous thromboembolism prophylaxis with betrixaban for patients re-admitted with venous thromboembolism.
Bikdeli B, Talasaz AH, Rashidi F, Bakhshandeh H, Rafiee F, Rezaeifar P, Baghizadeh E, Matin S, Jamalkhani S, Tahamtan O, Sharif-Kashani B, Beigmohammadi MT, Farrokhpour M, Sezavar SH, Payandemehr P, Dabbagh A, Moghadam KG, Khalili H, Yadollahzadeh M, Riahi T, Abedini A, Lookzadeh S, Rahmani H, Zoghi E, Mohammadi K, Sadeghipour P, Abri H, Tabrizi S, Mousavian SM, Shahmirzaei S, Amin A, Mohebbi B, Parhizgar SE, Aliannejad R, Eslami V, Kashefizadeh A, Dobesh PP, Kakavand H, Hosseini SH, Shafaghi S, Ghazi SF, Najafi A, Jimenez D, Gupta A, Madhavan MV, Sethi SS, Parikh SA, Monreal M, Hadavand N, Hajighasemi A, Maleki M, Sadeghian S, Piazza G, Kirtane AJ, Van Tassell BW, Stone GW, Lip GYH, Krumholz HM, Goldhaber SZ, Sadeghipour P
Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial. Thromb Haemost. 2022 01; 122(1):131-141.
Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial.
Fox KAA, Virdone S, Pieper KS, Bassand JP, Camm AJ, Fitzmaurice DA, Goldhaber SZ, Goto S, Haas S, Kayani G, Oto A, Misselwitz F, Piccini JP, Dalgaard F, Turpie AGG, Verheugt FWA, Kakkar AK
European heart journal. Quality of care & clinical outcomes
GARFIELD-AF risk score for mortality, stroke, and bleeding within 2 years in patients with atrial fibrillation. Eur Heart J Qual Care Clin Outcomes. 2022 03 02; 8(2):214-227.
GARFIELD-AF risk score for mortality, stroke, and bleeding within 2 years in patients with atrial fibrillation.
Talasaz AH, Sadeghipour P, Aghakouchakzadeh M, Dreyfus I, Kakavand H, Ariannejad H, Gupta A, Madhavan MV, Van Tassell BW, Jimenez D, Monreal M, Vaduganathan M, Fanikos J, Dixon DL, Piazza G, Parikh SA, Bhatt DL, Lip GY, Stone GW, Krumholz HM, Libby P, Goldhaber SZ, Bikdeli B
medRxiv : the preprint server for health sciences
Lipid-Modulating Agents for Prevention or Treatment of COVID-19 in Randomized Trials. medRxiv. 2021 May 04.
Lipid-Modulating Agents for Prevention or Treatment of COVID-19 in Randomized Trials.
Schellong S, Ageno W, Casella IB, Chee KH, Schulman S, Singer DE, Desch M, Tang W, Voccia I, Zint K, Goldhaber SZ
Profile of Patients with Isolated Distal Deep Vein Thrombosis versus Proximal Deep Vein Thrombosis or Pulmonary Embolism: RE-COVERY DVT/PE Study. Semin Thromb Hemost. 2022 Jun; 48(4):446-458.
Profile of Patients with Isolated Distal Deep Vein Thrombosis versus Proximal Deep Vein Thrombosis or Pulmonary Embolism: RE-COVERY DVT/PE Study.
Stroke risk factors and outcomes among hospitalized women with atrial fibrillation. J Thromb Thrombolysis. 2021 Nov; 52(4):1023-1031.
Stroke risk factors and outcomes among hospitalized women with atrial fibrillation.
Goto S, Turpie AGG, Farjat AE, Weitz JI, Haas S, Ageno W, Goldhaber SZ, Angchaisuksiri P, Kayani G, MacCallum P, Schellong S, Bounameaux H, Mantovani LG, Prandoni P, Kakkar AK
The influence of anemia on clinical outcomes in venous thromboembolism: Results from GARFIELD-VTE. Thromb Res. 2021 07; 203:155-162.
The influence of anemia on clinical outcomes in venous thromboembolism: Results from GARFIELD-VTE.
Cools F, Johnson D, Camm AJ, Bassand JP, Verheugt FWA, Yang S, Tsiatis A, Fitzmaurice DA, Goldhaber SZ, Kayani G, Goto S, Haas S, Misselwitz F, Turpie AGG, Fox KAA, Pieper KS, Kakkar AK
Risks associated with discontinuation of oral anticoagulation in newly diagnosed patients with atrial fibrillation: Results from the GARFIELD-AF Registry. J Thromb Haemost. 2021 09; 19(9):2322-2334.
Risks associated with discontinuation of oral anticoagulation in newly diagnosed patients with atrial fibrillation: Results from the GARFIELD-AF Registry.
Bikdeli B, Chatterjee S, Arora S, Monreal M, Jimenez D, Krumholz HM, Goldhaber SZ, Elkind MSV, Piazza G
Cerebral Venous Sinus Thrombosis in the U.S. Population, After Adenovirus-Based SARS-CoV-2 Vaccination, and After COVID-19. J Am Coll Cardiol. 2021 07 27; 78(4):408-411.
Cerebral Venous Sinus Thrombosis in the U.S. Population, After Adenovirus-Based SARS-CoV-2 Vaccination, and After COVID-19.
Wadhera RK, Secemsky EA, Wang Y, Yeh RW, Goldhaber SZ
Association of Socioeconomic Disadvantage With Mortality and Readmissions Among Older Adults Hospitalized for Pulmonary Embolism in the United States. J Am Heart Assoc. 2021 07 06; 10(13):e021117.
Association of Socioeconomic Disadvantage With Mortality and Readmissions Among Older Adults Hospitalized for Pulmonary Embolism in the United States.
Campia U, Rizzo SM, Snyder JE, Pfefferman MA, Morrison RB, Piazza G, Goldhaber SZ
Impact of Atrial Fibrillation on In-Hospital Mortality and Stroke in Acute Aortic Syndromes. Am J Med. 2021 11; 134(11):1419-1423.
Impact of Atrial Fibrillation on In-Hospital Mortality and Stroke in Acute Aortic Syndromes.
Barco S, Valerio L, Gallo A, Turatti G, Mahmoudpour SH, Ageno W, Castellucci LA, Cesarman-Maus G, Ddungu H, De Paula EV, Dumantepe M, Goldhaber SZ, Guillermo Esposito MC, Klok FA, Kucher N, McLintock C, Ní Áinle F, Simioni P, Spirk D, Spyropoulos AC, Urano T, Zhai ZG, Hunt BJ, Konstantinides SV
Global reporting of pulmonary embolism-related deaths in the World Health Organization mortality database: Vital registration data from 123 countries. Res Pract Thromb Haemost. 2021 Jul; 5(5):e12520.
Global reporting of pulmonary embolism-related deaths in the World Health Organization mortality database: Vital registration data from 123 countries.
Bikdeli B, Yanamandala M, Wang X, Campia U, Gravereaux EC, Padera RF, Gerhard-Herman M, Piazza G, Goldhaber SZ
Images in Vascular Medicine: Pulmonary embolism and acute aortic syndromes - Double trouble when vascular medicine emergencies meet. Vasc Med. 2022 02; 27(1):97-99.
Images in Vascular Medicine: Pulmonary embolism and acute aortic syndromes - Double trouble when vascular medicine emergencies meet.
Goldhaber SZ, Ageno W, Casella IB, Chee KH, Schellong S, Singer DE, Voccia I, Tang W, Schulman S
Safety and effectiveness of dabigatran in routine clinical practice: the RE-COVERY DVT/PE study. J Thromb Thrombolysis. 2022 Feb; 53(2):399-409.
Safety and effectiveness of dabigatran in routine clinical practice: the RE-COVERY DVT/PE study.
Bikdeli B, Jiménez D, Del Toro J, Piazza G, Rivas A, Fernández-Reyes JL, Sampériz Á, Otero R, Suriñach JM, Siniscalchi C, Martín-Guerra JM, Castro J, Muriel A, Lip GYH, Goldhaber SZ, Monreal M
Association Between Preexisting Versus Newly Identified Atrial Fibrillation and Outcomes of Patients With Acute Pulmonary Embolism. J Am Heart Assoc. 2021 09 07; 10(17):e021467.
Association Between Preexisting Versus Newly Identified Atrial Fibrillation and Outcomes of Patients With Acute Pulmonary Embolism.
Bikdeli B, Hogan H, Morrison RB, Fanikos J, Campia U, Barns BM, Pfeferman MB, Snyder JE, Khairani CD, Goldhaber SZ, Piazza G
Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in Patients with Provoked Venous Thromboembolism and Enduring Risk Factors: Rationale and Design of the HI-PRO Trial. Thromb Haemost. 2022 06; 122(6):1061-1070.
Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in Patients with Provoked Venous Thromboembolism and Enduring Risk Factors: Rationale and Design of the HI-PRO Trial.
Hoang BH, Do PG, Le LD, Bui TTH, Bui TN, Nguyen QM, To DH, Nguyen AD, Dinh MM, Goldhaber SZ, Day R, Nguyen HL
Safety, Efficacy of an Accelerated Regimen of Low-Dose Recombinant Tissue-Type Plasminogen Activator for Reperfusion Therapy of Acute Pulmonary Embolism. Clin Appl Thromb Hemost. 2021 Jan-Dec; 27:10760296211037920.
Safety, Efficacy of an Accelerated Regimen of Low-Dose Recombinant Tissue-Type Plasminogen Activator for Reperfusion Therapy of Acute Pulmonary Embolism.
Weitz JI, Farjat AE, Ageno W, Turpie AGG, Haas S, Goto S, Goldhaber SZ, Angchaisuksiri P, Gibbs H, MacCallum P, Carrier M, Kayani G, Schellong S, Bounameaux H, Mantovani LG, Prandoni P, Kakkar AK
Influence of body mass index on clinical outcomes in venous thromboembolism: Insights from GARFIELD-VTE. J Thromb Haemost. 2021 12; 19(12):3031-3043.
Influence of body mass index on clinical outcomes in venous thromboembolism: Insights from GARFIELD-VTE.
Fanikos J, Marquis K, Buckley L, Tran LK, McLaughlin K, Golash AJ, Campia U, Piazza G, Connors JM, Goldhaber SZ
Stability of alteplase for ultrasound-facilitated catheter-directed thrombolysis. Blood Adv. 2021 12 14; 5(23):5283-5289.
Stability of alteplase for ultrasound-facilitated catheter-directed thrombolysis.
Minhas J, Nardelli P, Hassan SM, Al-Naamani N, Harder E, Ash S, Sánchez-Ferrero GV, Mason S, Hunsaker AR, Piazza G, Goldhaber SZ, Waxman AB, Kawut SM, Estépar RSJ, Washko GR, Rahaghi FN
Loss of Pulmonary Vascular Volume as a Predictor of Right Ventricular Dysfunction and Mortality in Acute Pulmonary Embolism. Circ Cardiovasc Imaging. 2021 09; 14(9):e012347.
Loss of Pulmonary Vascular Volume as a Predictor of Right Ventricular Dysfunction and Mortality in Acute Pulmonary Embolism.
Talasaz AH, Sadeghipour P, Aghakouchakzadeh M, Kakavand H, Ariannejad H, Connors JM, Hunt BJ, Berger JS, Van Tassell BW, Middeldorp S, Piazza G, Weitz JI, Cushman M, Lip GYH, Goldhaber SZ, Bikdeli B
Use of novel antithrombotic agents for COVID-19: Systematic summary of ongoing randomized controlled trials. J Thromb Haemost. 2021 12; 19(12):3080-3089.
Use of novel antithrombotic agents for COVID-19: Systematic summary of ongoing randomized controlled trials.
Ross C, Kumar R, Pelland-Marcotte MC, Mehta S, Kleinman ME, Thiagarajan RR, Ghbeis MB, VanderPluym CJ, Friedman KG, Porras D, Fynn-Thompson F, Goldhaber SZ, Brandão LR
Acute Management of High-Risk and Intermediate-Risk Pulmonary Embolism in Children: A Review. Chest. 2022 03; 161(3):791-802.
Acute Management of High-Risk and Intermediate-Risk Pulmonary Embolism in Children: A Review.
Goldhaber SZ, Magnuson EA, Chinnakondepalli KM, Cohen DJ, Vedantham S
Catheter-directed thrombolysis for deep vein thrombosis: 2021 update. Vasc Med. 2021 12; 26(6):662-669.
Catheter-directed thrombolysis for deep vein thrombosis: 2021 update.
Talasaz AH, Sadeghipour P, Aghakouchakzadeh M, Dreyfus I, Kakavand H, Ariannejad H, Gupta A, Madhavan MV, Van Tassell BW, Jimenez D, Monreal M, Vaduganathan M, Fanikos J, Dixon DL, Piazza G, Parikh SA, Bhatt DL, Lip GYH, Stone GW, Krumholz HM, Libby P, Goldhaber SZ, Bikdeli B
Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19: JACC State-of-the-Art Review. J Am Coll Cardiol. 2021 10 19; 78(16):1635-1654.
Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19: JACC State-of-the-Art Review.
Streiff MB, Holmstrom B, Angelini D, Ashrani A, Elshoury A, Fanikos J, Fertrin KY, Fogerty AE, Gao S, Goldhaber SZ, Gundabolu K, Ibrahim I, Kraut E, Leavitt AD, Lee A, Lee JT, Lim M, Mann J, Martin K, McMahon B, Moriarty J, Morton C, Ortel TL, Paschal R, Schaefer J, Shattil S, Siddiqi T, Sudheendra D, Williams E, Hollinger L, Nguyen MQ
Cancer-Associated Venous Thromboembolic Disease, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021 10 15; 19(10):1181-1201.
Cancer-Associated Venous Thromboembolic Disease, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Cohen O, Ageno W, Farjat AE, Turpie AGG, Weitz JI, Haas S, Goto S, Goldhaber SZ, Angchaisuksiri P, Gibbs H, MacCallum P, Kayani G, Schellong S, Bounameaux H, Mantovani LG, Prandoni P, Kakkar AK
Management strategies and clinical outcomes in patients with inferior vena cava thrombosis: Data from GARFIELD-VTE. J Thromb Haemost. 2022 02; 20(2):366-374.
Management strategies and clinical outcomes in patients with inferior vena cava thrombosis: Data from GARFIELD-VTE.
Corrigendum to "Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE" [Thromb. Res. 2020 Jul; 191:103-112]. Thromb Res. 2022 Aug; 216:129.
Corrigendum to "Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE" [Thromb. Res. 2020 Jul; 191:103-112].
Corrigendum to "Venous thromboembolism in Asia and worldwide: Emerging insights from GARFIELD-VTE" [Thromb. Res. 2021 May;201:63-72]. Thromb Res. 2022 Jan; 209:105.
Corrigendum to "Venous thromboembolism in Asia and worldwide: Emerging insights from GARFIELD-VTE" [Thromb. Res. 2021 May;201:63-72].
Fox KAA, Virdone S, Bassand JP, Camm AJ, Goto S, Goldhaber SZ, Haas S, Kayani G, Koretsune Y, Misselwitz F, Oh S, Piccini JP, Parkhomenko A, Sawhney JPS, Stepinska J, Turpie AGG, Verheugt FWA, Kakkar AK
Do baseline characteristics and treatments account for geographical disparities in the outcomes of patients with newly diagnosed atrial fibrillation? The prospective GARFIELD-AF registry. BMJ Open. 2022 Jan 07; 12(1):e049933.
Do baseline characteristics and treatments account for geographical disparities in the outcomes of patients with newly diagnosed atrial fibrillation? The prospective GARFIELD-AF registry.
Kalayci A, Gibson CM, Hernandez AF, Hull RD, Cohen AT, Fitzgerald C, Hussain SD, Chi G, Alkhalfan F, Harrington RA, Goldhaber SZ
Inverse relationship between body mass index and risk of venous thromboembolism among medically ill hospitalized patients: Observations from the APEX trial. Thromb Res. 2022 Mar; 211:63-69.
Inverse relationship between body mass index and risk of venous thromboembolism among medically ill hospitalized patients: Observations from the APEX trial.
Pellegrini VD, Eikelboom JW, Evarts CM, Franklin PD, Garvin KL, Goldhaber SZ, Iorio R, Lambourne CA, Magaziner J, Magder L
Randomised comparative effectiveness trial of Pulmonary Embolism Prevention after hiP and kneE Replacement (PEPPER): the PEPPER trial protocol. BMJ Open. 2022 03 08; 12(3):e060000.
Randomised comparative effectiveness trial of Pulmonary Embolism Prevention after hiP and kneE Replacement (PEPPER): the PEPPER trial protocol.
Bikdeli B, Khairani CD, Barns BM, Rosovsky RP, Jimenez D, Monreal M, Sylvester KW, Middeldorp S, Bates SM, Krumholz HM, Goldhaber SZ, Hunt BJ, Piazza G
Women's representation in venous thromboembolism randomized trials and registries: The illustrative example of direct oral anticoagulants for acute treatment. Contemp Clin Trials. 2022 04; 115:106714.
Women's representation in venous thromboembolism randomized trials and registries: The illustrative example of direct oral anticoagulants for acute treatment.
Bikdeli B, Piazza G, Jimenez D, Muriel A, Wang Y, Khairani CD, Rosovsky RP, Mehdipoor G, O'Donoghue ML, Spagnolo P, Dreyer RP, Bertoletti L, López-Jiménez L, Núñez MJ, Blanco-Molina Á, Bates SM, Gerhard-Herman M, Goldhaber SZ, Monreal M, Krumholz HM
Sex Differences in PrEsentation, Risk Factors, Drug and Interventional Therapies, and OUtcomes of Elderly PatientS with Pulmonary Embolism: Rationale and design of the SERIOUS-PE study. Thromb Res. 2022 06; 214:122-131.
Sex Differences in PrEsentation, Risk Factors, Drug and Interventional Therapies, and OUtcomes of Elderly PatientS with Pulmonary Embolism: Rationale and design of the SERIOUS-PE study.
Abunimer AM, Lak AM, Calvachi P, Smith TR, Aglio LS, Almefty KK, Dunn IF, Bi WL, Goldhaber SZ, Al-Mefty O
Early Detection and Management of Venous Thrombosis in Skull Base Surgery: Role of Routine Doppler Ultrasound Monitoring. Neurosurgery. 2022 07 01; 91(1):115-122.
Early Detection and Management of Venous Thrombosis in Skull Base Surgery: Role of Routine Doppler Ultrasound Monitoring.
Sylvester KW, Chen A, Lewin A, Fanikos J, Goldhaber SZ, Connors JM
Optimization of DOAC management services in a centralized anticoagulation clinic. Res Pract Thromb Haemost. 2022 Mar; 6(3):e12696.
Optimization of DOAC management services in a centralized anticoagulation clinic.
Klok FA, Piazza G, Sharp ASP, Ní Ainle F, Jaff MR, Chauhan N, Patel B, Barco S, Goldhaber SZ, Kucher N, Lang IM, Schmidtmann I, Sterling KM, Becker D, Martin N, Rosenfield K, Konstantinides SV
Ultrasound-facilitated, catheter-directed thrombolysis vs anticoagulation alone for acute intermediate-high-risk pulmonary embolism: Rationale and design of the HI-PEITHO study. Am Heart J. 2022 09; 251:43-53.
Ultrasound-facilitated, catheter-directed thrombolysis vs anticoagulation alone for acute intermediate-high-risk pulmonary embolism: Rationale and design of the HI-PEITHO study.
Leiva O, Campia U, Snyder J, Barns BM, Rizzo S, Khairani CD, Brunner A, Al-Samkari H, Leaf RK, Rosovsky R, Goodarzi K, Bornikova L, Fathi A, Goldhaber SZ, Hobbs G, Piazza G
Patients with myeloproliferative neoplasms and COVID-19 have increased rates of arterial thrombosis. Res Pract Thromb Haemost. 2022 Jul; 6(5):e12752.
Patients with myeloproliferative neoplasms and COVID-19 have increased rates of arterial thrombosis.
Bikdeli B, Zahedi Tajrishi F, Sadeghipour P, Talasaz AH, Fanikos J, Lippi G, Siegal DM, Eikelboom JW, Monreal M, Jimenez D, Connors JM, Ageno W, Barnes GD, Piazza G, Angiolillo DJ, Parikh SA, Kirtane AJ, Lopes RD, Bhatt DL, Weitz JI, Mehran R, Krumholz HM, Goldhaber SZ, Lip GYH
Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants: A Review. JAMA Cardiol. 2022 07 01; 7(7):747-759.
Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants: A Review.
Nicolajsen CW, Søgaard M, Eldrup N, Jensen M, Larsen TB, Goldhaber SZ, Nielsen PB
European journal of preventive cardiology
Temporal trends in abdominal aortic aneurysmal disease: a nationwide cohort study on cardiovascular morbidity and medical cardioprotective therapy. Eur J Prev Cardiol. 2022 11 08; 29(15):1957-1964.
Temporal trends in abdominal aortic aneurysmal disease: a nationwide cohort study on cardiovascular morbidity and medical cardioprotective therapy.
Uninterrupted Oral Anticoagulation During Catheter Ablation of Ventricular Tachycardia: Is the Riskier Option the Safest? JACC Clin Electrophysiol. 2022 06; 8(6):749-753.
Uninterrupted Oral Anticoagulation During Catheter Ablation of Ventricular Tachycardia: Is the Riskier Option the Safest?
Chopard R, Campia U, Morin L, Jering KS, Almarzooq ZI, Snyder JE, Rizzo S, Waxman AB, Goldhaber SZ, Piazza G
Trends in management and outcomes of pulmonary embolism with a multidisciplinary response team. J Thromb Thrombolysis. 2022 Oct; 54(3):449-460.
Trends in management and outcomes of pulmonary embolism with a multidisciplinary response team.
Khairani CD, Bejjani A, Piazza G, Jimenez D, Monreal M, Chatterjee S, Pengo V, Woller SC, Cortes-Hernandez J, Connors JM, Kanthi Y, Krumholz HM, Middeldorp S, Falanga A, Cushman M, Goldhaber SZ, Garcia DA, Bikdeli B
Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes: Meta-Analysis of Randomized Trials. J Am Coll Cardiol. 2023 01 03; 81(1):16-30.
Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes: Meta-Analysis of Randomized Trials.
Sadeghipour P, Jenab Y, Moosavi J, Hosseini K, Mohebbi B, Hosseinsabet A, Chatterjee S, Pouraliakbar H, Shirani S, Shishehbor MH, Alizadehasl A, Farrashi M, Rezvani MA, Rafiee F, Jalali A, Rashedi S, Shafe O, Giri J, Monreal M, Jimenez D, Lang I, Maleki M, Goldhaber SZ, Krumholz HM, Piazza G, Bikdeli B
Catheter-Directed Thrombolysis vs Anticoagulation in Patients With Acute Intermediate-High-risk Pulmonary Embolism: The CANARY Randomized Clinical Trial. JAMA Cardiol. 2022 12 01; 7(12):1189-1197.
Catheter-Directed Thrombolysis vs Anticoagulation in Patients With Acute Intermediate-High-risk Pulmonary Embolism: The CANARY Randomized Clinical Trial.
Farmakis IT, Valerio L, Bikdeli B, Connors JM, Giannakoulas G, Goldhaber SZ, Hobohm L, Hunt BJ, Keller K, Spyropoulos AC, Barco S
Annual Mortality Related to Pulmonary Embolism in the U.S. Before and During the COVID-19 Pandemic. J Am Coll Cardiol. 2022 10 18; 80(16):1579-1581.
Annual Mortality Related to Pulmonary Embolism in the U.S. Before and During the COVID-19 Pandemic.
Haas S, Farjat AE, Pieper K, Ageno W, Angchaisuksiri P, Bounameaux H, Goldhaber SZ, Goto S, Mantovani L, Prandoni P, Schellong S, Turpie AGG, Weitz JI, MacCallum P, Cate HT, Panchenko E, Carrier M, Jerjes-Sanchez C, Gibbs H, Jansky P, Kayani G, Kakkar AK
On-treatment Comparative Effectiveness of Vitamin K Antagonists and Direct Oral Anticoagulants in GARFIELD-VTE, and Focus on Cancer and Renal Disease. TH Open. 2022 Oct; 6(4):e354-e364.
On-treatment Comparative Effectiveness of Vitamin K Antagonists and Direct Oral Anticoagulants in GARFIELD-VTE, and Focus on Cancer and Renal Disease.
Albertsen IE, Konstantinides SV, Piazza G, Goldhaber SZ, Larsen TB, Søgaard M, Nielsen PB
Risk of Recurrent Venous Thromboembolism in Selected Subgroups of Men: A Danish Nationwide Cohort Study. TH Open. 2022 Oct; 6(4):e378-e386.
Risk of Recurrent Venous Thromboembolism in Selected Subgroups of Men: A Danish Nationwide Cohort Study.
Turpie AGG, Farjat AE, Haas S, Ageno W, Weitz JI, Goldhaber SZ, Goto S, Angchaisuksiri P, Kayani G, Lopes RD, Chiang CE, Gibbs H, Tse E, Verhamme P, Ten Cate H, Muntaner J, Schellong S, Bounameaux H, Prandoni P, Maheshwari U, Kakkar AK
36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE. Thromb Res. 2023 02; 222:31-39.
36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE.
Chi G, Violi F, Pignatelli P, Vestri A, Spagnoli A, Loffredo L, Hernandez AF, Hull RD, Cohen AT, Harrington RA, Goldhaber SZ, Gibson CM
External validation of the ADA score for predicting thrombosis among acutely ill hospitalized medical patients from the APEX Trial. J Thromb Thrombolysis. 2023 Feb; 55(2):211-221.
External validation of the ADA score for predicting thrombosis among acutely ill hospitalized medical patients from the APEX Trial.
O'Toole RV, Stein DM, O'Hara NN, Frey KP, Taylor TJ, Scharfstein DO, Carlini AR, Sudini K, Degani Y, Slobogean GP, Haut ER, Obremskey W, Firoozabadi R, Bosse MJ, Goldhaber SZ, Marvel D, Castillo RC
Aspirin or Low-Molecular-Weight Heparin for Thromboprophylaxis after a Fracture. N Engl J Med. 2023 01 19; 388(3):203-213.
Aspirin or Low-Molecular-Weight Heparin for Thromboprophylaxis after a Fracture.
Chopard R, Campia U, Jering KS, Almarzooq ZI, Snyder JE, Rizzo S, Waxman AB, Goldhaber SZ, Piazza G
Guideline adherence and clinical outcomes of patients with acute pulmonary embolism evaluated by a multidisciplinary response team at a quaternary care center. Thromb Res. 2023 02; 222:113-116.
Guideline adherence and clinical outcomes of patients with acute pulmonary embolism evaluated by a multidisciplinary response team at a quaternary care center.
Nicolajsen CW, Nielsen PB, Jensen M, Eldrup N, Larsen TB, Lip GYH, Goldhaber SZ, Søgaard M
Stroke and Myocardial Infarction in Patients with Abdominal Aortic Aneurysm and New-Onset Atrial Fibrillation. Thromb Haemost. 2023 May; 123(5):555-564.
Stroke and Myocardial Infarction in Patients with Abdominal Aortic Aneurysm and New-Onset Atrial Fibrillation.
Bikdeli B, Lo YC, Khairani CD, Bejjani A, Jimenez D, Barco S, Mahajan S, Caraballo C, Secemsky EA, Klok FA, Hunsaker AR, Aghayev A, Muriel A, Wang Y, Hussain MA, Appah-Sampong A, Lu Y, Lin Z, Aneja S, Khera R, Goldhaber SZ, Zhou L, Monreal M, Krumholz HM, Piazza G
Developing Validated Tools to Identify Pulmonary Embolism in Electronic Databases: Rationale and Design of the PE-EHR+ Study. Thromb Haemost. 2023 Jun; 123(6):649-662.
Developing Validated Tools to Identify Pulmonary Embolism in Electronic Databases: Rationale and Design of the PE-EHR+ Study.
Bikdeli B, Muriel A, Wang Y, Piazza G, Khairani CD, Rosovsky RP, Mehdipoor G, O'Donoghue ML, Madridano O, Lopez-Saez JB, Mellado M, Brasero AMD, Grandone E, Spagnolo PA, Lu Y, Bertoletti L, López-Jiménez L, Núñez MJ, Blanco-Molina Á, Gerhard-Herman M, Goldhaber SZ, Bates SM, Jimenez D, Krumholz HM, Monreal M
Sex-Related Differences in Patient Characteristics, Risk Factors, and Symptomatology in Older Adults with Pulmonary Embolism: Findings from the SERIOUS-PE Study. Semin Thromb Hemost. 2023 Oct; 49(7):725-735.
Sex-Related Differences in Patient Characteristics, Risk Factors, and Symptomatology in Older Adults with Pulmonary Embolism: Findings from the SERIOUS-PE Study.
Mantovani LG, Cozzolino P, Ferrara P, Virdone S, Camm AJ, Verheugt FWA, Bassand JP, Turpie AGG, Hacke W, Kayani G, Goldhaber SZ, Goto S, Pieper KS, Gersh BJ, Fox KAA, Haas S, van Eickels M, Kakkar AK
Healthcare Resource Utilization in Patients with Newly Diagnosed Atrial Fibrillation: A Global Analysis from the GARFIELD-AF Registry. Healthcare (Basel). 2023 Feb 21; 11(5).
Healthcare Resource Utilization in Patients with Newly Diagnosed Atrial Fibrillation: A Global Analysis from the GARFIELD-AF Registry.
Taqueti VR, Shah AM, Everett BM, Pradhan AD, Piazza G, Bibbo C, Hainer J, Morgan V, Carolina do A H de Souza A, Skali H, Blankstein R, Dorbala S, Goldhaber SZ, Le May MR, Chow BJW, deKemp RA, Hage FG, Beanlands RS, Libby P, Glynn RJ, Solomon SD, Ridker PM, Di Carli MF
Coronary Flow Reserve, Inflammation, and Myocardial Strain: The CIRT-CFR Trial. JACC Basic Transl Sci. 2023 Feb; 8(2):141-151.
Coronary Flow Reserve, Inflammation, and Myocardial Strain: The CIRT-CFR Trial.
Talasaz AH, Sadeghipour P, Bakhshandeh H, Sharif-Kashani B, Rashidi F, Beigmohammadi MT, Moghadam KG, Rezaian S, Dabbagh A, Sezavar SH, Farrokhpour M, Abedini A, Aliannejad R, Riahi T, Yadollahzadeh M, Lookzadeh S, Rezaeifar P, Matin S, Tahamtan O, Mohammadi K, Zoghi E, Rahmani H, Hosseini SH, Mousavian SM, Abri H, Sadeghipour P, Baghizadeh E, Rafiee F, Jamalkhani S, Amin A, Mohebbi B, Parhizgar SE, Soleimanzadeh M, Aghakouchakzadeh M, Eslami V, Payandemehr P, Khalili H, Talakoob H, Tojari T, Shafaghi S, Tabrizi S, Kakavand H, Kashefizadeh A, Najafi A, Jimenez D, Gupta A, Madhavan MV, Sethi SS, Parikh SA, Monreal M, Hadavand N, Hajighasemi A, Ansarin K, Maleki M, Sadeghian S, Barco S, Siegerink B, Spatz ES, Piazza G, Kirtane AJ, Tassell BWV, Lip GYH, Klok FA, Goldhaber SZ, Stone GW, Krumholz HM, Bikdeli B
Atorvastatin versus Placebo in ICU Patients with COVID-19: Ninety-day Results of the INSPIRATION-S Trial. Thromb Haemost. 2023 Jul; 123(7):723-733.
Atorvastatin versus Placebo in ICU Patients with COVID-19: Ninety-day Results of the INSPIRATION-S Trial.
Rizzo SM, Tavakol S, Bi WL, Li S, Secemsky EA, Campia U, Piazza G, Goldhaber SZ, Schmaier AA
Meningioma resection and venous thromboembolism incidence, management, and outcomes. Res Pract Thromb Haemost. 2023 Feb; 7(2):100121.
Meningioma resection and venous thromboembolism incidence, management, and outcomes.
Piazza G, Hurwitz S, Campia U, Bikdeli B, Lou J, Khairani CD, Bejjani A, Snyder JE, Pfeferman M, Barns B, Rizzo S, Glezer A, Goldhaber SZ
Electronic alerts for ambulatory patients with atrial fibrillation not prescribed anticoagulation: A randomized, controlled trial (AF-ALERT2). Thromb Res. 2023 07; 227:1-7.
Electronic alerts for ambulatory patients with atrial fibrillation not prescribed anticoagulation: A randomized, controlled trial (AF-ALERT2).
Fanikos J, Tawfik Y, Almheiri D, Sylvester K, Buckley LF, Dew C, Dell'Orfano H, Armero A, Bejjani A, Bikdeli B, Campia U, Davies J, Fiumara K, Hogan H, Khairani CD, Krishnathasan D, Lou J, Makawi A, Morrison RH, Porio N, Tristani A, Connors JM, Goldhaber SZ, Piazza G
Anticoagulation-Associated Adverse Drug Events in Hospitalized Patients Across Two Time Periods. Am J Med. 2023 09; 136(9):927-936.e3.
Anticoagulation-Associated Adverse Drug Events in Hospitalized Patients Across Two Time Periods.
Bikdeli B, Khairani CD, Krishnathasan D, Bejjani A, Armero A, Tristani A, Davies J, Porio N, Assi AA, Nauffal V, Campia U, Almarzooq Z, Wei E, Achanta A, Jesudasen SJ, Tiu BC, Merli GJ, Leiva O, Fanikos J, Sharma A, Vishnevsky A, Hsia J, Nehler MR, Welker J, Bonaca MP, Carroll BJ, Lan Z, Goldhaber SZ, Piazza G
Major cardiovascular events after COVID-19, event rates post-vaccination, antiviral or anti-inflammatory therapy, and temporal trends: Rationale and methodology of the CORONA-VTE-Network study. Thromb Res. 2023 08; 228:94-104.
Major cardiovascular events after COVID-19, event rates post-vaccination, antiviral or anti-inflammatory therapy, and temporal trends: Rationale and methodology of the CORONA-VTE-Network study.
Bassand JP, Virdone S, Camm AJ, Fox KAA, Goldhaber SZ, Goto S, Haas S, Hacke W, Kayani G, Keltai M, Misselwitz F, Pieper KS, Turpie AGG, Verheugt FWA, Kakkar AK
Oral anticoagulation across diabetic subtypes in patients with newly diagnosed atrial fibrillation: A report from the GARFIELD-AF registry. Diabetes Obes Metab. 2023 10; 25(10):3040-3053.
Oral anticoagulation across diabetic subtypes in patients with newly diagnosed atrial fibrillation: A report from the GARFIELD-AF registry.
Camm AJ, Steffel J, Virdone S, Bassand JP, Fox KAA, Goldhaber SZ, Goto S, Haas S, Turpie AGG, Verheugt FWA, Misselwitz F, Herreros RC, Kayani G, Pieper KS, Kakkar AK
Guideline-directed medical therapies for comorbidities among patients with atrial fibrillation: results from GARFIELD-AF. Eur Heart J Open. 2023 May; 3(3):oead051.
Guideline-directed medical therapies for comorbidities among patients with atrial fibrillation: results from GARFIELD-AF.
Sista AK, Vedantham S, Kahn SR, Desai KR, Goldhaber SZ
Research Consensus Panel Follow-up: 8-Year Update on Submassive Pulmonary Embolism. J Vasc Interv Radiol. 2023 10; 34(10):1658-1663.
Research Consensus Panel Follow-up: 8-Year Update on Submassive Pulmonary Embolism.
Obesity and Pulmonary Embolism: Can We Dismantle the "Obesity Paradox". Thromb Haemost. 2024 01; 124(1):58-60.
Obesity and Pulmonary Embolism: Can We Dismantle the "Obesity Paradox".
Goldhaber SZ, Bassand JP, Camm AJ, Virdone S, Pieper K, Cools F, Corbalan R, Gersh BJ, Goto S, Haas S, Misselwitz F, Parkhomenko A, Steffel J, Stepinska J, Turpie AGG, Verheugt FWA, Kayani G, Kakkar AK
Clinical Outcomes in Older Patients with Atrial Fibrillation: Insights from the GARFIELD-AF Registry. Am J Med. 2024 02; 137(2):128-136.e13.
Clinical Outcomes in Older Patients with Atrial Fibrillation: Insights from the GARFIELD-AF Registry.
Nicolajsen CW, Søgaard M, Jensen M, Eldrup N, Larsen TB, Goldhaber SZ, Behrendt CA, Nielsen PB
Antiplatelet Therapy in Patients With Abdominal Aortic Aneurysm Without Symptomatic Atherosclerotic Disease. JAMA Netw Open. 2023 10 02; 6(10):e2339715.
Antiplatelet Therapy in Patients With Abdominal Aortic Aneurysm Without Symptomatic Atherosclerotic Disease.
Chen AC, Rao AS, Oropallo A, Goldhaber SZ, Fluharty ME, Maheshwari U, Carrier M, Turpie AGG, Pieper K, Kayani G, Kakkar AK
Comparing U.S. and Canadian treatment patterns on venous thromboembolism outcomes in the GARFIELD-VTE registry. Thromb Res. 2023 12; 232:123-132.
Comparing U.S. and Canadian treatment patterns on venous thromboembolism outcomes in the GARFIELD-VTE registry.
Bikdeli B, Sadeghipour P, Lou J, Bejjani A, Khairani CD, Rashedi S, Lookstein R, Lansky A, Vedantham S, Sobieszczyk P, Mena-Hurtado C, Aghayev A, Henke P, Mehdipoor G, Tufano A, Chatterjee S, Middeldorp S, Wasan S, Bashir R, Lang IM, Shishehbor MH, Gerhard-Herman M, Giri J, Menard MT, Parikh SA, Mazzolai L, Moores L, Monreal M, Jimenez D, Goldhaber SZ, Krumholz HM, Piazza G
Developmental or Procedural Vena Cava Interruption and Venous Thromboembolism: A Review. Semin Thromb Hemost. 2024 Sep; 50(6):851-865.
Developmental or Procedural Vena Cava Interruption and Venous Thromboembolism: A Review.
Bejjani A, Khairani CD, Assi A, Piazza G, Sadeghipour P, Talasaz AH, Fanikos J, Connors JM, Siegal DM, Barnes GD, Martin KA, Angiolillo DJ, Kleindorfer D, Monreal M, Jimenez D, Middeldorp S, Elkind MSV, Ruff CT, Goldhaber SZ, Krumholz HM, Mehran R, Cushman M, Eikelboom JW, Lip GYH, Weitz JI, Lopes RD, Bikdeli B
When Direct Oral Anticoagulants Should Not Be Standard Treatment: JACC State-of-the-Art Review. J Am Coll Cardiol. 2024 01 23; 83(3):444-465.
When Direct Oral Anticoagulants Should Not Be Standard Treatment: JACC State-of-the-Art Review.
Sterling KM, Goldhaber SZ, Sharp ASP, Kucher N, Jones N, Maholic R, Meneveau N, Zlotnick D, Sayfo S, Konstantinides SV, Piazza G
Prospective Multicenter International Registry of Ultrasound-Facilitated Catheter-Directed Thrombolysis in Intermediate-High and High-Risk Pulmonary Embolism (KNOCOUT PE). Circ Cardiovasc Interv. 2024 03; 17(3):e013448.
Prospective Multicenter International Registry of Ultrasound-Facilitated Catheter-Directed Thrombolysis in Intermediate-High and High-Risk Pulmonary Embolism (KNOCOUT PE).
Rashedi S, Greason CM, Sadeghipour P, Talasaz AH, O'Donoghue ML, Jimenez D, Monreal M, Anderson CD, Elkind MSV, Kreuziger LMB, Lang IM, Goldhaber SZ, Konstantinides SV, Piazza G, Krumholz HM, Braunwald E, Bikdeli B
Fibrinolytic Agents in Thromboembolic Diseases: Historical Perspectives and Approved Indications. Semin Thromb Hemost. 2024 Jul; 50(5):773-789.
Fibrinolytic Agents in Thromboembolic Diseases: Historical Perspectives and Approved Indications.
Nicolaides AN, Fareed J, Spyropoulos AC, Kakkar RHL, Antignani PL, Avgerinos E, Baekgaard N, Barber E, Bush RL, Caprini JA, Clarke-Pearson DL, VAN Dreden P, Elalami I, Gerotziafas G, Gibbs H, Goldhaber S, Kakkos S, Lefkou E, Labropoulos N, Lopes RD, Mansilha A, Papageorgiou C, Prandoni P, Ramacciotti E, Rognoni C, Urbanek T, Walenga JM
International angiology : a journal of the International Union of Angiology
Prevention and management of venous thromboembolism. International Consensus Statement. Guidelines according to scientific evidence. Int Angiol. 2024 Feb; 43(1):1-222.
Prevention and management of venous thromboembolism. International Consensus Statement. Guidelines according to scientific evidence.
Talasaz AH, Sadeghipour P, Ortega-Paz L, Kakavand H, Aghakouchakzadeh M, Beavers C, Fanikos J, Eikelboom JW, Siegal DM, Monreal M, Jimenez D, Vaduganathan M, Castellucci LA, Cuker A, Barnes GD, Connors JM, Secemsky EA, Van Tassell BW, De Caterina R, Kurlander JE, Aminian A, Piazza G, Goldhaber SZ, Moores L, Middeldorp S, Kirtane AJ, Elkind MSV, Angiolillo DJ, Konstantinides S, Lip GYH, Stone GW, Cushman M, Krumholz HM, Mehran R, Bhatt DL, Bikdeli B
Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease. Nat Rev Cardiol. 2024 08; 21(8):574-592.
Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease.
Wadhera RK, Secemsky EA, Xu J, Yeh RW, Song Y, Goldhaber SZ
Community Socioeconomic Status, Acute Cardiovascular Hospitalizations, and Mortality in Medicare, 2003 to 2019. Circ Cardiovasc Qual Outcomes. 2024 Apr; 17(4):e010090.
Community Socioeconomic Status, Acute Cardiovascular Hospitalizations, and Mortality in Medicare, 2003 to 2019.
Bikdeli B, Krishnathasan D, Khairani CD, Bejjani A, Davies J, Porio N, Tristani A, Armero A, Assi AA, Nauffal V, Campia U, Almarzooq Z, Wei E, Ortiz-Rios MD, Zuluaga-Sánchez V, Achanta A, Jesudasen SJ, Tiu B, Merli GJ, Leiva O, Fanikos J, Grandone E, Sharma A, Rizzo S, Pfeferman MB, Morrison RB, Vishnevsky A, Hsia J, Nehler MR, Welker J, Bonaca MP, Carroll B, Goldhaber SZ, Lan Z, Piazza G
Low absolute risk of thrombotic and cardiovascular events in outpatient pregnant women with COVID-19. Thromb Res. 2024 05; 237:209-215.
Low absolute risk of thrombotic and cardiovascular events in outpatient pregnant women with COVID-19.
Streiff MB, Holmstrom B, Angelini D, Ashrani A, Buckner T, Diep R, Fertrin KY, Fogerty AE, Crestani NG, Gangaraju R, Rojas-Hernandez C, Goldhaber SZ, Ibrahim I, Kubal T, Leavitt AD, Lim M, Mann J, Mantha S, Morton C, Nester A, O'Brien A, Ortel TL, Pine A, Pishko A, Ranade M, Salmasi A, Schaefer J, Williams E, Wool G, Wun T, Montgomery S, Nguyen J, Freedman-Cass D, Sliker B
Cancer-Associated Venous Thromboembolic Disease, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2024 09; 22(7):483-506.
Cancer-Associated Venous Thromboembolic Disease, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
Atay JK, Fanikos J, Barnes GD, Ehle M, Coatney J, Piazza G, Froehlich JB, Goldhaber SZ
Effect of dabigatran on referrals to and switching from warfarin in two academic anticoagulation management services. Am J Cardiol. 2013 Aug 01; 112(3):387-9.
Effect of dabigatran on referrals to and switching from warfarin in two academic anticoagulation management services.
Piazza G, Anderson FA, Ortel TL, Cox MJ, Rosenberg DJ, Rahimian S, Pendergast WJ, McLaren GD, Welker JA, Akus JJ, Stevens SM, Elliott CG, Freeman AL, Patton WF, Dabbagh O, Wyman A, Huang W, Rao AF, Goldhaber SZ
Randomized trial of physician alerts for thromboprophylaxis after discharge. Am J Med. 2013 May; 126(5):435-42.
Randomized trial of physician alerts for thromboprophylaxis after discharge.
Goldhaber SZ, Ortel TL, Berry CA, Stowell SA, Gardner AJ
Improving clinician performance of inpatient venous thromboembolism risk assessment and prophylaxis. Hosp Pract (1995). 2013 Apr; 41(2):123-31.
Improving clinician performance of inpatient venous thromboembolism risk assessment and prophylaxis.
Lester-Coll NH, Goldhaber SZ, Sher DJ, D'Amico AV
Death from high-risk prostate cancer versus cardiovascular mortality with hormonal therapy: a decision analysis. Cancer. 2013 May 15; 119(10):1808-15.
Death from high-risk prostate cancer versus cardiovascular mortality with hormonal therapy: a decision analysis.
Kakkar AK, Mueller I, Bassand JP, Fitzmaurice DA, Goldhaber SZ, Goto S, Haas S, Hacke W, Lip GY, Mantovani LG, Turpie AG, van Eickels M, Misselwitz F, Rushton-Smith S, Kayani G, Wilkinson P, Verheugt FW
Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry. PLoS One. 2013; 8(5):e63479.
Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry.
Konstantinides SV, Sanchez O, Goldhaber SZ, Meneveau N
Advancing the management of acute intermediate-high-risk pulmonary embolism: The enduring legacy of Professor Guy Meyer. Presse Med. 2024 Sep; 53(3):104248.
Advancing the management of acute intermediate-high-risk pulmonary embolism: The enduring legacy of Professor Guy Meyer.
Talasaz AH, McGonagle B, HajiQasemi M, Ghelichkhan ZA, Sadeghipour P, Rashedi S, Cuker A, Lech T, Goldhaber SZ, Jennings DL, Piazza G, Bikdeli B
Pharmacokinetic and Pharmacodynamic Interactions between Food or Herbal Products and Oral Anticoagulants: Evidence Review, Practical Recommendations, and Knowledge Gaps. Semin Thromb Hemost. 2025 Jun; 51(5):560-571.
Pharmacokinetic and Pharmacodynamic Interactions between Food or Herbal Products and Oral Anticoagulants: Evidence Review, Practical Recommendations, and Knowledge Gaps.
Bikdeli B, Khairani CD, Bejjani A, Lo YC, Mahajan S, Caraballo C, Jimenez JV, Krishnathasan D, Zarghami M, Rashedi S, Jimenez D, Barco S, Secemsky EA, Klok FA, Hunsaker AR, Aghayev A, Muriel A, Hussain MA, Appah-Sampong A, Lu Y, Lin Z, Mojibian H, Aneja S, Khera R, Konstantinides S, Goldhaber SZ, Wang L, Zhou L, Monreal M, Piazza G, Krumholz HM
Validating International Classification of Diseases Code 10th Revision algorithms for accurate identification of pulmonary embolism. J Thromb Haemost. 2025 Feb; 23(2):556-564.
Validating International Classification of Diseases Code 10th Revision algorithms for accurate identification of pulmonary embolism.
Bikdeli B, Leyva H, Muriel A, Lin Z, Piazza G, Khairani CD, Rosovsky RP, Mehdipour G, O'Donoghue ML, Madridano O, Lopez-Saez JB, Mellado M, Diaz Brasero AM, Grandone E, Spagnolo PA, Lu Y, Bertoletti L, López-Jiménez L, Jesús Núñez M, Blanco-Molina Á, Gerhard-Herman M, Goldhaber SZ, Bates SM, Jimenez D, Krumholz HM, Monreal M
Sex differences in treatment strategies for pulmonary embolism in older adults: The SERIOUS-PE study of RIETE participants and US Medicare beneficiaries. Vasc Med. 2025 02; 30(1):58-66.
Sex differences in treatment strategies for pulmonary embolism in older adults: The SERIOUS-PE study of RIETE participants and US Medicare beneficiaries.
Sista AK, Troxel AB, Tarpey T, Parpia S, Goldhaber SZ, Stringer WW, Magnuson EA, Cohen DJ, Kahn SR, Rao SV, Morris TA, Goldfeld KS, Vedantham S
Rationale and design of the PE-TRACT trial: A multicenter randomized trial to evaluate catheter-directed therapy for the treatment of intermediate-risk pulmonary embolism. Am Heart J. 2025 Mar; 281:112-122.
Rationale and design of the PE-TRACT trial: A multicenter randomized trial to evaluate catheter-directed therapy for the treatment of intermediate-risk pulmonary embolism.
Rashedi S, Bejjani A, Hunsaker AR, Aghayev A, Khairani CD, McGonagle B, Lo YC, Mahajan S, Caraballo C, Jimenez JV, Krishnathasan D, Zarghami M, Monreal M, Barco S, Secemsky EA, Klok FA, Muriel A, Hussain MA, Appah-Sampong A, Rahaghi FN, Sadeghipour P, Lin Z, Mojibian H, Aneja S, Konstantinides S, Goldhaber SZ, Wang L, Zhou L, Jimenez D, Krumholz HM, Piazza G, Bikdeli B
Isolated subsegmental pulmonary embolism identification based on international classification of diseases (ICD)-10 codes and imaging reports. Thromb Res. 2025 Mar; 247:109271.
Isolated subsegmental pulmonary embolism identification based on international classification of diseases (ICD)-10 codes and imaging reports.
Piazza G, Rao AF, Nguyen TN, Seger AC, Hohlfelder B, Fanikos J, Goldhaber SZ
Venous thromboembolism in hospitalized patients with active cancer. Clin Appl Thromb Hemost. 2013 Sep; 19(5):469-75.
Venous thromboembolism in hospitalized patients with active cancer.
Kimmel SE, French B, Anderson JL, Gage BF, Johnson JA, Rosenberg YD, Geller NL, Kasner SE, Eby CS, Joo J, Caldwell MD, Goldhaber SZ, Hart RG, Cifelli D, Madigan R, Brensinger CM, Goldberg S, Califf RM, Ellenberg JH
Rationale and design of the Clarification of Optimal Anticoagulation through Genetics trial. Am Heart J. 2013 Sep; 166(3):435-41.
Rationale and design of the Clarification of Optimal Anticoagulation through Genetics trial.
Scimeca G, Krishnathasan D, Rashedi S, Lan Z, Sato A, Hamade N, Bejjani A, Khairani CD, Davies J, Porio N, Assi AA, Armero A, Tristani A, Ortiz-Rios MD, Nauffal V, Almarzooq Z, Wei E, Zuluaga-Sánchez V, Zarghami M, Achanta A, Jesudasen SJ, Tiu B, Merli GJ, Leiva O, Fanikos J, Sharma A, Rizzo S, Pfeferman MB, Morrison RB, Vishnevsky A, Hsia J, Nehler MR, Welker J, Bonaca MP, Carroll B, Goldhaber SZ, Campia U, Bikdeli B, Piazza G
Predictors of venous thromboembolic events in hospitalized patients with COVID-19. J Thromb Thrombolysis. 2025 Apr; 58(4):485-496.
Predictors of venous thromboembolic events in hospitalized patients with COVID-19.
Streiff MB, Bockenstedt PL, Cataland SR, Chesney C, Eby C, Fanikos J, Fogerty AE, Gao S, Goldhaber SZ, Hassoun H, Hendrie P, Holmstrom B, Kuderer N, Lee JT, Millenson MM, Neff AT, Ortel TL, Siddiqi T, Smith JL, Yee GC, Zakarija A, McMillian N, Naganuma M
Venous thromboembolic disease. J Natl Compr Canc Netw. 2013 Nov; 11(11):1402-29.
Leyva H, Fanikos J, Lan Z, Scimeca G, Bikdeli B, Piazza G, Goldhaber SZ
Aspirin for Venous Thromboembolism Prophylaxis in Hip Fracture, Total Knee, and Hip Arthroplasty. Am J Med. 2025 Sep; 138(9):1185-1196.
Aspirin for Venous Thromboembolism Prophylaxis in Hip Fracture, Total Knee, and Hip Arthroplasty.
Leyva H, Hamade N, Krishnathasan D, Goldhaber SZ, Welker J, Carroll B, Bonaca M, Lan Z, Bikdeli B, Piazza G
Non-O Blood Groups and Cardiovascular Outcomes in COVID-19: Findings From a Large Multicenter Study. JACC Adv. 2025 Apr; 4(4):101641.
Non-O Blood Groups and Cardiovascular Outcomes in COVID-19: Findings From a Large Multicenter Study.
Venous thromboembolism in patients with prior stroke. Clin Appl Thromb Hemost. 2014 Jan; 20(1):43-9.
Venous thromboembolism in patients with prior stroke.
Kimmel SE, French B, Kasner SE, Johnson JA, Anderson JL, Gage BF, Rosenberg YD, Eby CS, Madigan RA, McBane RB, Abdel-Rahman SZ, Stevens SM, Yale S, Mohler ER, Fang MC, Shah V, Horenstein RB, Limdi NA, Muldowney JA, Gujral J, Delafontaine P, Desnick RJ, Ortel TL, Billett HH, Pendleton RC, Geller NL, Halperin JL, Goldhaber SZ, Caldwell MD, Califf RM, Ellenberg JH
A pharmacogenetic versus a clinical algorithm for warfarin dosing. N Engl J Med. 2013 Dec 12; 369(24):2283-93.
A pharmacogenetic versus a clinical algorithm for warfarin dosing.
Nicolaides AN, Fareed J, Kakkar AK, Comerota AJ, Goldhaber SZ, Hull R, Myers K, Samama M, Fletcher J, Kalodiki E, Bergqvist D, Bonnar J, Caprini JA, Carter C, Conard J, Eklof B, Elalamy I, Gerotziafas G, Geroulakos G, Giannoukas A, Greer I, Griffin M, Kakkos S, Lassen MR, Lowe GD, Markel A, Prandoni P, Raskob G, Spyropoulos AC, Turpie AG, Walenga JM, Warwick D
Prevention and treatment of venous thromboembolism--International Consensus Statement. Int Angiol. 2013 Apr; 32(2):111-260.
Prevention and treatment of venous thromboembolism--International Consensus Statement.
Rashedi S, Leyva H, Pfeferman MB, Krishnathasan D, Bejjani A, Khairani CD, Zarghami M, Jimenez D, Muriel A, Goldhaber SZ, Wang L, Secemsky EA, Piazza G, Krumholz HM, Lin Z, Bikdeli B
Use of Present-on-Admission Indicators to Improve Accuracy of Pulmonary Embolism Identification from Electronic Health Record Data. Semin Thromb Hemost. 2025 Oct; 51(7):829-833.
Use of Present-on-Admission Indicators to Improve Accuracy of Pulmonary Embolism Identification from Electronic Health Record Data.
Schulman S, Kakkar AK, Goldhaber SZ, Schellong S, Eriksson H, Mismetti P, Christiansen AV, Friedman J, Le Maulf F, Peter N, Kearon C
Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis. Circulation. 2014 Feb 18; 129(7):764-72.
Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis.
Cohen AT, Harrington R, Goldhaber SZ, Hull R, Gibson CM, Hernandez AF, Kitt MM, Lorenz TJ
The design and rationale for the Acute Medically Ill Venous Thromboembolism Prevention with Extended Duration Betrixaban (APEX) study. Am Heart J. 2014 Mar; 167(3):335-41.
The design and rationale for the Acute Medically Ill Venous Thromboembolism Prevention with Extended Duration Betrixaban (APEX) study.
Race and venous thromboembolism: nature or nurture? Circulation. 2014 Apr 08; 129(14):1463-5.
Race and venous thromboembolism: nature or nurture?
Meyer G, Vicaut E, Danays T, Agnelli G, Becattini C, Beyer-Westendorf J, Bluhmki E, Bouvaist H, Brenner B, Couturaud F, Dellas C, Empen K, Franca A, Galiè N, Geibel A, Goldhaber SZ, Jimenez D, Kozak M, Kupatt C, Kucher N, Lang IM, Lankeit M, Meneveau N, Pacouret G, Palazzini M, Petris A, Pruszczyk P, Rugolotto M, Salvi A, Schellong S, Sebbane M, Sobkowicz B, Stefanovic BS, Thiele H, Torbicki A, Verschuren F, Konstantinides SV
Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med. 2014 Apr 10; 370(15):1402-11.
Fibrinolysis for patients with intermediate-risk pulmonary embolism.
Savchenko AS, Martinod K, Seidman MA, Wong SL, Borissoff JI, Piazza G, Libby P, Goldhaber SZ, Mitchell RN, Wagner DD
Neutrophil extracellular traps form predominantly during the organizing stage of human venous thromboembolism development. J Thromb Haemost. 2014 Jun; 12(6):860-70.
Neutrophil extracellular traps form predominantly during the organizing stage of human venous thromboembolism development.
Rashedi S, Leyva H, Hamade N, Pfeferman MB, Ortega-Paz L, Sadeghipour P, Talasaz AH, O'Donoghue ML, Jimenez D, Monreal M, Anderson CD, Elkind MSV, Lang IM, Weitz JI, Goldhaber SZ, De Caterina R, Konstantinides SV, Piazza G, Krumholz HM, Braunwald E, Bikdeli B
Fibrinolytic Therapy for Thromboembolic Diseases: Approved Indications and Future Directions. J Am Coll Cardiol. 2025 10 07; 86(14):1065-1087.
Fibrinolytic Therapy for Thromboembolic Diseases: Approved Indications and Future Directions.
Pfeferman MB, Rashedi S, Lip GYH, Weber C, O'Donoghue ML, Nissen S, Nicholls SJ, Natarajan P, Plutzky J, Libby P, Goldhaber SZ, Piazza G, Bikdeli B
Lipoprotein(a) and Venous Thromboembolism: Association, Causality, and Medications. Thromb Haemost. 2025 Nov; 125(11):1069-1084.
Lipoprotein(a) and Venous Thromboembolism: Association, Causality, and Medications.
Piazza G, Krishnathasan D, Hamade N, Ujueta F, Scimeca G, Ortiz-Rios MD, McGonagle B, Galanaud JP, Jiménez D, Monreal M, Fanikos J, Dua A, Tefera L, Kolluri R, Parikh SA, Ageno W, Goldhaber SZ, Weitz JI, Moores LK, Quéré I, Bikdeli B
Superficial Vein Thrombosis: A Review. JAMA. 2025 Dec 09; 334(22):2020-2030.
McGonagle B, Greason C, Krishnathasan D, Scimeca G, Bejjani A, Khairani CD, Hamade N, Sato A, Leyva H, Campia U, Davies J, Porio N, Assi AA, Armero A, Tristani A, Ortiz-Rios MD, Nauffal V, Almarzooq Z, Wei E, Zuluaga-Sánchez V, Zarghami M, Achanta A, Jesudasen SJ, Tiu BC, Merli GJ, Leiva O, Fanikos J, Sharma A, Rizzo S, Pfeferman MB, Morrison RB, Vishnevsky A, Hsia J, Nehler MR, Welker J, Bonaca MP, Carroll BJ, Goldhaber SZ, Lan Z, Bikdeli B, Piazza G
Association between Active Cancer and Risk of Thrombotic and Cardiovascular Outcomes in Outpatients with COVID-19: A CORONA-VTE Network Analysis. TH Open. 2025; 9:a27132715.
Association between Active Cancer and Risk of Thrombotic and Cardiovascular Outcomes in Outpatients with COVID-19: A CORONA-VTE Network Analysis.
Bikdeli B, Krishnathasan D, Bejjani A, Khairani CD, Hamade N, Campia U, Davies J, Porio N, Assi A, Armero A, Tristani A, Ortiz-Rios MD, Nauffal V, Almarzooq ZI, Wei EQ, McGonagle B, Pfeferman M, Rashedi S, Sato A, Scimeca G, Zuluaga-Sánchez V, Zarghami M, Achanta A, Jesudasen S, Tiu BC, Merli GJ, Leiva O, Fanikos J, Sharma AM, Rizzo SM, Morrison RB, Vishnevsky A, Rao SJ, Naveh S, El Rafei A, Welker J, Bonaca MP, Carroll BJ, Goldhaber SZ, Lan Z, Piazza G
Adjudicated Cardiovascular Events in Patients With COVID-19: Association With Vaccination Status and Changes over Time. J Am Heart Assoc. 2025 Dec 16; 14(24):e044011.
Adjudicated Cardiovascular Events in Patients With COVID-19: Association With Vaccination Status and Changes over Time.
Pfeferman M, Rashedi S, Pandey AK, Krishnathasan D, Khairani CD, Bejjani A, Morrison RH, Hogan H, Lou J, Fanikos J, Porio N, Rosenbaum L, Sobieszczyk P, Lan Z, Gerhard-Herman M, Campia U, Goldhaber SZ, Bikdeli B, Piazza G
Impact of enduring risk factors on efficacy and safety of extended anticoagulation for provoked venous thromboembolism: Post-hoc analysis of the HI-PRO trial. Thromb Res. 2026 Feb; 258:109588.
Impact of enduring risk factors on efficacy and safety of extended anticoagulation for provoked venous thromboembolism: Post-hoc analysis of the HI-PRO trial.
Piazza G, Bikdeli B, Pandey AK, Krishnathasan D, Khairani CD, Bejjani A, Morrison RH, Hogan H, Rashedi S, Pfeferman M, Lou J, Fanikos J, Porio N, Rosenbaum L, Sobieszczyk P, Lan Z, Gerhard-Herman M, Campia U, Goldhaber SZ
Apixaban for Extended Treatment of Provoked Venous Thromboembolism. N Engl J Med. 2025 Sep 25; 393(12):1166-1176.
Apixaban for Extended Treatment of Provoked Venous Thromboembolism.
Rashedi S, Bukhari S, Krishnathasan D, Khairani CD, Bejjani A, Pfeferman MB, Malejczyk J, Zarghami M, Secemsky EA, Rahaghi FN, Hussain MA, Mojibian H, Goldhaber SZ, Jiménez D, Monreal M, Yang R, Zhou L, Piazza G, Krumholz HM, Wang L, Bikdeli B
Optimizing the Accuracy of Natural Language Processing Tools for Pulmonary Embolism Detection Through Integration with Claims Data: The PE-EHR+ Study. Thromb Haemost. 2026 Feb 09.
Optimizing the Accuracy of Natural Language Processing Tools for Pulmonary Embolism Detection Through Integration with Claims Data: The PE-EHR+ Study.
Direct oral anticoagulants in the treatment and long-term prevention of venous thrombo-embolism. Eur Heart J. 2014 Jul 21; 35(28):1836-43.
Direct oral anticoagulants in the treatment and long-term prevention of venous thrombo-embolism.
Levi M, Moore KT, Castillejos CF, Kubitza D, Berkowitz SD, Goldhaber SZ, Raghoebar M, Patel MR, Weitz JI, Levy JH
Comparison of three-factor and four-factor prothrombin complex concentrates regarding reversal of the anticoagulant effects of rivaroxaban in healthy volunteers. J Thromb Haemost. 2014 Sep; 12(9):1428-36.
Comparison of three-factor and four-factor prothrombin complex concentrates regarding reversal of the anticoagulant effects of rivaroxaban in healthy volunteers.
Cohen AT, Harrington R, Goldhaber SZ, Hull R, Gibson CM, Hernandez AF, Gold A
Recognition of biomarker identified high-risk patients in the acute medically ill venous thromboembolism prevention with extended duration betrixaban study resulting in a protocol amendment. Am Heart J. 2015 Jan; 169(1):186-7.
Recognition of biomarker identified high-risk patients in the acute medically ill venous thromboembolism prevention with extended duration betrixaban study resulting in a protocol amendment.
Fanikos J, Jenkins KL, Piazza G, Connors J, Goldhaber SZ
Medication use evaluation: pharmacist rubric for performance improvement. Pharmacotherapy. 2014 Dec; 34 Suppl 1:5S-13S.
Medication use evaluation: pharmacist rubric for performance improvement.
Fanikos J, Buckley LF, Aldemerdash A, Terry KJ, Piazza G, Connors JM, Goldhaber SZ
Regulatory, legislative, and policy updates with anticoagulant use. J Thromb Thrombolysis. 2015 Apr; 39(3):273-87.
Regulatory, legislative, and policy updates with anticoagulant use.
Halaby R, Popma CJ, Cohen A, Chi G, Zacarkim MR, Romero G, Goldhaber SZ, Hull R, Hernandez A, Mentz R, Harrington R, Lip G, Peacock F, Welker J, Martin-Loeches I, Daaboul Y, Korjian S, Gibson CM
D-Dimer elevation and adverse outcomes. J Thromb Thrombolysis. 2015 Jan; 39(1):55-9.
Vardi M, Piazza G, Pencina MJ, Burke DA, Lei L, Goldhaber SZ, Cutlip DE
Risk assessment to predict arterial and venous events in patients undergoing percutaneous coronary intervention. Clin Appl Thromb Hemost. 2014 Jul; 20(5):478-83.
Risk assessment to predict arterial and venous events in patients undergoing percutaneous coronary intervention.
Francis CW, Kessler CM, Goldhaber SZ, Kovacs MJ, Monreal M, Huisman MV, Bergqvist D, Turpie AG, Ortel TL, Spyropoulos AC, Pabinger I, Kakkar AK
Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN Study. J Thromb Haemost. 2015 Jun; 13(6):1028-35.
Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN Study.
Venous thromboembolism: "... an ounce of prevention is worth a pound of cure". Thromb Haemost. 2015 Jun; 113(6):1174-5.
Venous thromboembolism: "... an ounce of prevention is worth a pound of cure".
Lip GY, Rushton-Smith SK, Goldhaber SZ, Fitzmaurice DA, Mantovani LG, Goto S, Haas S, Bassand JP, Camm AJ, Ambrosio G, Janský P, Al Mahmeed W, Oh S, van Eickels M, Raatikainen P, Steffel J, Oto A, Kayani G, Accetta G, Kakkar AK
Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation? The prospective global anticoagulant registry in the FIELD-Atrial Fibrillation. Circ Cardiovasc Qual Outcomes. 2015 Mar; 8(2 Suppl 1):S12-20.
Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation? The prospective global anticoagulant registry in the FIELD-Atrial Fibrillation.
Cardiology Patient Page: inflammation and myocardial infarction. Circulation. 2014 Dec 09; 130(24):e334-6.
Cardiology Patient Page: inflammation and myocardial infarction.
Schulman S, Goldhaber SZ, Kearon C, Kakkar AK, Schellong S, Eriksson H, Hantel S, Feuring M, Kreuzer J
Treatment with dabigatran or warfarin in patients with venous thromboembolism and cancer. Thromb Haemost. 2015 Jul; 114(1):150-7.
Treatment with dabigatran or warfarin in patients with venous thromboembolism and cancer.
Mani V, Alie N, Ramachandran S, Robson PM, Besa C, Piazza G, Mercuri M, Grosso M, Taouli B, Goldhaber SZ, Fayad ZA
Journal of visualized experiments : JoVE
A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis. J Vis Exp. 2015 Jun 02; (100):e52761.
A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis.
Meinel FG, Nance JW, Schoepf UJ, Hoffmann VS, Thierfelder KM, Costello P, Goldhaber SZ, Bamberg F
Predictive Value of Computed Tomography in Acute Pulmonary Embolism: Systematic Review and Meta-analysis. Am J Med. 2015 Jul; 128(7):747-59.e2.
Predictive Value of Computed Tomography in Acute Pulmonary Embolism: Systematic Review and Meta-analysis.
Silveira PC, Ip IK, Goldhaber SZ, Piazza G, Benson CB, Khorasani R
Performance of Wells Score for Deep Vein Thrombosis in the Inpatient Setting. JAMA Intern Med. 2015 Jul; 175(7):1112-7.
Performance of Wells Score for Deep Vein Thrombosis in the Inpatient Setting.
Cardiology Patient Page. Obstructive Sleep Apnea. Circulation. 2015 Aug 11; 132(6):e114-6.
Cardiology Patient Page. Obstructive Sleep Apnea.
Piazza G, Hohlfelder B, Jaff MR, Ouriel K, Engelhardt TC, Sterling KM, Jones NJ, Gurley JC, Bhatheja R, Kennedy RJ, Goswami N, Natarajan K, Rundback J, Sadiq IR, Liu SK, Bhalla N, Raja ML, Weinstock BS, Cynamon J, Elmasri FF, Garcia MJ, Kumar M, Ayerdi J, Soukas P, Kuo W, Liu PY, Goldhaber SZ
A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism: The SEATTLE II Study. JACC Cardiovasc Interv. 2015 Aug 24; 8(10):1382-1392.
A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism: The SEATTLE II Study.
Korjian S, Daaboul Y, Halaby R, Goldhaber SZ, Cohen AT, Singh K, Susheela AT, Harrington RA, Hull RD, Hernandez AF, Gibson CM
Journal of cardiovascular pharmacology and therapeutics
Extended-Duration Thromboprophylaxis Among Acute Medically Ill Patients: An Unmet Need. J Cardiovasc Pharmacol Ther. 2016 05; 21(3):227-32.
Extended-Duration Thromboprophylaxis Among Acute Medically Ill Patients: An Unmet Need.
Streiff MB, Holmstrom B, Ashrani A, Bockenstedt PL, Chesney C, Eby C, Fanikos J, Fenninger RB, Fogerty AE, Gao S, Goldhaber SZ, Hendrie P, Kuderer N, Lee A, Lee JT, Lovrincevic M, Millenson MM, Neff AT, Ortel TL, Paschal R, Shattil S, Siddiqi T, Smock KJ, Soff G, Wang TF, Yee GC, Zakarija A, McMillian N, Engh AM
Cancer-Associated Venous Thromboembolic Disease, Version 1.2015. J Natl Compr Canc Netw. 2015 Sep; 13(9):1079-95.
Cancer-Associated Venous Thromboembolic Disease, Version 1.2015.
Neely RC, Byrne JG, Gosev I, Cohn LH, Javed Q, Rawn JD, Goldhaber SZ, Piazza G, Aranki SF, Shekar PS, Leacche M
Surgical Embolectomy for Acute Massive and Submassive Pulmonary Embolism in a Series of 115 Patients. Ann Thorac Surg. 2015 Oct; 100(4):1245-51; discussion 1251-2.
Surgical Embolectomy for Acute Massive and Submassive Pulmonary Embolism in a Series of 115 Patients.
Preblick R, Kwong WJ, White RH, Goldhaber SZ
Cost-effectiveness of edoxaban for the treatment of venous thromboembolism based on the Hokusai-VTE study. Hosp Pract (1995). 2015; 43(5):249-57.
Cost-effectiveness of edoxaban for the treatment of venous thromboembolism based on the Hokusai-VTE study.
Rybicki FJ, Udelson JE, Peacock WF, Goldhaber SZ, Isselbacher EM, Kazerooni E, Kontos MC, Litt H, Woodard PK
Journal of the American College of Radiology : JACR
2015 ACR/ACC/AHA/AATS/ACEP/ASNC/NASCI/SAEM/SCCT/SCMR/SCPC/SNMMI/STR/STS Appropriate Utilization of Cardiovascular Imaging in Emergency Department Patients With Chest Pain: A Joint Document of the American College of Radiology Appropriateness Criteria Committee and the American College of Cardiology Appropriate Use Criteria Task Force. J Am Coll Radiol. 2016 Feb; 13(2):e1-e29.
2015 ACR/ACC/AHA/AATS/ACEP/ASNC/NASCI/SAEM/SCCT/SCMR/SCPC/SNMMI/STR/STS Appropriate Utilization of Cardiovascular Imaging in Emergency Department Patients With Chest Pain: A Joint Document of the American College of Radiology Appropriateness Criteria Committee and the American College of Cardiology Appropriate Use Criteria Task Force.
Majeed A, Goldhaber SZ, Kakkar A, Kearon C, Eriksson H, Kreuzer J, Feuring M, Hantel S, Friedman J, Schellong S, Schulman S
Bleeding events with dabigatran or warfarin in patients with venous thromboembolism. Thromb Haemost. 2016 Jan; 115(2):291-8.
Bleeding events with dabigatran or warfarin in patients with venous thromboembolism.
2015 ACR/ACC/AHA/AATS/ACEP/ASNC/NASCI/SAEM/SCCT/SCMR/SCPC/SNMMI/STR/STS Appropriate Utilization of Cardiovascular Imaging in Emergency Department Patients With Chest Pain: A Joint Document of the American College of Radiology Appropriateness Criteria Committee and the American College of Cardiology Appropriate Use Criteria Task Force. J Am Coll Cardiol. 2016 Feb 23; 67(7):853-79.
Lau ES, O'Donoghue ML, Hamilton MA, Goldhaber SZ
Women and Heart Attacks. Circulation. 2016 Mar 08; 133(10):e428-9.
Bikdeli B, Wang Y, Minges KE, Desai NR, Kim N, Desai MM, Spertus JA, Masoudi FA, Nallamothu BK, Goldhaber SZ, Krumholz HM
Vena Caval Filter Utilization and Outcomes in Pulmonary Embolism: Medicare Hospitalizations From 1999 to 2010. J Am Coll Cardiol. 2016 Mar 08; 67(9):1027-1035.
Vena Caval Filter Utilization and Outcomes in Pulmonary Embolism: Medicare Hospitalizations From 1999 to 2010.
Four key questions surrounding thrombolytic therapy for submassive pulmonary embolism. Vasc Med. 2016 Feb; 21(1):47-52.
Four key questions surrounding thrombolytic therapy for submassive pulmonary embolism.
Ruff CT, Ansell JE, Becker RC, Benjamin EJ, Deicicchi DJ, Mark Estes NA, Ezekowitz MD, Fanikos J, Fareed J, Garcia D, Giugliano RP, Goldhaber SZ, Granger C, Healey JS, Hull R, Hylek EM, Libby P, Lopes RD, Mahaffey KW, Mega J, Piazza G, Sasahara AA, Sorond FA, Spyropoulos AC, Walenga JM, Weitz JI
North American Thrombosis Forum, AF Action Initiative Consensus Document. Am J Med. 2016 May; 129(5 Suppl):S1-S29.
North American Thrombosis Forum, AF Action Initiative Consensus Document.
Syncope (Fainting). Circulation. 2016 Apr 19; 133(16):e600-2.
Piazza G, Karipineni N, Goldberg HS, Jenkins KL, Goldhaber SZ
Underutilization of Anticoagulation for Stroke Prevention in Atrial Fibrillation. J Am Coll Cardiol. 2016 05 24; 67(20):2444-2446.
Underutilization of Anticoagulation for Stroke Prevention in Atrial Fibrillation.
Warfarin and Vascular Calcification. Am J Med. 2016 06; 129(6):635.e1-4.
Requiem for Liberalizing Indications for Vena Caval Filters? Circulation. 2016 May 24; 133(21):1992-4.
Requiem for Liberalizing Indications for Vena Caval Filters?
Sista AK, Goldhaber SZ, Vedantham S, Kline JA, Kuo WT, Kahn SR, Kabrhel C, McLaughlin VV, White SB, Kim NH, Gray M, Simon MA, Benenati JF, Misra S, Sterling KM, Kee ST, Konstantinides SV, Jaff MR, Kearon C
Research Priorities in Submassive Pulmonary Embolism: Proceedings from a Multidisciplinary Research Consensus Panel. J Vasc Interv Radiol. 2016 Jun; 27(6):787-94.
Research Priorities in Submassive Pulmonary Embolism: Proceedings from a Multidisciplinary Research Consensus Panel.
Piazza G, Mani V, Goldhaber SZ, Grosso MA, Mercuri M, Lanz HJ, Schussler S, Hsu C, Chinigo A, Ritchie B, Nadar V, Cannon K, Pullman J, Concha M, Schul M, Fayad ZA
Magnetic resonance venography to assess thrombus resolution with edoxaban monotherapy versus parenteral anticoagulation/warfarin for symptomatic deep vein thrombosis: A multicenter feasibility study. Vasc Med. 2016 08; 21(4):361-8.
Magnetic resonance venography to assess thrombus resolution with edoxaban monotherapy versus parenteral anticoagulation/warfarin for symptomatic deep vein thrombosis: A multicenter feasibility study.
Vedantham S, Kahn SR, Goldhaber SZ, Comerota AJ, Parpia S, Meleth S, Earp D, Williams R, Sista AK, Marston W, Rathbun S, Magnuson EA, Razavi MK, Jaff MR, Kearon C
Endovascular therapy for advanced post-thrombotic syndrome: Proceedings from a multidisciplinary consensus panel. Vasc Med. 2016 08; 21(4):400-7.
Endovascular therapy for advanced post-thrombotic syndrome: Proceedings from a multidisciplinary consensus panel.
Cohen AT, Harrington RA, Goldhaber SZ, Hull RD, Wiens BL, Gold A, Hernandez AF, Gibson CM
Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients. N Engl J Med. 2016 08 11; 375(6):534-44.
Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients.
EVALUATION OF AN I 123 COLLIMATOR FOR ASPECT
Crous-Bou M, De Vivo I, Camargo CA, Varraso R, Grodstein F, Jensen MK, Kraft P, Goldhaber SZ, Lindström S, Kabrhel C
Interactions of established risk factors and a GWAS-based genetic risk score on the risk of venous thromboembolism. Thromb Haemost. 2016 Sep 27; 116(4):705-13.
Interactions of established risk factors and a GWAS-based genetic risk score on the risk of venous thromboembolism.
Goldhaber SZ, Schellong S, Kakkar A, Eriksson H, Feuring M, Kreuzer J, Fraessdorf M, Schulman S
Treatment of acute pulmonary embolism with dabigatran versus warfarin. A pooled analysis of data from RE-COVER and RE-COVER II. Thromb Haemost. 2016 Sep 27; 116(4):714-21.
Treatment of acute pulmonary embolism with dabigatran versus warfarin. A pooled analysis of data from RE-COVER and RE-COVER II.
Barra ME, Fanikos J, Connors JM, Sylvester KW, Piazza G, Goldhaber SZ
Evaluation of Dose-Reduced Direct Oral Anticoagulant Therapy. Am J Med. 2016 Nov; 129(11):1198-1204.
Evaluation of Dose-Reduced Direct Oral Anticoagulant Therapy.
Goldhaber SZ, Eriksson H, Kakkar A, Schellong S, Feuring M, Fraessdorf M, Kreuzer J, Schueler E, Schulman S
Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: Findings from RE-COVER®, RE-COVER™ II, and RE-MEDY™. Vasc Med. 2016 12; 21(6):506-514.
Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: Findings from RE-COVER®, RE-COVER™ II, and RE-MEDY™.
Haas S, Ten Cate H, Accetta G, Angchaisuksiri P, Bassand JP, Camm AJ, Corbalan R, Darius H, Fitzmaurice DA, Goldhaber SZ, Goto S, Jacobson B, Kayani G, Mantovani LG, Misselwitz F, Pieper K, Schellong SM, Stepinska J, Turpie AG, van Eickels M, Kakkar AK
Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry. PLoS One. 2016; 11(10):e0164076.
Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry.
Bassand JP, Accetta G, Camm AJ, Cools F, Fitzmaurice DA, Fox KA, Goldhaber SZ, Goto S, Haas S, Hacke W, Kayani G, Mantovani LG, Misselwitz F, Ten Cate H, Turpie AG, Verheugt FW, Kakkar AK
Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF. Eur Heart J. 2016 Oct 07; 37(38):2882-2889.
Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF.
Ageno W, Casella IB, Han CK, Raskob GE, Schellong S, Schulman S, Singer DE, Kimura K, Tang W, Desch M, Goldhaber SZ
RE-COVERY DVT/PE: Rationale and design of a prospective observational study of acute venous thromboembolism with a focus on dabigatran etexilate. Thromb Haemost. 2017 01 26; 117(2):415-421.
RE-COVERY DVT/PE: Rationale and design of a prospective observational study of acute venous thromboembolism with a focus on dabigatran etexilate.
Gibson CM, Chi G, Halaby R, Korjian S, Daaboul Y, Jain P, Arbetter D, Goldhaber SZ, Hull R, Hernandez AF, Gold A, Bandman O, Harrington RA, Cohen AT
Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients: An APEX Trial Substudy (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban). Circulation. 2017 02 14; 135(7):648-655.
Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients: An APEX Trial Substudy (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban).
Weitz JI, Haas S, Ageno W, Angchaisuksiri P, Bounameaux H, Nielsen JD, Goldhaber SZ, Goto S, Kayani G, Mantovani L, Prandoni P, Schellong S, Turpie AG, Kakkar AK
Global Anticoagulant Registry in the Field - Venous Thromboembolism (GARFIELD-VTE). Rationale and design. Thromb Haemost. 2016 Nov 30; 116(6):1172-1179.
Global Anticoagulant Registry in the Field - Venous Thromboembolism (GARFIELD-VTE). Rationale and design.
Risk factors for major bleeding in the SEATTLE II trial. Vasc Med. 2017 02; 22(1):44-50.
Risk factors for major bleeding in the SEATTLE II trial.
Lester-Coll NH, Johnson S, Magnuson WJ, Goldhaber SZ, Sher DJ, D'Amico AV, Yu JB
Journal of the National Cancer Institute
Weighing Risk of Cardiovascular Mortality Against Potential Benefit of Hormonal Therapy in Intermediate-Risk Prostate Cancer. J Natl Cancer Inst. 2017 06; 109(6).
Weighing Risk of Cardiovascular Mortality Against Potential Benefit of Hormonal Therapy in Intermediate-Risk Prostate Cancer.
Camm AJ, Accetta G, Ambrosio G, Atar D, Bassand JP, Berge E, Cools F, Fitzmaurice DA, Goldhaber SZ, Goto S, Haas S, Kayani G, Koretsune Y, Mantovani LG, Misselwitz F, Oh S, Turpie AG, Verheugt FW, Kakkar AK
Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation. Heart. 2017 02 15; 103(4):307-314.
Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation.
Ouriel K, Ouriel RL, Lim YJ, Piazza G, Goldhaber SZ
Computed tomography angiography with pulmonary artery thrombus burden and right-to-left ventricular diameter ratio after pulmonary embolism. Vascular. 2017 Feb; 25(1):54-62.
Computed tomography angiography with pulmonary artery thrombus burden and right-to-left ventricular diameter ratio after pulmonary embolism.
Uses of low-molecular-weight heparin. Blood Rev. 1995 Dec; 9(4):213-9.
Pulmonary embolism. Cardiologia. 1995 Dec; 40(12 Suppl 1):339-43.
Cardiovascular risk stratification of pulmonary embolism. Am J Cardiol. 1996 Nov 15; 78(10):1149-51.
Cardiovascular risk stratification of pulmonary embolism.
McConnell MV, Solomon SD, Rayan ME, Come PC, Goldhaber SZ, Lee RT
Regional right ventricular dysfunction detected by echocardiography in acute pulmonary embolism. Am J Cardiol. 1996 Aug 15; 78(4):469-73.
Regional right ventricular dysfunction detected by echocardiography in acute pulmonary embolism.
Kessler CM, Hirsch DR, Jacobs H, MacDougall R, Goldhaber SZ
Intermittent pneumatic compression in chronic venous insufficiency favorably affects fibrinolytic potential and platelet activation. Blood Coagul Fibrinolysis. 1996 Jun; 7(4):437-46.
Intermittent pneumatic compression in chronic venous insufficiency favorably affects fibrinolytic potential and platelet activation.
Loh E, Sutton MS, Wun CC, Rouleau JL, Flaker GC, Gottlieb SS, Lamas GA, Moyé LA, Goldhaber SZ, Pfeffer MA
Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med. 1997 Jan 23; 336(4):251-7.
Ventricular dysfunction and the risk of stroke after myocardial infarction.
Epidemiologic characteristics, management, and outcome of deep venous thrombosis in a tertiary-care hospital: the Brigham and Women's Hospital DVT registry. Am Heart J. 1996 Nov; 132(5):1010-4.
Epidemiologic characteristics, management, and outcome of deep venous thrombosis in a tertiary-care hospital: the Brigham and Women's Hospital DVT registry.
Camargo CA, Stampfer MJ, Glynn RJ, Gaziano JM, Manson JE, Goldhaber SZ, Hennekens CH
Prospective study of moderate alcohol consumption and risk of peripheral arterial disease in US male physicians. Circulation. 1997 Feb 04; 95(3):577-80.
Prospective study of moderate alcohol consumption and risk of peripheral arterial disease in US male physicians.
A free-floating approach to filters. Arch Intern Med. 1997 Feb 10; 157(3):264-5.
Pulmonary embolism thrombolysis: broadening the paradigm for its administration. Circulation. 1997 Aug 05; 96(3):716-8.
Pulmonary embolism thrombolysis: broadening the paradigm for its administration.
A contemporary approach to thrombolytic therapy for pulmonary embolism. Vasc Med. 2000; 5(2):115-23.
A contemporary approach to thrombolytic therapy for pulmonary embolism.
Miles JS, Miletich JP, Goldhaber SZ, Hennekens CH, Ridker PM
G20210A mutation in the prothrombin gene and the risk of recurrent venous thromboembolism. J Am Coll Cardiol. 2001 Jan; 37(1):215-8.
G20210A mutation in the prothrombin gene and the risk of recurrent venous thromboembolism.
The probability of pulmonary embolism is a function of the diagnoses considered most likely before testing. Acad Emerg Med. 2006 Apr; 13(4):471-4.
The probability of pulmonary embolism is a function of the diagnoses considered most likely before testing.
Thromboembolism management in Europe vs North America: are the differences clinically significant? Chest. 2000 Jun; 117(6):1536-7.
Thromboembolism management in Europe vs North America: are the differences clinically significant?
Reis SE, Hirsch DR, Wilson MG, Donovan BC, Goldhaber SZ
Program for the prevention of venous thromboembolism in high-risk orthopaedic patients. J Arthroplasty. 1991; 6 Suppl:S11-6.
Program for the prevention of venous thromboembolism in high-risk orthopaedic patients.
Fanikos J, Stapinski C, Koo S, Kucher N, Tsilimingras K, Goldhaber SZ
Medication errors associated with anticoagulant therapy in the hospital. Am J Cardiol. 2004 Aug 15; 94(4):532-5.
Medication errors associated with anticoagulant therapy in the hospital.
McGarry LJ, Thompson D, Weinstein MC, Goldhaber SZ
Cost effectiveness of thromboprophylaxis with a low-molecular-weight heparin versus unfractionated heparin in acutely ill medical inpatients. Am J Manag Care. 2004 Sep; 10(9):632-42.
Cost effectiveness of thromboprophylaxis with a low-molecular-weight heparin versus unfractionated heparin in acutely ill medical inpatients.
Ridker PM, Glynn RJ, Miletich JP, Goldhaber SZ, Stampfer MJ, Hennekens CH
Age-specific incidence rates of venous thromboembolism among heterozygous carriers of factor V Leiden mutation. Ann Intern Med. 1997 Apr 01; 126(7):528-31.
Age-specific incidence rates of venous thromboembolism among heterozygous carriers of factor V Leiden mutation.
Contemporary pulmonary embolism thrombolysis. Int J Cardiol. 1998 May 29; 65 Suppl 1:S91-3.
More than an anticoagulant: Do heparins have direct anti-inflammatory effects? Thromb Haemost. 2017 02 28; 117(3):437-444.
More than an anticoagulant: Do heparins have direct anti-inflammatory effects?
Meyerovitz MF, Mannting F, Polak JF, Goldhaber SZ
Frequency of pulmonary embolism in patients with low-probability lung scan and negative lower extremity venous ultrasound. Chest. 1999 Apr; 115(4):980-2.
Frequency of pulmonary embolism in patients with low-probability lung scan and negative lower extremity venous ultrasound.
Venous thromboembolism: an ounce of prevention. Mayo Clin Proc. 2005 Jun; 80(6):725-6.
Venous thromboembolism: an ounce of prevention.
Management of massive pulmonary embolism. Circulation. 2005 Jul 12; 112(2):e28-32.
Gibson CM, Halaby R, Korjian S, Daaboul Y, Arbetter DF, Yee MK, Goldhaber SZ, Hull R, Hernandez AF, Lu SP, Bandman O, Leeds JM, Gold A, Harrington RA, Cohen AT
The safety and efficacy of full- versus reduced-dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended-Duration Betrixaban (APEX) trial. Am Heart J. 2017 Mar; 185:93-100.
The safety and efficacy of full- versus reduced-dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended-Duration Betrixaban (APEX) trial.
Camm AJ, Accetta G, Al Mahmeed W, Ambrosio G, Goldhaber SZ, Haas S, Jansky P, Kayani G, Misselwitz F, Oh S, Oto A, Raatikainen P, Steffel J, van Eickels M, Kakkar AK
Impact of gender on event rates at 1 year in patients with newly diagnosed non-valvular atrial fibrillation: contemporary perspective from the GARFIELD-AF registry. BMJ Open. 2017 03 06; 7(3):e014579.
Impact of gender on event rates at 1 year in patients with newly diagnosed non-valvular atrial fibrillation: contemporary perspective from the GARFIELD-AF registry.
Feuring M, Schulman S, Eriksson H, Kakkar AJ, Schellong S, Hantel S, Schueler E, Kreuzer J, Goldhaber SZ
Net clinical benefit of dabigatran vs. warfarin in venous thromboembolism: analyses from RE-COVER®, RE-COVER™ II, and RE-MEDY™. J Thromb Thrombolysis. 2017 May; 43(4):484-489.
Net clinical benefit of dabigatran vs. warfarin in venous thromboembolism: analyses from RE-COVER®, RE-COVER™ II, and RE-MEDY™.
Grodstein F, Stampfer MJ, Goldhaber SZ, Manson JE, Colditz GA, Speizer FE, Willett WC, Hennekens CH
Prospective study of exogenous hormones and risk of pulmonary embolism in women. Lancet. 1996 Oct 12; 348(9033):983-7.
Prospective study of exogenous hormones and risk of pulmonary embolism in women.
Few predictors of massive deep vein thrombosis. Thromb Haemost. 2005 Nov; 94(5):986-90.
Few predictors of massive deep vein thrombosis.
Fiumara K, Kucher N, Fanikos J, Goldhaber SZ
Predictors of major hemorrhage following fibrinolysis for acute pulmonary embolism. Am J Cardiol. 2006 Jan 01; 97(1):127-9.
Predictors of major hemorrhage following fibrinolysis for acute pulmonary embolism.
Urbankova J, Quiroz R, Kucher N, Goldhaber SZ
Intermittent pneumatic compression and deep vein thrombosis prevention. A meta-analysis in postoperative patients. Thromb Haemost. 2005 Dec; 94(6):1181-5.
Intermittent pneumatic compression and deep vein thrombosis prevention. A meta-analysis in postoperative patients.
Shrivastava S, Ridker PM, Glynn RJ, Goldhaber SZ, Moll S, Bounameaux H, Bauer KA, Kessler CM, Cushman M
D-dimer, factor VIII coagulant activity, low-intensity warfarin and the risk of recurrent venous thromboembolism. J Thromb Haemost. 2006 Jun; 4(6):1208-14.
D-dimer, factor VIII coagulant activity, low-intensity warfarin and the risk of recurrent venous thromboembolism.
Wagman LD, Baird MF, Bennett CL, Bockenstedt PL, Cataland SR, Fanikos J, Fogarty PF, Goldhaber SZ, Grover TS, Haire W, Hassoun H, Jahanzeb M, Leung LL, Linenberger ML, Millenson MM, Ortel TL, Salem R, Smith JL, Streiff MB
Venous thromboembolic disease. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2006 Oct; 4(9):838-69.
Venous thromboembolic disease. Clinical practice guidelines in oncology.
Prevention of pulmonary embolism in general surgery patients. Circulation. 2007 Mar 06; 115(9):e302-7.
Prevention of pulmonary embolism in general surgery patients.
Daniels LB, Parker JA, Patel SR, Grodstein F, Goldhaber SZ
Relation of duration of symptoms with response to thrombolytic therapy in pulmonary embolism. Am J Cardiol. 1997 Jul 15; 80(2):184-8.
Relation of duration of symptoms with response to thrombolytic therapy in pulmonary embolism.
Clinical overview of venous thromboembolism. Vasc Med. 1998; 3(1):35-40.
Clinical overview of venous thromboembolism.
Goldhaber SZ, Morrison RB, Diran LL, Creager MA, Lee TH
Abbreviated hospitalization for deep venous thrombosis with the use of ardeparin. Arch Intern Med. 1998 Nov 23; 158(21):2325-8.
Abbreviated hospitalization for deep venous thrombosis with the use of ardeparin.
Diagnosis, treatment, and prevention of pulmonary embolism. Report of the WHO/International Society and Federation of Cardiology Task Force. JAMA. 1992 Oct 07; 268(13):1727-33.
Diagnosis, treatment, and prevention of pulmonary embolism. Report of the WHO/International Society and Federation of Cardiology Task Force.
Feinstein JA, Goldhaber SZ, Lock JE, Ferndandes SM, Landzberg MJ
Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension. Circulation. 2001 Jan 02; 103(1):10-3.
Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension.
Unsolved issues in the treatment of pulmonary embolism. Thromb Res. 2001 Sep 15; 103(6):V245-55.
Unsolved issues in the treatment of pulmonary embolism.
The bleeding time: its potential utility among patients receiving thrombolytic therapy. Am Heart J. 1990 Jan; 119(1):158-67.
The bleeding time: its potential utility among patients receiving thrombolytic therapy.
Shetty R, Seddighzadeh A, Parasuraman S, Vallurupalli NG, Gerhard-Herman M, Goldhaber SZ
Once-daily fondaparinux monotherapy without warfarin for long-term treatment of venous thromboembolism. Thromb Haemost. 2007 Dec; 98(6):1384-6.
Once-daily fondaparinux monotherapy without warfarin for long-term treatment of venous thromboembolism.
PEITHO Long-Term Outcomes Study: Data Disrupt Dogma. J Am Coll Cardiol. 2017 03 28; 69(12):1545-1548.
PEITHO Long-Term Outcomes Study: Data Disrupt Dogma.
Current treatment options in cardiovascular medicine
Prophylaxis of Venous Thrombosis. Curr Treat Options Cardiovasc Med. 2001 Jun; 3(3):225-235.
Cardiac biomarkers in pulmonary embolism. Chest. 2003 Jun; 123(6):1782-4.
Cardiac biomarkers in pulmonary embolism.
Torbicki A, Galié N, Covezzoli A, Rossi E, De Rosa M, Goldhaber SZ
Right heart thrombi in pulmonary embolism: results from the International Cooperative Pulmonary Embolism Registry. J Am Coll Cardiol. 2003 Jun 18; 41(12):2245-51.
Right heart thrombi in pulmonary embolism: results from the International Cooperative Pulmonary Embolism Registry.
Quiroz R, Kucher N, Schoepf UJ, Kipfmueller F, Solomon SD, Costello P, Goldhaber SZ
Right ventricular enlargement on chest computed tomography: prognostic role in acute pulmonary embolism. Circulation. 2004 May 25; 109(20):2401-4.
Right ventricular enlargement on chest computed tomography: prognostic role in acute pulmonary embolism.
Goldhaber SZ, Manson JE, Stampfer MJ, LaMotte F, Rosner B, Buring JE, Hennekens CH
Low-dose aspirin and subsequent peripheral arterial surgery in the Physicians' Health Study. Lancet. 1992 Jul 18; 340(8812):143-5.
Low-dose aspirin and subsequent peripheral arterial surgery in the Physicians' Health Study.
Chan AT, Atiemo A, Diran LK, Licholai GP, McLaren Black P, Creager MA, Goldhaber SZ
Venous thromboembolism occurs frequently in patients undergoing brain tumor surgery despite prophylaxis. J Thromb Thrombolysis. 1999 Aug; 8(2):139-42.
Venous thromboembolism occurs frequently in patients undergoing brain tumor surgery despite prophylaxis.
Treatment of pulmonary thromboembolism. Intern Med. 1999 Aug; 38(8):620-5.
The current role of thrombolytic therapy for pulmonary embolism. Semin Vasc Surg. 2000 Sep; 13(3):217-20.
The current role of thrombolytic therapy for pulmonary embolism.
New onset of venous thromboembolism among hospitalized patients at Brigham and Women's Hospital is caused more often by prophylaxis failure than by withholding treatment. Chest. 2000 Dec; 118(6):1680-4.
New onset of venous thromboembolism among hospitalized patients at Brigham and Women's Hospital is caused more often by prophylaxis failure than by withholding treatment.
Thrombolysis for pulmonary embolism. N Engl J Med. 2002 Oct 10; 347(15):1131-2.
Goldhaber SZ, Dunn K, Gerhard-Herman M, Park JK, Black PM
Low rate of venous thromboembolism after craniotomy for brain tumor using multimodality prophylaxis. Chest. 2002 Dec; 122(6):1933-7.
Low rate of venous thromboembolism after craniotomy for brain tumor using multimodality prophylaxis.
Ridker PM, Goldhaber SZ, Danielson E, Rosenberg Y, Eby CS, Deitcher SR, Cushman M, Moll S, Kessler CM, Elliott CG, Paulson R, Wong T, Bauer KA, Schwartz BA, Miletich JP, Bounameaux H, Glynn RJ
Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med. 2003 Apr 10; 348(15):1425-34.
Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
Rationale and design of a clinical trial of a low-molecular-weight heparin in preventing clinically important venous thromboembolism in medical patients: the prospective evaluation of dalteparin efficacy for prevention of venous thromboembolism in immobilized patients trial (the PREVENT study). Vasc Med. 2002; 7(4):269-73.
Rationale and design of a clinical trial of a low-molecular-weight heparin in preventing clinically important venous thromboembolism in medical patients: the prospective evaluation of dalteparin efficacy for prevention of venous thromboembolism in immobilized patients trial (the PREVENT study).
Seminars in respiratory and critical care medicine
The approach to massive pulmonary embolism. Semin Respir Crit Care Med. 2000; 21(6):555-61.
The approach to massive pulmonary embolism.
An overview of contemporary etiologies of congestive heart failure. Am Heart J. 1991 Jun; 121(6 Pt 1):1852-3.
An overview of contemporary etiologies of congestive heart failure.
Anticoagulants and transaminase elevation. Circulation. 2006 Apr 18; 113(15):e698-702.
Anticoagulants and transaminase elevation.
Quiroz R, Gerhard-Herman M, Kosowsky JM, DeSantis SM, Kucher N, McKean SC, Goldhaber SZ
Comparison of a single end point to determine optimal initial warfarin dosing (5 mg versus 10 mg) for venous thromboembolism. Am J Cardiol. 2006 Aug 15; 98(4):535-7.
Comparison of a single end point to determine optimal initial warfarin dosing (5 mg versus 10 mg) for venous thromboembolism.
Bleeding time and other laboratory tests to monitor the safety and efficacy of thrombolytic therapy. Chest. 1990 Apr; 97(4 Suppl):124S-131S.
Bleeding time and other laboratory tests to monitor the safety and efficacy of thrombolytic therapy.
Brown MD, Rowe BH, Reeves MJ, Bermingham JM, Goldhaber SZ
The accuracy of the enzyme-linked immunosorbent assay D-dimer test in the diagnosis of pulmonary embolism: a meta-analysis. Ann Emerg Med. 2002 Aug; 40(2):133-44.
The accuracy of the enzyme-linked immunosorbent assay D-dimer test in the diagnosis of pulmonary embolism: a meta-analysis.
Clinical uses of low-molecular-weight heparins. Chest. 1999 May; 115(5):1418-23.
Clinical uses of low-molecular-weight heparins.
Pulmonary embolism thrombolysis: Do we need another agent? Am Heart J. 1999 Jul; 138(1 Pt 1):1-2.
Pulmonary embolism thrombolysis: Do we need another agent?
Piccioli A, Prandoni P, Ewenstein BM, Goldhaber SZ
Cancer and venous thromboembolism. Am Heart J. 1996 Oct; 132(4):850-5.
Monitoring anticoagulation. J Invasive Cardiol. 2000; 12 Suppl C:11C-12C.
Thrombolysis in pulmonary embolism: a debatable indication. Thromb Haemost. 2001 Jul; 86(1):444-51.
Thrombolysis in pulmonary embolism: a debatable indication.
Ridker PM, Manson JE, Goldhaber SZ, Hennekens CH, Buring JE
Comparison of delay times to hospital presentation for physicians and nonphysicians with acute myocardial infarction. Am J Cardiol. 1992 Jul 01; 70(1):10-3.
Comparison of delay times to hospital presentation for physicians and nonphysicians with acute myocardial infarction.
Schulman S, Singer D, Ageno W, Casella IB, Desch M, Goldhaber SZ
NOACs for treatment of venous thromboembolism in clinical practice. Thromb Haemost. 2017 06 28; 117(7):1317-1325.
NOACs for treatment of venous thromboembolism in clinical practice.
Pulmonary embolism thrombolysis: a clarion call for international collaboration. J Am Coll Cardiol. 1992 Feb; 19(2):246-7.
Pulmonary embolism thrombolysis: a clarion call for international collaboration.
Thrombolysis for pulmonary embolism. Prog Cardiovasc Dis. 1991 Sep-Oct; 34(2):113-34.
Kucher N, Tapson VF, Quiroz R, Mir SS, Morrison RB, McKenzie D, Goldhaber SZ
Gender differences in the administration of prophylaxis to prevent deep venous thrombosis. Thromb Haemost. 2005 Feb; 93(2):284-8.
Gender differences in the administration of prophylaxis to prevent deep venous thrombosis.
Kucher N, Koo S, Quiroz R, Cooper JM, Paterno MD, Soukonnikov B, Goldhaber SZ
Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med. 2005 Mar 10; 352(10):969-77.
Electronic alerts to prevent venous thromboembolism among hospitalized patients.
Clinical gestalt and the diagnosis of pulmonary embolism: does experience matter? Chest. 2005 May; 127(5):1627-30.
Clinical gestalt and the diagnosis of pulmonary embolism: does experience matter?
Echocardiography in the diagnosis and management of pulmonary embolism: a limerick. Chest. 2000 Nov; 118(5):1518-9.
Echocardiography in the diagnosis and management of pulmonary embolism: a limerick.
Use of enoxaparin in a patient with unstable angina. J Invasive Cardiol. 2000; 12 Suppl C:18C-20C.
Use of enoxaparin in a patient with unstable angina.
Patel SR, Parker JA, Grodstein F, Goldhaber SZ
Similarity in Presentation and Response to Thrombolysis Among Women and Men with Pulmonary Embolism. J Thromb Thrombolysis. 1998 May; 5(2):95-100.
Similarity in Presentation and Response to Thrombolysis Among Women and Men with Pulmonary Embolism.
Diagnosis of pulmonary embolism. Clin Cornerstone. 2000; 2(4):38-46.
Routine pelvic and lower extremity CT venography in patients undergoing pulmonary CT angiography. AJR. 2008; 190:322-328..
Heparin-Induced Thrombocytopenia. Third Edition edited by Theodore E. Warkentin and Andreas Greinacher
Heparin-Induced Thrombocytopenia. Third Edition edited by Theodore E. Warkentin and Andreas Greinacher. 2004.
Time-resolved MR angiography: a primary screening examination of patients with suspected pulmonary emoblism and contraindications to administration of iodinated contrast material. AJR. 2007; 188:1246-1254.
Time-resolved MR angiography: a primary screening examination of patients with suspected pulmonary emoblism and contraindications to administration of iodinated contrast material
Pulmonary embolism. Braunwald E, ed. Heart Disease. 1988; 1577-1596.
Intermittent pneumatic compression and deep vein thrombosis prevention in postoperative patients. Phlebology. 2006; 21:1-3.
Intermittent pneumatic compression and deep vein thrombosis prevention in postoperative patients
Barrier to Prevention in DVT/PE: An Integrated Approach.
Barrier to Prevention in DVT/PE: An Integrated Approach. 2007.
Valvular Heart Disease, editec by Muayed Al Zaibag and Carlos M. G. Duran
Valvular Heart Disease, editec by Muayed Al Zaibag and Carlos M. G. Duran. 1994.
Goldhaber SZ, eds., Atlas of Heart Diseases, Volume III, Cardiopulmonary Diseases and Cardiac Tumors, Braunwald E, Series Ed
Treatment of acute pulmonary embolism. Goldhaber SZ, eds., Atlas of Heart Diseases, Volume III, Cardiopulmonary Diseases and Cardiac Tumors, Braunwald E, Series Ed. 1995; 3.1-3.25.
Thrombosis and Thromboembolism. Edited By Samuel Z. Goldhaber and Paul M Ridker
Thrombosis and Thromboembolism. Edited By Samuel Z. Goldhaber and Paul M Ridker. 2002.
Pulmonary embolism. Braunwald E, ed. Heart Disease. 1991; 1558-1580.
Future directions in noninvasive cardiac imaging. Morganroth J, Parisi A, Pohost GM, eds. Noninvasive Cardiac Imaging. 1983; 421-431.
Future directions in noninvasive cardiac imaging
Venous thromboembolism risk among hospitalized patients: magnitude of the risk is staggering. Am J Hematol. 2007 Sep; 82(9):775-6.
Venous thromboembolism risk among hospitalized patients: magnitude of the risk is staggering.
Goldhaber SZ, Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Speizer FE, Willett WC, Hennekens CH
A prospective study of risk factors for pulmonary embolism in women. JAMA. 1997 Feb 26; 277(8):642-5.
A prospective study of risk factors for pulmonary embolism in women.
Venous thromboembolism in the intensive care unit: the last frontier for prophylaxis. Chest. 1998 Jan; 113(1):5-7.
Venous thromboembolism in the intensive care unit: the last frontier for prophylaxis.
Contemporary use of laboratory tests to monitor safety and efficacy of thrombolytic therapy. Chest. 1992 Apr; 101(4 Suppl):98S-105S.
Contemporary use of laboratory tests to monitor safety and efficacy of thrombolytic therapy.
Cardiology patient pages. Pulmonary embolism and deep vein thrombosis. Circulation. 2002 Sep 17; 106(12):1436-8.
Cardiology patient pages. Pulmonary embolism and deep vein thrombosis.
Buring JE, O'Connor GT, Goldhaber SZ, Rosner B, Herbert PN, Blum CB, Breslow JL, Hennekens CH
Decreased HDL2 and HDL3 cholesterol, Apo A-I and Apo A-II, and increased risk of myocardial infarction. Circulation. 1992 Jan; 85(1):22-9.
Decreased HDL2 and HDL3 cholesterol, Apo A-I and Apo A-II, and increased risk of myocardial infarction.
Acute pulmonary embolism: part II: risk stratification, treatment, and prevention. Circulation. 2003 Dec 09; 108(23):2834-8.
Acute pulmonary embolism: part II: risk stratification, treatment, and prevention.
Ridker PM, Manson JE, Buring JE, Goldhaber SZ, Hennekens CH
Clinical characteristics of nonfatal myocardial infarction among individuals on prophylactic low-dose aspirin therapy. Circulation. 1991 Aug; 84(2):708-11.
Clinical characteristics of nonfatal myocardial infarction among individuals on prophylactic low-dose aspirin therapy.
"Bridging" and mechanical heart valves: perils, promises, and predictions. Circulation. 2006 Jan 31; 113(4):470-2.
"Bridging" and mechanical heart valves: perils, promises, and predictions.
Mikkola KM, Patel SR, Parker JA, Grodstein F, Goldhaber SZ
Attenuation over 24 hours of the efficacy of thrombolysis of pulmonary embolism among patients with cancer. Am Heart J. 1997 Oct; 134(4):603-7.
Attenuation over 24 hours of the efficacy of thrombolysis of pulmonary embolism among patients with cancer.
Levine MN, Goldhaber SZ, Califf RM, Gore JM, Hirsh J
Hemorrhagic complications of thrombolytic therapy in the treatment of myocardial infarction and venous thromboembolism. Chest. 1992 Oct; 102(4 Suppl):364S-373S.
Hemorrhagic complications of thrombolytic therapy in the treatment of myocardial infarction and venous thromboembolism.
Integration of catheter thrombectomy into our armamentarium to treat acute pulmonary embolism. Chest. 1998 Nov; 114(5):1237-8.
Integration of catheter thrombectomy into our armamentarium to treat acute pulmonary embolism.
Laboratory thrombophilias and venous thromboembolism. Vasc Med. 2002 May; 7(2):93-102.
Laboratory thrombophilias and venous thromboembolism.
Kibel AS, Creager MA, Goldhaber SZ, Richie JP, Loughlin KR
Late venous thromboembolic disease after radical prostatectomy: effect of risk factors, warfarin and early discharge. J Urol. 1997 Dec; 158(6):2211-5.
Late venous thromboembolic disease after radical prostatectomy: effect of risk factors, warfarin and early discharge.
Ginsburg KS, Liang MH, Newcomer L, Goldhaber SZ, Schur PH, Hennekens CH, Stampfer MJ
Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann Intern Med. 1992 Dec 15; 117(12):997-1002.
Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis.
Beckman JA, Dunn K, Sasahara AA, Goldhaber SZ
Enoxaparin monotherapy without oral anticoagulation to treat acute symptomatic pulmonary embolism. Thromb Haemost. 2003 Jun; 89(6):953-8.
Enoxaparin monotherapy without oral anticoagulation to treat acute symptomatic pulmonary embolism.
Ask the doctor. I have been taking ginkgo pills for my memory for several years. I was just diagnosed with atrial fibrillation, and my doctor put me on Coumadin. Is it okay to keep taking ginkgo? Harv Heart Lett. 2010 Jan; 20(5):8.
Ask the doctor. I have been taking ginkgo pills for my memory for several years. I was just diagnosed with atrial fibrillation, and my doctor put me on Coumadin. Is it okay to keep taking ginkgo?
Interruption of the inferior vena cava for prevention of pulmonary embolism: transvenous filter devices. Herz. 1989 Jun; 14(3):182-91.
Interruption of the inferior vena cava for prevention of pulmonary embolism: transvenous filter devices.
Ridker PM, Vaughan DE, Stampfer MJ, Manson JE, Shen C, Newcomer LM, Goldhaber SZ, Hennekens CH
Baseline fibrinolytic state and the risk of future venous thrombosis. A prospective study of endogenous tissue-type plasminogen activator and plasminogen activator inhibitor. Circulation. 1992 May; 85(5):1822-7.
Baseline fibrinolytic state and the risk of future venous thrombosis. A prospective study of endogenous tissue-type plasminogen activator and plasminogen activator inhibitor.
Managing pulmonary embolism. Hosp Pract (Off Ed). 1991 Sep 15; 26(9):37-48.
Cardiology patient pages. Prevention of deep vein thrombosis and pulmonary embolism. Circulation. 2004 Oct 19; 110(16):e445-7.
Cardiology patient pages. Prevention of deep vein thrombosis and pulmonary embolism.
Agnelli G, ed. Thrombolisi Yearbook 1993
La terapia throbolitica nell'embolia polmonare. Agnelli G, ed. Thrombolisi Yearbook 1993. 1993; 155-175.
ISIS-2 (Second International Study of Infarct Survival) Collaborative Group
Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet. 1988; 2:349-360.
Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2
Management of Deep Vein Thrombosis in Pregnancy. Advances in Vascular Surgery. 2001; 9:133-142.
Management of Deep Vein Thrombosis in Pregnancy
Quiroz R, Kucher N, Zou KH, Kipfmueller F, Costello P, Goldhaber SZ, Schoepf UJ
Clinical validity of a negative computed tomography scan in patients with suspected pulmonary embolism: a systematic review. JAMA. 2005 Apr 27; 293(16):2012-7.
Clinical validity of a negative computed tomography scan in patients with suspected pulmonary embolism: a systematic review.
Leacche M, Unic D, Goldhaber SZ, Rawn JD, Aranki SF, Couper GS, Mihaljevic T, Rizzo RJ, Cohn LH, Aklog L, Byrne JG
Modern surgical treatment of massive pulmonary embolism: results in 47 consecutive patients after rapid diagnosis and aggressive surgical approach. J Thorac Cardiovasc Surg. 2005 May; 129(5):1018-23.
Modern surgical treatment of massive pulmonary embolism: results in 47 consecutive patients after rapid diagnosis and aggressive surgical approach.
Spiral computed tomography for acute pulmonary embolism. Circulation. 2004 May 11; 109(18):2160-7.
Spiral computed tomography for acute pulmonary embolism.
Berl T, Hunsicker LG, Lewis JB, Pfeffer MA, Porush JG, Rouleau JL, Drury PL, Esmatjes E, Hricik D, Pohl M, Raz I, Vanhille P, Wiegmann TB, Wolfe BM, Locatelli F, Goldhaber SZ, Lewis EJ
Journal of the American Society of Nephrology : JASN
Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial. J Am Soc Nephrol. 2005 Jul; 16(7):2170-9.
Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial.
Goldhaber SZ, Vaughan DE, Tumeh SS, Loscalzo J
Utility of cross-linked fibrin degradation products in the diagnosis of pulmonary embolism. Am Heart J. 1988 Aug; 116(2 Pt 1):505-8.
Utility of cross-linked fibrin degradation products in the diagnosis of pulmonary embolism.
Multislice computed tomography for pulmonary embolism--a technological marvel. N Engl J Med. 2005 Apr 28; 352(17):1812-4.
Multislice computed tomography for pulmonary embolism--a technological marvel.
Kucher N, Quiroz R, McKean S, Sasahara AA, Goldhaber SZ
Extended enoxaparin monotherapy for acute symptomatic pulmonary embolism. Vasc Med. 2005 Nov; 10(4):251-6.
Extended enoxaparin monotherapy for acute symptomatic pulmonary embolism.
Parker JA, Nagel JS, Drum DE, Tumeh SS, Goldhaber SZ
Pulmonary embolism: segmental appearance of perfusion lung scan defects correlates with successful response to thrombolytic therapy. Radiology. 1990 Feb; 174(2):483-6.
Pulmonary embolism: segmental appearance of perfusion lung scan defects correlates with successful response to thrombolytic therapy.
Pulmonary embolism for cardiologists. J Am Coll Cardiol. 1997 Nov 01; 30(5):1172-3.
Paterno MD, Cina JL, Goldhaber SZ, Kucher N
AMIA ... Annual Symposium proceedings. AMIA Symposium
Preventing DVT and PE in hospitalized patients: improving a successful electronic alert. AMIA Annu Symp Proc. 2006; 1058.
Preventing DVT and PE in hospitalized patients: improving a successful electronic alert.
Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER) Lancet. 1999 Apr 24; 353(9162):1386-9.
Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER)
Student-student polarization plagues u.s. Campuses. Science. 1970 Jul 03; 169(3940):38.
Student-student polarization plagues u.s. Campuses.
Newly diagnosed venous thromboembolism: which patients will bleed after anticoagulation is initiated? Thromb Haemost. 2008 Jul; 100(1):5-6.
Newly diagnosed venous thromboembolism: which patients will bleed after anticoagulation is initiated?
Mechanical catheter intervention in massive pulmonary embolism: proof of concept. Chest. 2008 Jul; 134(1):2-4.
Mechanical catheter intervention in massive pulmonary embolism: proof of concept.
Hacobian M, Shetty R, Niles CM, Gerhard-Herman M, Vallurupalli N, Baroletti S, McKean SC, Sonis J, Parasuraman S, Kosowsky JM, Goldhaber SZ
Once daily enoxaparin for outpatient treatment of acute venous thromboembolism: a case-control study. Clin Appl Thromb Hemost. 2010 Feb; 16(1):21-5.
Once daily enoxaparin for outpatient treatment of acute venous thromboembolism: a case-control study.
Acute pulmonary embolism: part I: epidemiology and diagnosis. Circulation. 2006 Jul 11; 114(2):e28-32.
Acute pulmonary embolism: part I: epidemiology and diagnosis.
DVT Prevention: what is happening in the "real world"? Semin Thromb Hemost. 2003 Dec; 29 Suppl 1:23-31.
DVT Prevention: what is happening in the "real world"?
Reis SE, Polak JF, Hirsch DR, Cohn LH, Creager MA, Donovan BC, Goldhaber SZ
Frequency of deep venous thrombosis in asymptomatic patients with coronary artery bypass grafts. Am Heart J. 1991 Aug; 122(2):478-82.
Frequency of deep venous thrombosis in asymptomatic patients with coronary artery bypass grafts.
Challapalli H, Goldhaber SZ, Brown DF, Nadel ES
Shortness of breath in the postoperative patient. J Emerg Med. 2004 Aug; 27(2):171-7.
Shortness of breath in the postoperative patient.
Doc, is my pulmonary embolism gone? Thromb Res. 2008; 122(5):581-3.
Preventing pulmonary embolism and deep vein thrombosis: a 'call to action' for vascular medicine specialists. J Thromb Haemost. 2007 Aug; 5(8):1607-9.
Preventing pulmonary embolism and deep vein thrombosis: a 'call to action' for vascular medicine specialists.
Fanikos J, Cina JL, Baroletti S, Fiumara K, Matta L, Goldhaber SZ
Adverse drug events in hospitalized cardiac patients. Am J Cardiol. 2007 Nov 01; 100(9):1465-9.
Adverse drug events in hospitalized cardiac patients.
Pulmonary embolism after coronary artery bypass grafting. Circulation. 2004 Jun 08; 109(22):2712-5.
Pulmonary embolism after coronary artery bypass grafting.
Increasing age is a major risk factor for hemorrhagic complications after pulmonary embolism thrombolysis. Am Heart J. 1997 Jul; 134(1):69-72.
Increasing age is a major risk factor for hemorrhagic complications after pulmonary embolism thrombolysis.
Pulmonary embolism presenting as seizures. Chest. 1997 Sep; 112(3):840-2.
Pulmonary embolism presenting as seizures.
Seddighzadeh A, Zurawska U, Shetty R, Goldhaber SZ
Venous thromboembolism in patients undergoing surgery: low rates of prophylaxis and high rates of filter insertion. Thromb Haemost. 2007 Dec; 98(6):1220-5.
Venous thromboembolism in patients undergoing surgery: low rates of prophylaxis and high rates of filter insertion.
Administration of epinephrine by emergency medical technicians. N Engl J Med. 2000 Mar 16; 342(11):822.
Administration of epinephrine by emergency medical technicians.
Carroll BJ, Goldhaber SZ, Liu PY, Piazza G
Ultrasound-facilitated, catheter-directed, low-dose fibrinolysis in elderly patients with pulmonary embolism: A SEATTLE II sub-analysis. Vasc Med. 2017 08; 22(4):324-330.
Ultrasound-facilitated, catheter-directed, low-dose fibrinolysis in elderly patients with pulmonary embolism: A SEATTLE II sub-analysis.
Tapson VF, Hazelton JP, Myers J, Robertson C, Gilani R, Dunn JA, Bukur M, Croce MA, Peick A, West S, Lottenberg L, Doucet J, Miller PR, Crookes B, Gandhi RR, Croft CA, Manasia A, Hoey BA, Lieberman H, Guillamondegui OD, Novack V, Piazza G, Goldhaber SZ
Evaluation of a Device Combining an Inferior Vena Cava Filter and a Central Venous Catheter for Preventing Pulmonary Embolism Among Critically Ill Trauma Patients. J Vasc Interv Radiol. 2017 Sep; 28(9):1248-1254.
Evaluation of a Device Combining an Inferior Vena Cava Filter and a Central Venous Catheter for Preventing Pulmonary Embolism Among Critically Ill Trauma Patients.
Gibson CM, Goldhaber SZ, Cohen AT, Nafee T, Hernandez AF, Hull R, Korjian S, Daaboul Y, Chi G, Yee M, Harrington RA
When academic research organizations and clinical research organizations disagree: Processes to minimize discrepancies prior to unblinding of randomized trials. Am Heart J. 2017 07; 189:1-8.
When academic research organizations and clinical research organizations disagree: Processes to minimize discrepancies prior to unblinding of randomized trials.
Sica GT, Pugach ME, Koniaris LS, Goldhaber SZ, Polak JF, Mukerjee A, Tempany CM
Isolated calf vein thrombosis: comparison of MR venography and conventional venography after initial sonography in symptomatic patients. Acad Radiol. 2001 Sep; 8(9):856-63.
Isolated calf vein thrombosis: comparison of MR venography and conventional venography after initial sonography in symptomatic patients.
Fiumara K, Piovella C, Hurwitz S, Piazza G, Niles CM, Fanikos J, Paterno M, Labreche M, Stevens LA, Baroletti S, Goldhaber SZ
Multi-screen electronic alerts to augment venous thromboembolism prophylaxis. Thromb Haemost. 2010 Feb; 103(2):312-7.
Multi-screen electronic alerts to augment venous thromboembolism prophylaxis.
Fanikos J, Rao A, Seger AC, Carter D, Piazza G, Goldhaber SZ
Hospital costs of acute pulmonary embolism. Am J Med. 2013 Feb; 126(2):127-32.
Hospital costs of acute pulmonary embolism.
How to select patients with deep vein thrombosis for tPA therapy. Chest. 1989 May; 95(5 Suppl):276S-278S.
How to select patients with deep vein thrombosis for tPA therapy.
TPA versus urokinase in acute pulmonary embolism: results of a randomized controlled trial. Vasa Suppl. 1989; 27:292-4.
TPA versus urokinase in acute pulmonary embolism: results of a randomized controlled trial.
Kearon C, Kahn SR, Agnelli G, Goldhaber SZ, Raskob GE, Comerota AJ.
Antithrombotic therapy for venous thromboembolic disease. CHEST. 2008; 133:454S-545S.
Antithrombotic therapy for venous thromboembolic disease
Heparin-induced thrombocytopenia (HIT) happens: The optimal approach to prevention and management. 2004.
Zipes DP, Libby P, Bonow RO, Braunwald E, eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine
Pulmonary embolism. Zipes DP, Libby P, Bonow RO, Braunwald E, eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 2005; 1789-1806.
New frontiers in hematology for the cardiologist
New frontiers in hematology for the cardiologist. 2004.
Prevention of High-Risk Cardiovascular Disease. Edited by Antonio Gotto and Peter P. Toth
Prevention of High-Risk Cardiovascular Disease. Edited by Antonio Gotto and Peter P. Toth. 2007.
Wagman LD, Baird MF, Bennett CL, Bockenstedt PL, Cataland SR, Fanikos J, Fogarty PF, Goldhaber SZ, Grover TS, Haire W, Hassoun H, Hutchinson S, Jahanzeb M, Lee J, Linenberger ML, Milenson MM, Ortel TL, Salem R, Smith JL, Streiff MB, Vedantham S.
Venous thromboembolic disease. J Natl Compr Canc Netw. 2008; 8:716-753.
Agnelli G, ed. Thrombolisi Yearbook 1995
La terapia thrombolitica nell'embolia polmonare. Agnelli G, ed. Thrombolisi Yearbook 1995. 1995; 167-191.
Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism. N Engl J Med. 2003 Nov 27; 349(22):2164-7; author reply 2164-7.
Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism.
Goldhaber SZ, Nadel ES, King ME, Sharma A
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 17-2004. A 42-year-old woman with cardiac arrest several weeks after an ankle fracture. N Engl J Med. 2004 May 27; 350(22):2281-90.
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 17-2004. A 42-year-old woman with cardiac arrest several weeks after an ankle fracture.
Koo S, Kucher N, Nguyen PL, Fanikos J, Marks PW, Goldhaber SZ
The effect of excessive anticoagulation on mortality and morbidity in hospitalized patients with anticoagulant-related major hemorrhage. Arch Intern Med. 2004 Jul 26; 164(14):1557-60.
The effect of excessive anticoagulation on mortality and morbidity in hospitalized patients with anticoagulant-related major hemorrhage.
Schoepf UJ, Kucher N, Kipfmueller F, Quiroz R, Costello P, Goldhaber SZ
Right ventricular enlargement on chest computed tomography: a predictor of early death in acute pulmonary embolism. Circulation. 2004 Nov 16; 110(20):3276-80.
Right ventricular enlargement on chest computed tomography: a predictor of early death in acute pulmonary embolism.
High utilization rate of vena cava filters in deep vein thrombosis. Thromb Haemost. 2005 Jun; 93(6):1117-9.
High utilization rate of vena cava filters in deep vein thrombosis.
Seshadri N, Goldhaber SZ, Elkayam U, Grimm RA, Groce JB, Heit JA, Spinler SA, Turpie AG, Bosker G, Klein AL
The clinical challenge of bridging anticoagulation with low-molecular-weight heparin in patients with mechanical prosthetic heart valves: an evidence-based comparative review focusing on anticoagulation options in pregnant and nonpregnant patients. Am Heart J. 2005 Jul; 150(1):27-34.
The clinical challenge of bridging anticoagulation with low-molecular-weight heparin in patients with mechanical prosthetic heart valves: an evidence-based comparative review focusing on anticoagulation options in pregnant and nonpregnant patients.
Baim DS, Grossman W, eds., Cardiac Catheterization, Angiography, and Intervention
Profiles in pulmonary embolism. Baim DS, Grossman W, eds., Cardiac Catheterization, Angiography, and Intervention. 1996; 773-786.
Gibson CM, Korjian S, Chi G, Daaboul Y, Jain P, Arbetter D, Goldhaber SZ, Hull R, Hernandez AF, Lopes RD, Gold A, Cohen AT, Harrington RA
Comparison of Fatal or Irreversible Events With Extended-Duration Betrixaban Versus Standard Dose Enoxaparin in Acutely Ill Medical Patients: An APEX Trial Substudy. J Am Heart Assoc. 2017 Jul 11; 6(7).
Comparison of Fatal or Irreversible Events With Extended-Duration Betrixaban Versus Standard Dose Enoxaparin in Acutely Ill Medical Patients: An APEX Trial Substudy.
Goldhaber SZ, Bloom BS, Sugarbaker PH, O'Connor NE
Effects of the fiberoptic laparoscope and colonoscope on morbidity and cost. Ann Surg. 1974 Feb; 179(2):160-2.
Effects of the fiberoptic laparoscope and colonoscope on morbidity and cost.
Cardiovascular effects of potential occupational hazards. J Am Coll Cardiol. 1983 Dec; 2(6):1210-5.
Cardiovascular effects of potential occupational hazards.
Parker JA, Drum DE, Feldstein ML, Goldhaber SZ
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Lung scan evaluation of thrombolytic therapy for pulmonary embolism. J Nucl Med. 1995 Mar; 36(3):364-8.
Lung scan evaluation of thrombolytic therapy for pulmonary embolism.
Gaziano JM, Buring JE, Breslow JL, Goldhaber SZ, Rosner B, VanDenburgh M, Willett W, Hennekens CH
Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med. 1993 Dec 16; 329(25):1829-34.
Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction.
Goldhaber SZ, Hirsch DR, MacDougall RC, Polak JF, Creager MA
Bolus recombinant urokinase versus heparin in deep venous thrombosis: a randomized controlled trial. Am Heart J. 1996 Aug; 132(2 Pt 1):314-8.
Bolus recombinant urokinase versus heparin in deep venous thrombosis: a randomized controlled trial.
Fanikos J, Grasso-Correnti N, Shah R, Kucher N, Goldhaber SZ
Major bleeding complications in a specialized anticoagulation service. Am J Cardiol. 2005 Aug 15; 96(4):595-8.
Major bleeding complications in a specialized anticoagulation service.
Pulmonary embolism associated with olanzapine. Thromb Haemost. 2006 Nov; 96(5):690-1.
Pulmonary embolism associated with olanzapine.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
Percutaneous mechanical thrombectomy for massive pulmonary embolism: improve safety and efficacy by sharing information. Catheter Cardiovasc Interv. 2007 Nov 15; 70(6):807-8.
Clues to early death from symptomatic pulmonary embolism in subjects presenting as outpatients. Thromb Haemost. 2008 Nov; 100(5):733-4.
Clues to early death from symptomatic pulmonary embolism in subjects presenting as outpatients.
Selection of patients with acute pulmonary embolism for thrombolytic therapy. Thrombolysis in pulmonary embolism (TIPE) patient survey. The TIPE Investigators. Chest. 1989 May; 95(5 Suppl):279S-281S.
Selection of patients with acute pulmonary embolism for thrombolytic therapy. Thrombolysis in pulmonary embolism (TIPE) patient survey. The TIPE Investigators.
The Surgeon General's call to action exemplifies the role of advocacy in preventing venous thromboembolism. Am J Med. 2009 Sep; 122(9):791-2.
The Surgeon General's call to action exemplifies the role of advocacy in preventing venous thromboembolism.
Computerized decision support for the cardiovascular clinician: applications for venous thromboembolism prevention and beyond. Circulation. 2009 Sep 22; 120(12):1133-7.
Computerized decision support for the cardiovascular clinician: applications for venous thromboembolism prevention and beyond.
Fanikos J, Piazza G, Zayaruzny M, Goldhaber SZ
Long-term complications of medical patients with hospital-acquired venous thromboembolism. Thromb Haemost. 2009 Oct; 102(4):688-93.
Long-term complications of medical patients with hospital-acquired venous thromboembolism.
Emotional and psychological coping after venous thromboembolism. Thromb Haemost. 2009 Dec; 102(6):1007-8.
Emotional and psychological coping after venous thromboembolism.
O'Connor GT, Buring JE, Yusuf S, Goldhaber SZ, Olmstead EM, Paffenbarger RS, Hennekens CH
An overview of randomized trials of rehabilitation with exercise after myocardial infarction. Circulation. 1989 Aug; 80(2):234-44.
An overview of randomized trials of rehabilitation with exercise after myocardial infarction.
Hunsaker AR, Lu MT, Goldhaber SZ, Rybicki FJ
Imaging in acute pulmonary embolism with special clinical scenarios. Circ Cardiovasc Imaging. 2010 Jul; 3(4):491-500.
Imaging in acute pulmonary embolism with special clinical scenarios.
Goldhaber SZ, Newell JB, Ingwall JS, Pohost GM, Alpert NM, Fossel ET
Effects of reduced coronary flow on thallium-201 accumulation and release in an in vitro rat heart preparation. Am J Cardiol. 1983 Mar 01; 51(5):891-6.
Effects of reduced coronary flow on thallium-201 accumulation and release in an in vitro rat heart preparation.
Goldhaber SZ, Hennekens CH, Evans DA, Newton EC, Godleski JJ
Factors associated with correct antemortem diagnosis of major pulmonary embolism. Am J Med. 1982 Dec; 73(6):822-6.
Factors associated with correct antemortem diagnosis of major pulmonary embolism.
Lin BW, Schreiber DH, Liu G, Briese B, Hiestand B, Slattery D, Kline JA, Goldhaber SZ, Pollack CV
The American journal of emergency medicine
Therapy and outcomes in massive pulmonary embolism from the Emergency Medicine Pulmonary Embolism in the Real World Registry. Am J Emerg Med. 2012 Nov; 30(9):1774-81.
Therapy and outcomes in massive pulmonary embolism from the Emergency Medicine Pulmonary Embolism in the Real World Registry.
Thrombolytic therapy. Adv Intern Med. 1999; 44:311-25.
The perils of D-dimer in the medical intensive care unit. Crit Care Med. 2000 Feb; 28(2):583-4.
The perils of D-dimer in the medical intensive care unit.
Diagnosis of acute pulmonary embolism: always be vigilant. Am J Med. 2007 Oct; 120(10):827-8.
Diagnosis of acute pulmonary embolism: always be vigilant.
Chest computed tomography in the emergency department for suspected pulmonary embolism: it's time to practice what we preach. Ann Emerg Med. 2009 Jul; 54(1):49-52.
Chest computed tomography in the emergency department for suspected pulmonary embolism: it's time to practice what we preach.
European society of cardiology practice guidelines on acute pulmonary embolism: an American's commentary and personal perspectives. Pol Arch Med Wewn. 2009 Jan-Feb; 119(1-2):6-7.
European society of cardiology practice guidelines on acute pulmonary embolism: an American's commentary and personal perspectives.
Buckley O, DeVore A, Ersoy H, Sobieszczyk P, Auger WR, Kwong R, Rybicki FJ, Goldhaber SZ
Embolism after inferior vena cava filter mesh fragmentation. J Vasc Interv Radiol. 2010 Nov; 21(11):1782-4.
Embolism after inferior vena cava filter mesh fragmentation.
Wolpin BM, Kabrhel C, Varraso R, Kraft P, Rimm EB, Goldhaber SZ, Camargo CA, Fuchs CS
Prospective study of ABO blood type and the risk of pulmonary embolism in two large cohort studies. Thromb Haemost. 2010 Nov; 104(5):962-71.
Prospective study of ABO blood type and the risk of pulmonary embolism in two large cohort studies.
Ask the doctor. I am a 79-year-old man with atrial fibrillation that is well controlled by Pacerone. I also take warfarin and aspirin to prevent stroke. I plan to have a tooth pulled next month and wonder if is is safe to go off the blood thinners. How are these medications handled when more serious surgery is needed? Harv Heart Lett. 2010 Nov; 21(3):8.
Ask the doctor. I am a 79-year-old man with atrial fibrillation that is well controlled by Pacerone. I also take warfarin and aspirin to prevent stroke. I plan to have a tooth pulled next month and wonder if is is safe to go off the blood thinners. How are these medications handled when more serious surgery is needed?
Optimal duration of anticoagulation after venous thromboembolism. Circulation. 2011 Feb 15; 123(6):664-7.
Optimal duration of anticoagulation after venous thromboembolism.
Goldhaber SZ, Vaughan DE, Markis JE, Selwyn AP, Meyerovitz MF, Loscalzo J, Kim DS, Kessler CM, Dawley DL, Sharma GV
Acute pulmonary embolism treated with tissue plasminogen activator. Lancet. 1986 Oct 18; 2(8512):886-9.
Acute pulmonary embolism treated with tissue plasminogen activator.
Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, Nelson ME, Wells PS, Gould MK, Dentali F, Crowther M, Kahn SR
Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb; 141(2 Suppl):e419S-e496S.
Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Rationale supporting an "opt-out" policy for pharmacological venous thromboembolism prophylaxis in hospitalized medical patients. J Thromb Thrombolysis. 2013 Apr; 35(3):371-4.
Rationale supporting an "opt-out" policy for pharmacological venous thromboembolism prophylaxis in hospitalized medical patients.
European Atherosclerosis Society screening recommendations for lipoprotein(a) and high-sensitivity C-reactive protein: double standard or failure of evidence-based medicine? Clin Chem. 2010 Oct; 56(10):1544-6.
European Atherosclerosis Society screening recommendations for lipoprotein(a) and high-sensitivity C-reactive protein: double standard or failure of evidence-based medicine?
Epidemiologic concepts and strategies. Goldhaber SZ, ed. Pulmonary Embolism and Deep Venous Thrombosis. 1985; 3-9.
Vaughan DE, Goldhaber SZ, Kim J, Loscalzo J
Recombinant tissue plasminogen activator in patients with pulmonary embolism: correlation of fibrinolytic specificity and efficacy. Circulation. 1987 Jun; 75(6):1200-3.
Recombinant tissue plasminogen activator in patients with pulmonary embolism: correlation of fibrinolytic specificity and efficacy.
Lowering Cholesterol in High-Risk Individuals and Populations, edited by Basil M. Rifkind
Lowering Cholesterol in High-Risk Individuals and Populations, edited by Basil M. Rifkind. 1995.
Pulmonary embolism. Kloner RA, ed. The Guide to Cardiology. 1984; 483-492.
In: Kitchens CS, Alving BM, Kessler CM, eds. Consultative Hemostasis and Thrombosis.
Deep Vein Thrombosis and Pulmonary Embolism. In: Kitchens CS, Alving BM, Kessler CM, eds. Consultative Hemostasis and Thrombosis. 2007; 245-256.
Fuster V, Verstraete M, eds. Thrombosis in Cardiovascular Disorders
Treatment of venous thrombosis and pulmonary embolism. Fuster V, Verstraete M, eds. Thrombosis in Cardiovascular Disorders. 1992; 465-484.
Treatment of venous thrombosis and pulmonary embolism
Arbetter DF, Jain P, Yee MK, Michalak N, Hernandez AF, Hull RD, Goldhaber SZ, Harrington RA, Gold A, Cohen AT, Gibson CM
Competing risk analysis in a large cardiovascular clinical trial: An APEX substudy. Pharm Stat. 2017 11; 16(6):445-450.
Competing risk analysis in a large cardiovascular clinical trial: An APEX substudy.
ISIS-3 (Third International Study of Infarct Survival) Collaborative Group
ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. Lancet. 1992; 1:753-770.
ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction
Agnelli G. ed. Thrombolysis Yearbook 1995
Thrombolytic therapy in pulmonary embolism. Agnelli G. ed. Thrombolysis Yearbook 1995. 1995; 163-185.
Advanced treatment strategies for acute pulmonary embolism, including thrombolysis and embolectomy. J Thromb Haemost. 2009 Jul; 7 Suppl 1:322-7.
Advanced treatment strategies for acute pulmonary embolism, including thrombolysis and embolectomy.
Chi G, Goldhaber SZ, Kittelson JM, Turpie AGG, Hernandez AF, Hull RD, Gold A, Curnutte JT, Cohen AT, Harrington RA, Gibson CM
Effect of extended-duration thromboprophylaxis on venous thromboembolism and major bleeding among acutely ill hospitalized medical patients: a bivariate analysis. J Thromb Haemost. 2017 10; 15(10):1913-1922.
Effect of extended-duration thromboprophylaxis on venous thromboembolism and major bleeding among acutely ill hospitalized medical patients: a bivariate analysis.
Goldhaber SZ, Kessler CM, Heit J, Markis J, Sharma GV, Dawley D, Nagel JS, Meyerovitz M, Kim D, Vaughan DE
Randomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism. Lancet. 1988 Aug 06; 2(8606):293-8.
Randomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism.
Dorfman DM, Goonan EM, Boutilier MK, Jarolim P, Tanasijevica M, Goldhaber SZ
Point-of-care (POC) versus central laboratory instrumentation for monitoring oral anticoagulation. Vasc Med. 2005 Feb; 10(1):23-7.
Point-of-care (POC) versus central laboratory instrumentation for monitoring oral anticoagulation.
Recent advances in the diagnosis and lytic therapy of pulmonary embolism. Chest. 1991 Apr; 99(4 Suppl):173S-179S.
Recent advances in the diagnosis and lytic therapy of pulmonary embolism.
Wilson MG, Pei LF, Malone KM, Polak JF, Creager MA, Goldhaber SZ
Fixed low-dose versus adjusted higher-dose warfarin following orthopedic surgery. A randomized prospective trial. J Arthroplasty. 1994 Apr; 9(2):127-30.
Fixed low-dose versus adjusted higher-dose warfarin following orthopedic surgery. A randomized prospective trial.
Pulmonary embolism. N Engl J Med. 1998 Jul 09; 339(2):93-104.
Conjunctive heparin therapy. Limitations of subcutaneous administration. Circulation. 1992 Nov; 86(5):1639-41.
Conjunctive heparin therapy. Limitations of subcutaneous administration.
Alper EC, Ip IK, Balthazar P, Piazza G, Goldhaber SZ, Benson CB, Lacson R, Khorasani R
Risk Stratification Model: Lower-Extremity Ultrasonography for Hospitalized Patients with Suspected Deep Vein Thrombosis. J Gen Intern Med. 2018 01; 33(1):21-25.
Risk Stratification Model: Lower-Extremity Ultrasonography for Hospitalized Patients with Suspected Deep Vein Thrombosis.
Giants in Chest Medicine: Jack Hirsh, CM, MD, DSc. Chest. 2017 09; 152(3):463-465.
Giants in Chest Medicine: Jack Hirsh, CM, MD, DSc.
Chi G, Januzzi JL, Korjian S, Daaboul Y, Goldhaber SZ, Hernandez AF, Hull RD, Gold A, Cohen AT, Harrington RA, Gibson CM
N-terminal pro-B-type natriuretic peptide and the risk of stroke among patients hospitalized with acute heart failure: an APEX trial substudy. J Thromb Thrombolysis. 2017 Nov; 44(4):457-465.
N-terminal pro-B-type natriuretic peptide and the risk of stroke among patients hospitalized with acute heart failure: an APEX trial substudy.
Thrombolysis in pulmonary embolism: a large-scale clinical trial is overdue. Circulation. 2001 Dec 11; 104(24):2876-8.
Thrombolysis in pulmonary embolism: a large-scale clinical trial is overdue.
Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Vaitkus PT, Goldhaber SZ
Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation. 2004 Aug 17; 110(7):874-9.
Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients.
Anavekar NS, Gans DJ, Berl T, Rohde RD, Cooper W, Bhaumik A, Hunsicker LG, Rouleau JL, Lewis JB, Rosendorff C, Porush JG, Drury PL, Esmatjes E, Raz I, Vanhille P, Locatelli F, Goldhaber S, Lewis EJ, Pfeffer MA
Predictors of cardiovascular events in patients with type 2 diabetic nephropathy and hypertension: a case for albuminuria. Kidney Int Suppl. 2004 Nov; (92):S50-5.
Predictors of cardiovascular events in patients with type 2 diabetic nephropathy and hypertension: a case for albuminuria.
The effect of chronic platelet inhibition with low-dose aspirin on atherosclerotic progression and acute thrombosis: clinical evidence from the Physicians' Health Study. Am Heart J. 1991 Dec; 122(6):1588-92.
The effect of chronic platelet inhibition with low-dose aspirin on atherosclerotic progression and acute thrombosis: clinical evidence from the Physicians' Health Study.
Prognostic role of echocardiography among patients with acute pulmonary embolism and a systolic arterial pressure of 90 mm Hg or higher. Arch Intern Med. 2005 Aug 8-22; 165(15):1777-81.
Prognostic role of echocardiography among patients with acute pulmonary embolism and a systolic arterial pressure of 90 mm Hg or higher.
The acutely decompensated right ventricle: pathways for diagnosis and management. Chest. 2005 Sep; 128(3):1836-52.
The acutely decompensated right ventricle: pathways for diagnosis and management.
Laboratory parameters to monitor safety and efficacy during thrombolytic therapy. Chest. 1991 Apr; 99(4 Suppl):113S-120S.
Laboratory parameters to monitor safety and efficacy during thrombolytic therapy.
Low intensity warfarin anticoagulation is safe and effective as a long-term venous thromboembolism prevention strategy. J Thromb Thrombolysis. 2006 Feb; 21(1):51-2.
Low intensity warfarin anticoagulation is safe and effective as a long-term venous thromboembolism prevention strategy.
Douketis JD, Arneklev K, Goldhaber SZ, Spandorfer J, Halperin F, Horrow J
Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding. Arch Intern Med. 2006 Apr 24; 166(8):853-9.
Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding.
Risk factors for the assessment of patients with pulmonary embolism. J Natl Compr Canc Netw. 2006 Oct; 4(9):871-80.
Risk factors for the assessment of patients with pulmonary embolism.
Risk stratification of acute pulmonary embolism. Semin Thromb Hemost. 2006 Nov; 32(8):838-47.
Risk stratification of acute pulmonary embolism.
Outpatient venous thromboembolism: a common but often preventable public health threat. Arch Intern Med. 2007 Jul 23; 167(14):1451-2.
Outpatient venous thromboembolism: a common but often preventable public health threat.
Bikdeli B, Chatterjee S, Desai NR, Kirtane AJ, Desai MM, Bracken MB, Spencer FA, Monreal M, Goldhaber SZ, Krumholz HM
Inferior Vena Cava Filters to Prevent Pulmonary Embolism: Systematic Review and Meta-Analysis. J Am Coll Cardiol. 2017 Sep 26; 70(13):1587-1597.
Inferior Vena Cava Filters to Prevent Pulmonary Embolism: Systematic Review and Meta-Analysis.
Satterfield S, Greco PJ, Goldhaber SZ, Stampfer MJ, Swartz SL, Stein EA, Kaplan L, Hennekens CH
Biochemical markers of compliance in the Physicians' Health Study. Am J Prev Med. 1990 Sep-Oct; 6(5):290-4.
Biochemical markers of compliance in the Physicians' Health Study.
Cohen AT, Tapson VF, Bergmann JF, Goldhaber SZ, Kakkar AK, Deslandes B, Huang W, Zayaruzny M, Emery L, Anderson FA
Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet. 2008 Feb 02; 371(9610):387-94.
Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study.
Jaff MR, McMurtry MS, Archer SL, Cushman M, Goldenberg N, Goldhaber SZ, Jenkins JS, Kline JA, Michaels AD, Thistlethwaite P, Vedantham S, White RJ, Zierler BK
Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation. 2011 Apr 26; 123(16):1788-830.
Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association.
Surgical pulmonary embolectomy: the resurrection of an almost discarded operation. Tex Heart Inst J. 2013; 40(1):5-8.
Surgical pulmonary embolectomy: the resurrection of an almost discarded operation.
Baim DS, Grossman W, ed., Grossman's Cardiac Catheterization, Angiography, and Intervention
Profiles in Pulmonary Embolism. Baim DS, Grossman W, ed., Grossman's Cardiac Catheterization, Angiography, and Intervention. 2000; 799-811.
The Steering Committee of the Physicians' Health Study Research Group
Preliminary report: Findings from the aspirin component of the ongoing Physicians' Health Study. N Engl J Med. 1988; 318:262-264.
Preliminary report: Findings from the aspirin component of the ongoing Physicians' Health Study
Argatroban in the management of heparin-induced thrombocytopenia. Cardiology Scientific Update. 2000.
Argatroban in the management of heparin-induced thrombocytopenia
Practical Critical Care in Cardiology, edited by Zab Mohsenifar and P.K. Shah
Practical Critical Care in Cardiology, edited by Zab Mohsenifar and P.K. Shah. 1998.
Improving clinical effectiveness in thromboprophylaxis. Am J Med. 2009.
Improving clinical effectiveness in thromboprophylaxis
Cardiac arrest from massive pulmonary embolism. Intl Circualtion. 2009.
Cardiac arrest from massive pulmonary embolism
Pulmonary Embolism. Heart Disease. 2007.
Acute Coronary Syndromes. Third Edition edited by Eric Topol
Acute Coronary Syndromes. Third Edition edited by Eric Topol. 2006.
Strategies for management. Goldhaber SZ, ed. Pulmonary Embolism and Deep Venous Thrombosis. 1985; 121-133.
Bates ER, ed. Thrombolysis and Adjunctive Therapy for Acute Myocardial Infarction
Warfarin. Bates ER, ed. Thrombolysis and Adjunctive Therapy for Acute Myocardial Infarction. 1992; 257-270.
Cannon CP, O'Gara PT, eds. Critical Pathways in Cardiology
Venous Thromboembolism. Cannon CP, O'Gara PT, eds. Critical Pathways in Cardiology. 2007; 224-237.
Frequently Asked Questions from the BWH Venous Thromboembolism Support Group http://web.mit.edu/karen/www/faq.html
Frequently Asked Questions from the BWH Venous Thromboembolism Support Group http://web.mit.edu/karen/www/faq.html. 2007.
Cardiovascular Diseases in the Elderly Patient, edited by Donald D. Tresch and Wilbert S. Aronow
Cardiovascular Diseases in the Elderly Patient, edited by Donald D. Tresch and Wilbert S. Aronow. 1993.
Goldhaber SZ, Schulman S, Eriksson H, Feuring M, Fraessdorf M, Kreuzer J, Schüler E, Schellong S, Kakkar AK
Dabigatran versus Warfarin for Acute Venous Thromboembolism in Elderly or Impaired Renal Function Patients: Pooled Analysis of RE-COVER and RE-COVER II. Pooled analysis of RE-COVER and RE-COVER II. Thromb Haemost. 2017 Oct 04; 117(11).
Dabigatran versus Warfarin for Acute Venous Thromboembolism in Elderly or Impaired Renal Function Patients: Pooled Analysis of RE-COVER and RE-COVER II. Pooled analysis of RE-COVER and RE-COVER II.
Medical school admissions: a raw deal for applicants. Science. 1972 Jul 28; 177(4046):332-4.
Medical school admissions: a raw deal for applicants.
Venous thrombosis: prevention, treatment, and relationship to paradoxical embolization. Cardiol Clin. 1994 Aug; 12(3):505-16.
Venous thrombosis: prevention, treatment, and relationship to paradoxical embolization.
Zlotnick AY, Lennon PF, Goldhaber SZ, Aranki SF
Intraoperative detection of pulmonary thromboemboli with epicardial echocardiography. Chest. 1999 Jun; 115(6):1749-51.
Intraoperative detection of pulmonary thromboemboli with epicardial echocardiography.
Treatment of Advanced Heart Disease. Edited by Kenneth L. Baughman and William A. Baumgartner
Treatment of Advanced Heart Disease. Edited by Kenneth L. Baughman and William A. Baumgartner. 2006.
Foundations of Cardiac Arrhythmias: Basic Concepts and Clinical Approaches, edited by Peter M. Spooner and Michael R. Rosen
Foundations of Cardiac Arrhythmias: Basic Concepts and Clinical Approaches, edited by Peter M. Spooner and Michael R. Rosen. 2001.
Current and Emerging Therapies in the Management of VTE.
Current and Emerging Therapies in the Management of VTE. 2007.
Freeman LM, Weissman HS, eds. Nuclear Medicine Annual 1983
The role of nuclear medicine in non-coronary heart disease. Freeman LM, Weissman HS, eds. Nuclear Medicine Annual 1983. 1983; 97-129.
The role of nuclear medicine in non-coronary heart disease
Management of deep venous thrombosis and pulmonary embolism. Clin Cornerstone. 2000; 2(4):47-58; quiz 59-64.
Management of deep venous thrombosis and pulmonary embolism.
Blood tests that predict thrombosis and the relation of these blood tests to primary (inherited) and acquired risk factors. Goldhaber SZ, ed. Prevention of Venous Thromboembolism. 1993; 3-24.
Blood tests that predict thrombosis and the relation of these blood tests to primary (inherited) and acquired risk factors
'Beverly Hills, 90210': The lap belts don't show on TV. JAMA. 1992 Jul 08; 268(2):200.
'Beverly Hills, 90210': The lap belts don't show on TV.
Nicolaides AN, Breddin HK, Fareed J, Goldhaber S, Haas S, Hull R, Kalodiki E, Myers K, Samama M, Sasahara A
Prevention of venous thromboembolism. International Consensus Statement. Guidelines compiled in accordance with the scientific evidence. Int Angiol. 2001 Mar; 20(1):1-37.
Prevention of venous thromboembolism. International Consensus Statement. Guidelines compiled in accordance with the scientific evidence.
Kucher N, Leizorovicz A, Vaitkus PT, Cohen AT, Turpie AG, Olsson CG, Goldhaber SZ
Efficacy and safety of fixed low-dose dalteparin in preventing venous thromboembolism among obese or elderly hospitalized patients: a subgroup analysis of the PREVENT trial. Arch Intern Med. 2005 Feb 14; 165(3):341-5.
Efficacy and safety of fixed low-dose dalteparin in preventing venous thromboembolism among obese or elderly hospitalized patients: a subgroup analysis of the PREVENT trial.
Thrombolytic therapy for patients with pulmonary embolism who are hemodynamically stable but have right ventricular dysfunction: pro. Arch Intern Med. 2005 Oct 24; 165(19):2197-9; discussion 2204-5.
Thrombolytic therapy for patients with pulmonary embolism who are hemodynamically stable but have right ventricular dysfunction: pro.
Pathophysiology of haemostasis and thrombosis
Acute pulmonary embolism: risk stratification. Pathophysiol Haemost Thromb. 2006; 35(1-2):153-6.
Acute pulmonary embolism: risk stratification.
Agnelli G, Gallus A, Goldhaber SZ, Haas S, Huisman MV, Hull RD, Kakkar AK, Misselwitz F, Schellong S
Treatment of proximal deep-vein thrombosis with the oral direct factor Xa inhibitor rivaroxaban (BAY 59-7939): the ODIXa-DVT (Oral Direct Factor Xa Inhibitor BAY 59-7939 in Patients With Acute Symptomatic Deep-Vein Thrombosis) study. Circulation. 2007 Jul 10; 116(2):180-7.
Treatment of proximal deep-vein thrombosis with the oral direct factor Xa inhibitor rivaroxaban (BAY 59-7939): the ODIXa-DVT (Oral Direct Factor Xa Inhibitor BAY 59-7939 in Patients With Acute Symptomatic Deep-Vein Thrombosis) study.
Sobieszczyk P, Fishbein MC, Goldhaber SZ
Acute pulmonary embolism: don't ignore the platelet. Circulation. 2002 Oct 01; 106(14):1748-9.
Acute pulmonary embolism: don't ignore the platelet.
Byrne JG, Karavas AN, Colson YL, Bueno R, Richards WG, Sugarbaker DJ, Goldhaber SZ
Cardiac decortication (epicardiectomy) for occult constrictive cardiac physiology after left extrapleural pneumonectomy. Chest. 2002 Dec; 122(6):2256-9.
Cardiac decortication (epicardiectomy) for occult constrictive cardiac physiology after left extrapleural pneumonectomy.
A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis. Am J Cardiol. 2004 Jan 15; 93(2):259-62.
A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis.
Thrombolysis in submassive pulmonary embolism. J Thromb Haemost. 2004 Aug; 2(8):1473-4; discussion 1474-8.
Thrombolysis in submassive pulmonary embolism.
Sutton MS, Cole P, Plappert M, Saltzman D, Goldhaber S
Effects of subsequent pregnancy on left ventricular function in peripartum cardiomyopathy. Am Heart J. 1991 Jun; 121(6 Pt 1):1776-8.
Effects of subsequent pregnancy on left ventricular function in peripartum cardiomyopathy.
Fanikos J, Fiumara K, Baroletti S, Luppi C, Saniuk C, Mehta A, Silverman J, Goldhaber SZ
Impact of smart infusion technology on administration of anticoagulants (unfractionated Heparin, Argatroban, Lepirudin, and Bivalirudin). Am J Cardiol. 2007 Apr 01; 99(7):1002-5.
Impact of smart infusion technology on administration of anticoagulants (unfractionated Heparin, Argatroban, Lepirudin, and Bivalirudin).
Assessing the prognosis of acute pulmonary embolism: tricks of the trade. Chest. 2008 Feb; 133(2):334-6.
Assessing the prognosis of acute pulmonary embolism: tricks of the trade.
Baroletti S, Piovella C, Fanikos J, Labreche M, Lin J, Goldhaber SZ
Heparin-induced thrombocytopenia (HIT): clinical and economic outcomes. Thromb Haemost. 2008 Dec; 100(6):1130-5.
Heparin-induced thrombocytopenia (HIT): clinical and economic outcomes.
Venous thromboembolism prophylaxis: quality, location (hospital vs. home), and duration. Thromb Haemost. 2009 Jul; 102(1):1-2.
Venous thromboembolism prophylaxis: quality, location (hospital vs. home), and duration.
Bergmann JF, Cohen AT, Tapson VF, Goldhaber SZ, Kakkar AK, Deslandes B, Huang W, Anderson FA
Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients. The ENDORSE Global Survey. Thromb Haemost. 2010 Apr; 103(4):736-48.
Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients. The ENDORSE Global Survey.
Fine-tuning risk stratification for acute pulmonary embolism with cardiac biomarkers. J Am Coll Cardiol. 2010 May 11; 55(19):2158-9.
Fine-tuning risk stratification for acute pulmonary embolism with cardiac biomarkers.
Nature clinical practice. Cardiovascular medicine
Outpatient venous thromboembolism: the importance of optimum prophylaxis. Nat Clin Pract Cardiovasc Med. 2008 Jan; 5(1):12-3.
Outpatient venous thromboembolism: the importance of optimum prophylaxis.
Venous Thromboembolism Guidebook, fourth edition. Crit Pathw Cardiol. 2003 Dec; 2(4):247-65.
Venous Thromboembolism Guidebook, fourth edition.
Daneschvar HL, Seddighzadeh A, Piazza G, Goldhaber SZ
Deep vein thrombosis in patients with chronic kidney disease. Thromb Haemost. 2008 Jun; 99(6):1035-9.
Deep vein thrombosis in patients with chronic kidney disease.
Pollack CV, Schreiber D, Goldhaber SZ, Slattery D, Fanikos J, O'Neil BJ, Thompson JR, Hiestand B, Briese BA, Pendleton RC, Miller CD, Kline JA
Clinical characteristics, management, and outcomes of patients diagnosed with acute pulmonary embolism in the emergency department: initial report of EMPEROR (Multicenter Emergency Medicine Pulmonary Embolism in the Real World Registry). J Am Coll Cardiol. 2011 Feb 08; 57(6):700-6.
Clinical characteristics, management, and outcomes of patients diagnosed with acute pulmonary embolism in the emergency department: initial report of EMPEROR (Multicenter Emergency Medicine Pulmonary Embolism in the Real World Registry).
Kabrhel C, Varraso R, Goldhaber SZ, Rimm E, Camargo CA
Physical inactivity and idiopathic pulmonary embolism in women: prospective study. BMJ. 2011 Jul 04; 343:d3867.
Physical inactivity and idiopathic pulmonary embolism in women: prospective study.
Pulmonary embolism following shoulder arthroplasty: don't shrug it off. JBJS. 2002.
Pulmonary embolism following shoulder arthroplasty: don't shrug it off
Low-dose and very-low-dose warfarin. Goldhaber SZ, ed. Prevention of Venous Thromboembolism. 1993; 231-244.
Steering Committee of the Physicians' Health Study Research Group
Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med. 1989; 321:129-135.
Final report on the aspirin component of the ongoing Physicians' Health Study
Pulmonary embolism. Kloner RA, ed. The Guide to Cardiology. 1990; 449-454.
Palla A, Tumeh SS, Nagel JS, Meyerovitz MF, Goldhaber SZ, Holman BL
The Journal of nuclear medicine and allied sciences
Detection of pulmonary perfusion defects by single photon emission computed tomography (SPECT). J Nucl Med Allied Sci. 1988 Jan-Mar; 32(1):27-32.
Detection of pulmonary perfusion defects by single photon emission computed tomography (SPECT).
Cohn PF, Wynne J, eds. Diagnostic Methods in Clinical Cardiology
Blood Tests. Cohn PF, Wynne J, eds. Diagnostic Methods in Clinical Cardiology. 1982; 333-365.
Pulmonary embolism death rates. Am Heart J. 1988 Jun; 115(6):1342-3.
Chronic venous insufficiency: mechanisms and management. Am Heart J. 1996 Oct; 132(4):856-60.
Chronic venous insufficiency: mechanisms and management.
Risk factors associated with symptomatic pulmonary embolism in a large cohort of deep vein thrombosis patients. Thromb Haemost. 2005 Mar; 93(3):494-8.
Risk factors associated with symptomatic pulmonary embolism in a large cohort of deep vein thrombosis patients.
Heparin-induced thrombocytopenia. Circulation. 2006 Aug 22; 114(8):e355-6.
Optimizing anticoagulant therapy in the management of pulmonary embolism. Semin Thromb Hemost. 1999; 25 Suppl 3:129-33.
Optimizing anticoagulant therapy in the management of pulmonary embolism.
Pulmonary Embolism Thrombolysis Improves Survival in Massive Pulmonary Embolism. J Thromb Thrombolysis. 1995; 2(3):219-220.
Pulmonary Embolism Thrombolysis Improves Survival in Massive Pulmonary Embolism.
Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement. Vasc Med. 2001; 6(1):23-9.
Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement.
Glynn RJ, Ridker PM, Goldhaber SZ, Buring JE
Effect of low-dose aspirin on the occurrence of venous thromboembolism: a randomized trial. Ann Intern Med. 2007 Oct 16; 147(8):525-33.
Effect of low-dose aspirin on the occurrence of venous thromboembolism: a randomized trial.
HEW decentralizers exempt research. Science. 1970 Jun 26; 168(3939):1557.
Piana RN, Adams MR, Orford JL, Popma JJ, Adams DH, Goldhaber SZ
Rescue percutaneous coronary intervention immediately following coronary artery bypass grafting. Chest. 2001 Oct; 120(4):1417-20.
Rescue percutaneous coronary intervention immediately following coronary artery bypass grafting.
Aklog L, Williams CS, Byrne JG, Goldhaber SZ
Acute pulmonary embolectomy: a contemporary approach. Circulation. 2002 Mar 26; 105(12):1416-9.
Acute pulmonary embolectomy: a contemporary approach.
Fanikos J, Tsilimingras K, Kucher N, Rosen AB, Hieblinger MD, Goldhaber SZ
Comparison of efficacy, safety, and cost of low-molecular-weight heparin with continuous-infusion unfractionated heparin for initiation of anticoagulation after mechanical prosthetic valve implantation. Am J Cardiol. 2004 Jan 15; 93(2):247-50.
Comparison of efficacy, safety, and cost of low-molecular-weight heparin with continuous-infusion unfractionated heparin for initiation of anticoagulation after mechanical prosthetic valve implantation.
Pulmonary embolism in Black Americans. Am J Hematol. 2010 Jul; 85(7):465-6.
Prevention of recurrent idiopathic venous thromboembolism. Circulation. 2004 Dec 14; 110(24 Suppl 1):IV20-4.
Prevention of recurrent idiopathic venous thromboembolism.
Venous thromboembolism in patients with symptomatic atherosclerosis. Thromb Haemost. 2011 Dec; 106(6):1095-102.
Venous thromboembolism in patients with symptomatic atherosclerosis.
Fanikos J, Rao A, Seger AC, Piazza G, Catapane E, Chen X, Goldhaber SZ
Venous thromboembolism prophylaxis for medical service-mostly cancer-patients at hospital discharge. Am J Med. 2011 Dec; 124(12):1143-50.
Venous thromboembolism prophylaxis for medical service-mostly cancer-patients at hospital discharge.
Yee MK, Nafee T, Daaboul Y, Korjian S, AlKhalfan F, Kerneis M, Wiest C, Goldhaber SZ, Hernandez AF, Hull RD, Cohen AT, Harrington RA, Gibson CM
Increased benefit of betrixaban among patients with a history of venous thromboembolism: a post-hoc analysis of the APEX trial. J Thromb Thrombolysis. 2018 Jan; 45(1):1-8.
Increased benefit of betrixaban among patients with a history of venous thromboembolism: a post-hoc analysis of the APEX trial.
Vedantham S, Rundback JH, Comerota AJ, Hunter DW, Meissner MH, Hofmann LV, Horne M, Gloviczki P, Andrews RT, Fan CM, Hume KM, Goldhaber SK, Tapson VF, Razavi MK, Min RJ
Development of a research agenda for endovascular treatment of venous thromboembolism: proceedings from a multidisciplinary consensus panel. J Vasc Interv Radiol. 2005 Dec; 16(12):1567-73.
Development of a research agenda for endovascular treatment of venous thromboembolism: proceedings from a multidisciplinary consensus panel.
Meyerovitz MF, Goldhaber SZ, Reagan K, Polak JF, Kandarpa K, Grassi CJ, Donovan BC, Bettmann MA, Harrington DP
Recombinant tissue-type plasminogen activator versus urokinase in peripheral arterial and graft occlusions: a randomized trial. Radiology. 1990 Apr; 175(1):75-8.
Recombinant tissue-type plasminogen activator versus urokinase in peripheral arterial and graft occlusions: a randomized trial.
Ask the doctor. Is warfarin turning my toes purple? Harv Heart Lett. 2007 Jul; 17(11):7.
Ask the doctor. Is warfarin turning my toes purple?
Prandoni P, Goldhaber SZ, Piccioli A, Girolami A
Prevention of venous thromboembolism in major othropedic surgery. Clin Appl Thrombosis/Hemostasis. 1996; 2:153-157.
Prevention of venous thromboembolism in major othropedic surgery
Beta-Blockers and Cardiac Arrhythmias, edited by Prakash C. Deedwania
Beta-Blockers and Cardiac Arrhythmias, edited by Prakash C. Deedwania. 1992.
Syncope. May H, ed. Emergency Medicine. 1984; 181-198.
Willerson JT, Cohn JN, Wellens HJJ, Holmes DR, eds., Cardiovascular Medicine
Venous Disease. Willerson JT, Cohn JN, Wellens HJJ, Holmes DR, eds., Cardiovascular Medicine. 2007; 1705-1716.
Advances in Diagnosis and Management of Pulmonary Embolism
Advances in Diagnosis and Management of Pulmonary Embolism. 1997.
Systemic Cardiac Embolism, edited by Michael D. Ezekowitz
Systemic Cardiac Embolism, edited by Michael D. Ezekowitz. 1994.
Periprocedural management of the chronically anticoagulated patient. Crit Pathways in Cardiology. 2003; 2:96-103.
Periprocedural management of the chronically anticoagulated patient
Opinions regarding the diagnosis and management of venous thromboembolic disease. CHEST. 1996; 109:233-237.
Stunned Myocardium: Properties, Mechanisms, and Clinical Manifestations, edited by Robert A. Kloner and Karin Przyklenk
Stunned Myocardium: Properties, Mechanisms, and Clinical Manifestations, edited by Robert A. Kloner and Karin Przyklenk. 1992.
Rationale and design of a clinical trial of a low-molecular-weight heparin in preventing clincally important venous thromboembolis in medical patients: the Prospective Evaluation of Dalteparin Efficacy for Prevention of Venous Thromboembolism in Immobilized Patients Trial (the PREVENT study). Vascular Medicine. 2002; 7:269-73.
Rationale and design of a clinical trial of a low-molecular-weight heparin in preventing clincally important venous thromboembolis in medical patients: the Prospective Evaluation of Dalteparin Efficacy for Prevention of Venous Thromboembolism in Immobilized Patients Trial (the PREVENT study)
Cardiovascular Disease in the Elderly Patient: Second Edition, Revised and Expanded, edited by Donald D. Tresch and Wilbert S. Aronow
Cardiovascular Disease in the Elderly Patient: Second Edition, Revised and Expanded, edited by Donald D. Tresch and Wilbert S. Aronow. 1999.
Coronary Heart Disease Prevention, edited by Frank G. Yanowitz
Coronary Heart Disease Prevention, edited by Frank G. Yanowitz. 1992.
Fiberoptics: morbidity and cost. N Engl J Med. 1973 Feb 15; 288(7):368-9.
Goldhaber SZ, Hennekens CH, Spark RF, Evans DA, Rosner B, Taylor JO, Kass EH
Plasma renin substrate, renin activity, and aldosterone levels in a sample of oral contraceptive users from a community survey. Am Heart J. 1984 Jan; 107(1):119-22.
Plasma renin substrate, renin activity, and aldosterone levels in a sample of oral contraceptive users from a community survey.
Unstable Angina, edited by John D. Rutherford
Unstable Angina, edited by John D. Rutherford. 1991.
Kuo WT, Sze DY, Hofmann LV, Goldhaber SZ.
Catheter-directed intervention for acute pulmonary embolism: A shining saber. CHEST. 2008; 133:317-318.
Catheter-directed intervention for acute pulmonary embolism: A shining saber
Pulmonary embolism. Kloner R, ed. The Guide to Cardiology. 1995; 627-636.
t-PA and urokinase thrombolysis in pulmonary embolism Video Journal of Cardiology
t-PA and urokinase thrombolysis in pulmonary embolism Video Journal of Cardiology. 1987.
D'Amico AV, Denham JW, Crook J, Chen MH, Goldhaber SZ, Lamb DS, Joseph D, Tai KH, Malone S, Ludgate C, Steigler A, Kantoff PW
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions. J Clin Oncol. 2007 Jun 10; 25(17):2420-5.
Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions.
Percutaneous mechanical thrombectomy for acute pulmonary embolism: a double-edged sword. Chest. 2007 Aug; 132(2):363-5.
Percutaneous mechanical thrombectomy for acute pulmonary embolism: a double-edged sword.
Baroletti S, Munz K, Sonis J, Fanikos J, Fiumara K, Paterno M, Goldhaber SZ
Electronic alerts for hospitalized high-VTE risk patients not receiving prophylaxis: a cohort study. J Thromb Thrombolysis. 2008 Apr; 25(2):146-50.
Electronic alerts for hospitalized high-VTE risk patients not receiving prophylaxis: a cohort study.
Pulmonary embolism in heart failure. Circulation. 2008 Oct 07; 118(15):1598-601.
Steinberg BA, Gao H, Shrader P, Pieper K, Thomas L, Camm AJ, Ezekowitz MD, Fonarow GC, Gersh BJ, Goldhaber S, Haas S, Hacke W, Kowey PR, Ansell J, Mahaffey KW, Naccarelli G, Reiffel JA, Turpie A, Verheugt F, Piccini JP, Kakkar A, Peterson ED, Fox KAA
International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: Results from the GARFIELD-AF, ORBIT-AF I, and ORBIT-AF II registries. Am Heart J. 2017 Dec; 194:132-140.
International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation: Results from the GARFIELD-AF, ORBIT-AF I, and ORBIT-AF II registries.
Chi G, Goldhaber SZ, Hull RD, Hernandez AF, Kerneis M, Al Khalfan F, Cohen AT, Harrington RA, Gibson CM
Thrombus Burden of Deep Vein Thrombosis and Its Association with Thromboprophylaxis and D-Dimer Measurement: Insights from the APEX Trial. Thromb Haemost. 2017 12; 117(12):2389-2395.
Thrombus Burden of Deep Vein Thrombosis and Its Association with Thromboprophylaxis and D-Dimer Measurement: Insights from the APEX Trial.
Fox KAA, Lucas JE, Pieper KS, Bassand JP, Camm AJ, Fitzmaurice DA, Goldhaber SZ, Goto S, Haas S, Hacke W, Kayani G, Oto A, Mantovani LG, Misselwitz F, Piccini JP, Turpie AGG, Verheugt FWA, Kakkar AK
Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation. BMJ Open. 2017 12 21; 7(12):e017157.
Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation.
Goldhaber SZ, Schulman S, Eriksson H, Feuring M, Fraessdorf M, Kreuzer J, Schüler E, Schellong S, Kakkar A
Dabigatran versus Warfarin for Acute Venous Thromboembolism in Elderly or Impaired Renal Function Patients: Pooled Analysis of RE-COVER and RE-COVER II. Thromb Haemost. 2017 11; 117(11):2045-2052.
Dabigatran versus Warfarin for Acute Venous Thromboembolism in Elderly or Impaired Renal Function Patients: Pooled Analysis of RE-COVER and RE-COVER II.
Vedantham S, Goldhaber SZ, Julian JA, Kahn SR, Jaff MR, Cohen DJ, Magnuson E, Razavi MK, Comerota AJ, Gornik HL, Murphy TP, Lewis L, Duncan JR, Nieters P, Derfler MC, Filion M, Gu CS, Kee S, Schneider J, Saad N, Blinder M, Moll S, Sacks D, Lin J, Rundback J, Garcia M, Razdan R, VanderWoude E, Marques V, Kearon C
Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis. N Engl J Med. 2017 12 07; 377(23):2240-2252.
Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis.
Sylvester KW, Ting C, Lewin A, Collins P, Fanikos J, Goldhaber SZ, Connors JM
Expanding anticoagulation management services to include direct oral anticoagulants. J Thromb Thrombolysis. 2018 Feb; 45(2):274-280.
Expanding anticoagulation management services to include direct oral anticoagulants.
Maron BA, Goldhaber SZ, Sturzu AC, Rhee DK, Ali BS, Shah PB, Kirshenbaum JM
Catheter-directed thrombolysis for giant right atrial thrombus. Circ Cardiovasc Imaging. 2010 Jan; 3(1):126-7.
Catheter-directed thrombolysis for giant right atrial thrombus.
Peripherally inserted central catheters: bigger is not necessarily better. Chest. 2011 Jul; 140(1):6-7.
Peripherally inserted central catheters: bigger is not necessarily better.
Chi G, Yee MK, Amin AN, Goldhaber SZ, Hernandez AF, Hull RD, Cohen AT, Harrington RA, Gibson CM
Extended-Duration Betrixaban Reduces the Risk of Rehospitalization Associated With Venous Thromboembolism Among Acutely Ill Hospitalized Medical Patients: Findings From the APEX Trial (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban Trial). Circulation. 2018 01 02; 137(1):91-94.
Extended-Duration Betrixaban Reduces the Risk of Rehospitalization Associated With Venous Thromboembolism Among Acutely Ill Hospitalized Medical Patients: Findings From the APEX Trial (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban Trial).
D'Amico AV, Chen MH, Dosoretz D, Katin M, Salenius S, Ross R, Goldhaber SZ
Coronary artery revascularization and the risk of death in men with prostate cancer. J Urol. 2011 Sep; 186(3):898-902.
Coronary artery revascularization and the risk of death in men with prostate cancer.
Vedantham S, Goldhaber SZ, Kahn SR, Julian J, Magnuson E, Jaff MR, Murphy TP, Cohen DJ, Comerota AJ, Gornik HL, Razavi MK, Lewis L, Kearon C
Rationale and design of the ATTRACT Study: a multicenter randomized trial to evaluate pharmacomechanical catheter-directed thrombolysis for the prevention of postthrombotic syndrome in patients with proximal deep vein thrombosis. Am Heart J. 2013 Apr; 165(4):523-530.e3.
Rationale and design of the ATTRACT Study: a multicenter randomized trial to evaluate pharmacomechanical catheter-directed thrombolysis for the prevention of postthrombotic syndrome in patients with proximal deep vein thrombosis.
Clinical, Interventional, and Investigational Thrombocardiology. Edited by Richard Becker and Rober A. Harrington
Clinical, Interventional, and Investigational Thrombocardiology. Edited by Richard Becker and Rober A. Harrington. 2005.
Creager MA, Dzau VJ, Loscalzo J, eds. Vascular Medicine: A Companion to Braunwald's Heart Disease
Pulmonary Embolism. Creager MA, Dzau VJ, Loscalzo J, eds. Vascular Medicine: A Companion to Braunwald's Heart Disease. 2006; 765-776.
Morrow DA, ed. Cardiovascular Biomarkers: Pathophysiology and Disease Management
Is ther a role for cardiac troponin and toher biomarkers in patients with pulmonary embolism:. Morrow DA, ed. Cardiovascular Biomarkers: Pathophysiology and Disease Management. 2006; 129-137.
Is ther a role for cardiac troponin and toher biomarkers in patients with pulmonary embolism:
Goldhaber SZ, Markis JE, Kessler CM, Meyerovitz MF, Kim D, Vauchan DE, Selwyn AP, Loscalzo J, Dawley DL, Sharma GV
Perspectives on treatment of acute pulmonary embolism with tissue plasminogen activator. Semin Thromb Hemost. 1987 Apr; 13(2):171-7.
Perspectives on treatment of acute pulmonary embolism with tissue plasminogen activator.
When do you order a serum digoxin level?. J Cardiolvasc Med. 1981; 6:570-573.
When do you order a serum digoxin level?
Venous thromboembolism: how to prevent a tragedy. Hosp Pract (Off Ed). 1988 Oct 15; 23(10):164, 169-70, 173-4.
Venous thromboembolism: how to prevent a tragedy.
TPA versus urokinase for pulmonary embolus
TPA versus urokinase for pulmonary embolus. 1992.
Goldhaber S, on behalf of the Steering Committee of the Physician's Health Study
Crepaldi G, Gotto AM, Manzato E, Baggio G, eds. Atherosclerosis VIII
Aspirin and cardiovascular disease in the U.S. Physicians' Health Study. Crepaldi G, Gotto AM, Manzato E, Baggio G, eds. Atherosclerosis VIII. 1989; 719-723.
Aspirin and cardiovascular disease in the U.S. Physicians' Health Study
Sabiston DC, ed. Textbook of Surgery-Update 8
Management of pulmonary embolism. Sabiston DC, ed. Textbook of Surgery-Update 8. 1990; 115-127.
Colman RW, Marder VJ, Clowes AW, George JN, Goldhaber SZ, eds.
Hemostasis and Thrombosis: Basic Principles and Clinical Practice
Hemostasis and Thrombosis: Basic Principles and Clinical Practice. 2006.
Braunwald E, Fauci AS, Hauser SL, Jameson JL, Kasper DL, Longo DL, ed., Harrison's Principles of Internal Medicine
Pulmonary Thromboembolism. Braunwald E, Fauci AS, Hauser SL, Jameson JL, Kasper DL, Longo DL, ed., Harrison's Principles of Internal Medicine. 2001; 1508-1513.
An obsessive-complusive neurotic patient in crisis - Psychiatric Grands Rounds, University of California, San Diego and Curtis W. Gifford Mental Health Center. Western J Med. 1997; 127:120-128.
An obsessive-complusive neurotic patient in crisis - Psychiatric Grands Rounds, University of California, San Diego and Curtis W. Gifford Mental Health Center
Saphenous Vein Bypass Graft Disease, edited by Eric R. Bates and David R. Holmes, JR.
Saphenous Vein Bypass Graft Disease, edited by Eric R. Bates and David R. Holmes, JR. 1998.
Bounameaux H, Simonneau G, ed. Embolie Pulmonaire: Strategies Actuelles de Prise en Charge
Epidemiologie de l'embolie pulmonaire. Bounameaux H, Simonneau G, ed. Embolie Pulmonaire: Strategies Actuelles de Prise en Charge. 1998; 11-20.
Levine MN, Goldhaber SZ, Gore JM, Hirsh J, Califf RM
Hemorrhagic complications of thrombolytic therapy in the treatment of myocardial infarction and venous thromboembolism. Chest. 1995 Oct; 108(4 Suppl):291S-301S.
Sorensen SV, Dewilde S, Singer DE, Goldhaber SZ, Monz BU, Plumb JM
Cost-effectiveness of warfarin: trial versus "real-world" stroke prevention in atrial fibrillation. Am Heart J. 2009 Jun; 157(6):1064-73.
Cost-effectiveness of warfarin: trial versus "real-world" stroke prevention in atrial fibrillation.
Catheter-directed, ultrasound-facilitated fibrinolysis in obese patients with massive and submassive pulmonary embolism. J Thromb Thrombolysis. 2018 Feb; 45(2):257-263.
Catheter-directed, ultrasound-facilitated fibrinolysis in obese patients with massive and submassive pulmonary embolism.
Risk factors for venous thromboembolism. J Am Coll Cardiol. 2010 Jun 29; 56(1):1-7.
Risk factors for venous thromboembolism.
Kang DK, Thilo C, Schoepf UJ, Barraza JM, Nance JW, Bastarrika G, Abro JA, Ravenel JG, Costello P, Goldhaber SZ
CT signs of right ventricular dysfunction: prognostic role in acute pulmonary embolism. JACC Cardiovasc Imaging. 2011 Aug; 4(8):841-9.
CT signs of right ventricular dysfunction: prognostic role in acute pulmonary embolism.
Perlstein TS, Goldhaber SZ, Nelson K, Joshi V, Morgan TV, Lesko LJ, Lee JY, Gobburu J, Schoenfeld D, Kucherlapati R, Freeman MW, Creager MA
The Creating an Optimal Warfarin Nomogram (CROWN) Study. Thromb Haemost. 2012 Jan; 107(1):59-68.
The Creating an Optimal Warfarin Nomogram (CROWN) Study.
Prevention of pulmonary embolism: The nonpharmacological approach. Morpurgo M, ed., Pulmonary Embolism. 1994; 261-270.
Prevention of pulmonary embolism: The nonpharmacological approach
Aspirin: Benefits and limitations. 1994.
Medical patients. Goldhaber SZ, ed. Prevention of Venous Thromboembolism. 1993; 485-496.
Goldhaber SZ, Ridker PM, ed., Thrombosis an Thromboembolism
Thrombolysis in pulmonary embolism. Goldhaber SZ, Ridker PM, ed., Thrombosis an Thromboembolism. 2002; 247-259.
Loscalzo J, Creager MA, Dzau VJ, eds., Vascular Medicine
Pulmonary Embolism. Loscalzo J, Creager MA, Dzau VJ, eds., Vascular Medicine. 1996; 1069-1079.
Interpreting Electrocardiograms: Using Basic Principles and Vector Concepts, edited by J. Willis Hurst
Interpreting Electrocardiograms: Using Basic Principles and Vector Concepts, edited by J. Willis Hurst. 2001.
Possible Requiem: trial-and-error warfarin dosing. Blood. 2007; (110):1404-1405.
Possible Requiem: trial-and-error warfarin dosing
Goldman L, Braunwald E, eds., Primary Cardiology
Reogniction and management of patients with pulmonary embolism, deep venous thrombosis, and cor pulmonale. Goldman L, Braunwald E, eds., Primary Cardiology. 1998; 468-486.
Reogniction and management of patients with pulmonary embolism, deep venous thrombosis, and cor pulmonale
Profiles in pulmonary embolism and pulmonary hypertension. Baim DS, ed. Grossman's Cardiac Catheterization, Angiography, and Intervention. 2006; 677-724.
Profiles in pulmonary embolism and pulmonary hypertension
Venous thromboembolism in patients with active cancer. Thromb Haemost. 2007 Sep; 98(3):656-61.
Venous thromboembolism in patients with active cancer.
Occurence of venous thromboembolism in a randomized trial of low-dose aspirin. Ann Internal Med. 2007; (116):1497-1503.
Occurence of venous thromboembolism in a randomized trial of low-dose aspirin
Venous Thromboembolism "Handbook" on the BICS computer system
Venous Thromboembolism "Handbook" on the BICS computer system. 1992.
Yusuf S, Collins R, Peto R, Furberg C, Stampfer MJ, Goldhaber SZ, Hennekens CH
Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials. Eur Heart J. 1985 Jul; 6(7):556-85.
Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials.
Goldhaber SZ, White HD, Holman BL, Nesto RW, Mudge GH, Muller JE, Kozlowski J, Wynne J
Prevention by nifedipine of cold pressor-induced decrease in left ventricular ejection fraction. J Am Coll Cardiol. 1983 Jun; 1(6):1512-7.
Prevention by nifedipine of cold pressor-induced decrease in left ventricular ejection fraction.
Utilization of venous thromboembolism prophylaxis in the medical intensive care unit. Chest. 1994 Jul; 106(1):13-4.
Utilization of venous thromboembolism prophylaxis in the medical intensive care unit.
Hirsch DR, Mikkola KM, Marks PW, Fox EA, Dorfman DM, Ewenstein BM, Goldhaber SZ
Pulmonary embolism and deep venous thrombosis during pregnancy or oral contraceptive use: prevalence of factor V Leiden. Am Heart J. 1996 Jun; 131(6):1145-8.
Pulmonary embolism and deep venous thrombosis during pregnancy or oral contraceptive use: prevalence of factor V Leiden.
Nicolaides A, Goldhaber SZ, Maxwell GL, Labropoulos N, Clarke-Pearson DL, Tyllis TH, Griffin MB
Cost benefit of intermittent pneumatic compression for venous thromboembolism prophylaxis in general surgery. Int Angiol. 2008 Dec; 27(6):500-6.
Cost benefit of intermittent pneumatic compression for venous thromboembolism prophylaxis in general surgery.
Improving clinical effectiveness in thromboprophylaxis for hospitalized medical patients. Am J Med. 2009 Mar; 122(3):230-2.
Improving clinical effectiveness in thromboprophylaxis for hospitalized medical patients.
Ask the doctor. A year ago, I had an orchiectomy for prostate cancer; my PSA is now 0.74. Not long afterward, I had two cardiac stents implanted. I still have some angina and shortness of breath. I started Ranexa a couple of weeks ago, which helps my angina. Do you have any suggestions for my heart since I no longer make testosterone, which I understand helps protect men's hearts and arteries. Harv Heart Lett. 2010 Jul; 20(11):8.
Ask the doctor. A year ago, I had an orchiectomy for prostate cancer; my PSA is now 0.74. Not long afterward, I had two cardiac stents implanted. I still have some angina and shortness of breath. I started Ranexa a couple of weeks ago, which helps my angina. Do you have any suggestions for my heart since I no longer make testosterone, which I understand helps protect men's hearts and arteries.
Management of submassive pulmonary embolism. Circulation. 2010 Sep 14; 122(11):1124-9.
Management of submassive pulmonary embolism.
Parker JA, Markis JE, Palla A, Goldhaber SZ, Royal HD, Tumeh S, Kim D, Rustgi AK, Holman BL, Kolodny GM
Pulmonary perfusion after rt-PA therapy for acute embolism: early improvement assessed with segmental perfusion scanning. Radiology. 1988 Feb; 166(2):441-5.
Pulmonary perfusion after rt-PA therapy for acute embolism: early improvement assessed with segmental perfusion scanning.
Anticoagulation in dilated cardiomyopathy. J Am Coll Cardiol. 1998 Mar 15; 31(4):745-8.
Anticoagulation in dilated cardiomyopathy.
Deep venous thrombosis: early discharge strategies and outpatient management. J Thromb Thrombolysis. 1999 Apr; 7(2):113-22.
McHugh KB, Visani L, DeRosa M, Covezzoli A, Rossi E, Goldhaber SZ
Gender comparisons in pulmonary embolism (results from the International Cooperative Pulmonary Embolism Registry [ICOPER]). Am J Cardiol. 2002 Mar 01; 89(5):616-9.
Gender comparisons in pulmonary embolism (results from the International Cooperative Pulmonary Embolism Registry [ICOPER]).
Echocardiography in the management of pulmonary embolism. Ann Intern Med. 2002 May 07; 136(9):691-700.
Echocardiography in the management of pulmonary embolism.
Prognostic role of brain natriuretic peptide in acute pulmonary embolism. Circulation. 2003 May 27; 107(20):2545-7.
Prognostic role of brain natriuretic peptide in acute pulmonary embolism.
Aguilar D, Goldhaber SZ, Gans DJ, Levey AS, Porush JG, Lewis JB, Rouleau JL, Berl T, Lewis EJ, Pfeffer MA
Clinically unrecognized Q-wave myocardial infarction in patients with diabetes mellitus, systemic hypertension, and nephropathy. Am J Cardiol. 2004 Aug 01; 94(3):337-9.
Clinically unrecognized Q-wave myocardial infarction in patients with diabetes mellitus, systemic hypertension, and nephropathy.
Imaging. Improving healthcare delivery. Lancet. 1998 Dec 19-26; 352 Suppl 4:SIV17.
Pulmonary embolism thrombolysis improves survival in massive pulmonary embolism. J Thrombosis and Thrombolysis. 1995; 2:219-220.
Goldhaber SZ, ed. Atlas of Heart Diseases, Volume III, Cardiopulmonary Diseases and Cardiac Tumors, Braunwald E, Series Ed.
Treatment of venous thrombosis. Goldhaber SZ, ed. Atlas of Heart Diseases, Volume III, Cardiopulmonary Diseases and Cardiac Tumors, Braunwald E, Series Ed. 1995; 12.1-12.14.
In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J, ed., Harrison's Principles of Internal Medicine
Deep Vein Thrombosis and Pulmonary Embolism. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J, ed., Harrison's Principles of Internal Medicine. 2008; 1651-1657.
Adult Cardiology Self-Assessment Program
Cardiopulmonary disease. Adult Cardiology Self-Assessment Program. 1993; 9.6-9.8.
Nonspecific elevation of troponin I. ACC Current Journal Review. 1998; 7:29-31.
Strategies for diagnosis. Goldhaber SZ, ed. Pulmonary Embolism and Deep Venous Thrombosis. 1985; 79-97.
Braunwald E, Zipes DP, Libby P, ed., Heart Disease
Pulmonary Embolism. Braunwald E, Zipes DP, Libby P, ed., Heart Disease. 2001; 1886-1907.
Delays in diagnosis of deep vein thrombosis and pulmonary embolism. Chest. 2005 Nov; 128(5):3372-6.
Delays in diagnosis of deep vein thrombosis and pulmonary embolism.
Goldhaber SZ, Meyerovitz MF, Green D, Vogelzang RL, Citrin P, Heit J, Sobel M, Wheeler HB, Plante D, Kim H
Randomized controlled trial of tissue plasminogen activator in proximal deep venous thrombosis. Am J Med. 1990 Mar; 88(3):235-40.
Randomized controlled trial of tissue plasminogen activator in proximal deep venous thrombosis.
Goldhaber SZ, Rubin IL, Brown W, Robertson N, Stubblefield F, Sloss LJ
Valvular heart disease (aortic regurgitation and mitral valve prolapse) among institutionalized adults with Down's syndrome. Am J Cardiol. 1986 Feb 01; 57(4):278-81.
Valvular heart disease (aortic regurgitation and mitral valve prolapse) among institutionalized adults with Down's syndrome.
High frequency of mitral valve prolapse and aortic regurgitation among asymptomatic adults with Down's syndrome. JAMA. 1987 Oct 02; 258(13):1793-5.
High frequency of mitral valve prolapse and aortic regurgitation among asymptomatic adults with Down's syndrome.
Exercise and the Heart in Health and Disease: Second Edition, Revised and Expanded, edited by Roy J. Shephard and Henry S. Miller, Jr.
Exercise and the Heart in Health and Disease: Second Edition, Revised and Expanded, edited by Roy J. Shephard and Henry S. Miller, Jr. . 1999.
Schulman S, Kearon C, Kakkar AK, Schellong S, Eriksson H, Baanstra D, Kvamme AM, Friedman J, Mismetti P, Goldhaber SZ
Extended use of dabigatran, warfarin, or placebo in venous thromboembolism. N Engl J Med. 2013 Feb 21; 368(8):709-18.
Extended use of dabigatran, warfarin, or placebo in venous thromboembolism.
Colman RW, Marder VJ, Clowes AW, George JN, Goldhaber SZ, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice
Anticoagulation clinics. Colman RW, Marder VJ, Clowes AW, George JN, Goldhaber SZ, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. 2006; 1689-1698.
Venous Thromboembolism Guidebook- Second Edition
Venous Thromboembolism Guidebook- Second Edition. 1997.
Braunwald E, ed., Goldhaber SZ, Guest Ed., Essential Atlas of Heart Disease
Cor pulmonale, primary pulmonary hypertension, and cardiac tumors. Braunwald E, ed., Goldhaber SZ, Guest Ed., Essential Atlas of Heart Disease. 2001; 307-322.
Cor pulmonale, primary pulmonary hypertension, and cardiac tumors
Medical risk factors. Goldhaber SZ, ed. Prevention of Venous Thromboembolism. 1993; 51-68.
Wier EK, Archer SL, Reeves JT, eds. The Diagnosis and Treatment of Pulmonary Hypertension
Effects of lytic therapy in pulmonary embolism. Wier EK, Archer SL, Reeves JT, eds. The Diagnosis and Treatment of Pulmonary Hypertension. 1992; 297-310.
Effects of lytic therapy in pulmonary embolism
Deep vein thrombosis in the elderly. Clin Appl Thromb/Hemostasis. 2008; 14:393-398.
The ACTIVE Writing Group on behalf of the ACTIVE Investigators
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the atrial fibrillation colpidogrel trial with irbesartan for prevention of vascular events (ACTIVE W): A randomized controlled trial. Lancet. 2006; 367:1903-1912.
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the atrial fibrillation colpidogrel trial with irbesartan for prevention of vascular events (ACTIVE W): A randomized controlled trial
Arrhythmias. May H, ed. Emergency Medicine. 1984; 129-152.
Atlas of Coronary Balloon Angioplasty, Bernhard Meier and Vivek K. Mehan
Atlas of Coronary Balloon Angioplasty, Bernhard Meier and Vivek K. Mehan. 1995.
Wright SA, Sawyer DB, Sacks DB, Chyu S, Goldhaber SZ
Elevation of troponin I levels in patients without evidence of myocardial injury. JAMA. 1997 Dec 24-31; 278(24):2144.
Elevation of troponin I levels in patients without evidence of myocardial injury.
Venous thromboembolism prophylaxis in the craniotomy patient: an editorial. Surg Neurol. 1998 Aug; 50(2):182-3.
Venous thromboembolism prophylaxis in the craniotomy patient: an editorial.
Goldhaber SZ, Buring JE, Lipnick RJ, Stubblefield F, Hennekens CH
Interruption of the inferior vena cava by clip or filter. Am J Med. 1984 Mar; 76(3):512-6.
Interruption of the inferior vena cava by clip or filter.
Schorge JO, Goldhaber SZ, Duska LR, Goodman A, Feldman S
Clinically significant venous thromboembolism after gynecologic surgery. J Reprod Med. 1999 Aug; 44(8):669-73.
Clinically significant venous thromboembolism after gynecologic surgery.
Goldhaber SZ, Kessler CM, Heit JA, Elliott CG, Friedenberg WR, Heiselman DE, Wilson DB, Parker JA, Bennett D, Feldstein ML
Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial. J Am Coll Cardiol. 1992 Jul; 20(1):24-30.
Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial.
Tributes to Lewis Dexter. Tex Heart Inst J. 2001; 28(3):238.
Effectiveness and safety of long-term anticoagulation of patients >/=90 years of age with atrial fibrillation. Am J Cardiol. 2002 Dec 15; 90(12):1397-8.
Effectiveness and safety of long-term anticoagulation of patients >/=90 years of age with atrial fibrillation.
Comerota AJ, ed., Thrombolytic therapy for peripheral vascular disease
Thrombolytic therapy for pulmonary embolism. Comerota AJ, ed., Thrombolytic therapy for peripheral vascular disease. 1995; 161-174.
Thrombolytic therapy for pulmonary embolism
Ingwall JS, Goldhaber SZ, Roeske WR, Wildenthal K
Nathanielsz PW, ed. Animal Models in Fetal Medicine (II)
Mouse hearts in organ culture: a preparation for studying fetal cardiac function, structure, and metabolism. Nathanielsz PW, ed. Animal Models in Fetal Medicine (II). 1982; 196-217.
Mouse hearts in organ culture: a preparation for studying fetal cardiac function, structure, and metabolism
Cardiac Rehabilitation: A Guide to Practice in the 21st Century, edited by Nanette K. Wnger, L. Kent Smith, Erika Sivarajan Froelicher, and Patricia McCall Comoss
Cardiac Rehabilitation: A Guide to Practice in the 21st Century, edited by Nanette K. Wnger, L. Kent Smith, Erika Sivarajan Froelicher, and Patricia McCall Comoss. 1999.
The role of antiplatelet agents in patients with peripheral vascular disease. Vascular Medicine Review. 1995; 6:109-119.
The role of antiplatelet agents in patients with peripheral vascular disease
The Endothelium in Clinical Practice: Source and Target of Novel Therapies, edited by Gabor M. Rubanyi and Victor J. Dzau
The Endothelium in Clinical Practice: Source and Target of Novel Therapies, edited by Gabor M. Rubanyi and Victor J. Dzau. 1997.
Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD, ed., Haemostasis and Thrombosis
Epidemiology of pulmonary embolism and deep vein thrombosis. Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD, ed., Haemostasis and Thrombosis. 1994; 1327-1333.
Epidemiology of pulmonary embolism and deep vein thrombosis
Cardiovascular Plaque Rupture. Edited by David L. Brown
Cardiovascular Plaque Rupture. Edited by David L. Brown. 2002.
Controversies surrounding long-term anticoagulation of very elderly patients in atrial fibrillation. Chest. 1998 Apr; 113(4):1115-8.
Controversies surrounding long-term anticoagulation of very elderly patients in atrial fibrillation.